







































Frontotemporal" lobar" degenerations" (FTLD)" represent" a" group" of" neurodegenerative"
conditions"characterised"by" their"often"overlapping"but"yet"diverse"clinical," radiological"
and"pathological"features."Clinically"they"may"manifest"as"either"a"behavioural"syndrome,"
termed" behavioural" variant" frontotemporal" dementia" (bvFTD)" or" as" a" language" led"
dementia,"termed"primary"progressive"aphasia"(PPA).""
"
The" same" protein" can" cause" multiple" disease" phenotypes," whilst" the" same" clinical"
phenotype"may"result"from"any"of"several"different"proteinopathies."Our"understanding"
of" this" apparent" divergence" (or" indeed" convergence)" remains" poor." The" concept" of"
networkSled" neurodegeneration" may" offer" an" explanation." This" suggests" that" specific"
brain"networks"are"vulnerable"to"certain"proteins"and"an"attack"on"certain"brain"networks"




of" white" matter" and" as" it" is" white" matter" that" binds" functional" networks" together,"








initial"chapters"will" set"out" to"establish" these"changes" in"both"clinically"and"molecularly"




the" spectrum" of" FTLD" using" advanced" imaging" methods." " Secondary" aims" include"
establishing" the" role"of"DTI"as"a"potential" imaging"biomarker" for" future"clinical" trials" in"





























































































































































3.( CrossFsectional( profiles( of( white( matter( disease( in( behavioural( variant(
frontotemporal(dementia((
3.1(Comparison(of( fractional( anisotropy(changes( in( studies(of( frontotemporal(dementia(using(diffusion(
tensor(imaging.(Tracts(listed(are(bilateral(unless(otherwise(stated.(A(statistical(threshold(of(p(<0.05(was(
used(for(citing(tracts(with(significant(change(from(individual(papers.((






3.5( Summary( of( adjusted( diffusivity( data( by( diffusivity(metric( and( region(of( interest( comparing( bvFTD(
with( healthy( controls( after( adjustment( for( global( diffusivity.( Results( are( ordered( by( %( of( tract(
involvement.(
3.6( Summary( of( diffusivity( data( indicating( regions( of( interest(with( greater(white(matter( pathology( in(
those( with( bvFTD( when( compared( with( Alzheimer’s( disease),( after( adjustment( for( global( mean(
diffusivity.( Each( DTI( metric( was( contrasted( in( both( directions( only( results( surviving( FWE( correction(
p<0.05(are(displayed(above.(Results(are(ordered(by(%(of(tract(involvement.(
3.7( Summary( of( diffusivity( data( indicating( regions( of( interest(with( greater(white(matter( pathology( in(
those( with( Alzheimer’s( disease( (AD)( when( compared( with( bvFTD,( after( adjustment( for( global( mean(















time)( of( all( bvFTD( (n=23)( participants( with( control( participants( after( adjustment( for( age,( gender( and(
disease(duration.(^(Total(scores(on(the(TASIT(are(scaled(scores.((




4.4( Baseline( FA( for( individual( white( matter( regions( of( interest( for( control( participants( and( patients.(
*Linear( regression( comparing( bvFTD( (n=19)( with( controls( after( adjusting( for( age,( gender( and( disease(
duration.(Data(is(uncorrected(for(multiple(comparisons.(
4.5( Baseline( MD( for( individual( white( matter( regions( of( interest( for( control( participants( and( patients.(
*Linear( regression( comparing( bvFTD( (n=19)( with( controls( after( adjusting( for( age,( gender( and( disease(
duration.(Data(is(uncorrected(for(multiple(comparisons.(
4.6( Baseline( RD( for( individual( white( matter( regions( of( interest( for( control( participants( and( patients.(
*Linear( regression( comparing( bvFTD( (n=19)( with( controls( after( adjusting( for( age,( gender( and( disease(
duration.(Data(is(uncorrected(for(multiple(comparisons.(
4.7( Baseline( AX( for( individual( white( matter( regions( of( interest( for( control( participants( and( patients.(














5.( CrossFsectional( signatures( of( white( matter( disease( in( the( primary( progressive(
aphasias(
5.1( Comparison( of( FA( changes( in( DTI( studies( of( PPA.( Results( reported( reflect(most( statistically( robust(
findings((for(present(study,(only(significance(values(p<0.01(are( included(here;(see(also(Table(5.2( to(5.5).(
*=only( left( hemispheric( tracts( reported.( ( ^=Results( reported( based( on( authors( figures.( nt( =( data( not(
reported/tested,( F( indicates( no( significant( result( found.( 1=Arcuate( and( frontoFparietal( SLF,( 2=Genu,(





5.3.( Profiles( of( changes( in( FA( in( each( PPA( groups( compared( with( healthy( controls.( Results( are( FWE(
corrected(p(<0.05.(Results(are(ordered(by(%(of(tract(involvement.((
5.4.( Profiles( of( changes( in( AX( in( each( PPA( groups( compared( with( healthy( controls.( Results( are( FWE(
corrected(p(<0.05.(Results(are(ordered(by(%(of(tract(involvement.(
5.5.( Profiles( of( changes( in( RD( in( each( PPA( group( compared( with( healthy( controls.( Results( are( FWE(
corrected(p(<0.05.(Results(are(ordered(by(%(of(tract(involvement.(









6.1.( Study( participants’( clinical( and( imaging( characteristics.( Linear( regression( comparing( controls( with(
each( PPA( subFgroup,( §( Fisher’s( exact( test.( ( *( BBSI( is( only( available( for( 8( patients( with( nvPPA( due( to(
significant(motion(artefact(in(either(baseline(or(followFup(scan.(
6.2.( Neuropsychological( performance( at( baseline( and( longitudinally( displayed( as( estimated( mean(
difference( from( controls( with( change( expressed( as( a( percentage( per( year.( *Indicates( baseline( values(
signifantly((p<0.05)(different(from(controls.(Bold(values(indicate(significant((p<0.05)(change(over(time.(((
6.4( Baseline( FA( values( and( estimated( mean( differences( within( white( matter( regions( of( interest(
comparing( control( participants( and( PPA( syndromic( groups.( *( pFvalue( following( linear( regression(
comparing(PPA( syndromic(group(with( controls( adjusting( for( age,(gender( and(disease(duration.(Data( is(
uncorrected(for(multiple(comparisons.(
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6.5( Baseline( MD( values( and( estimated( mean( differences( within( white( matter( regions( of( interest(
comparing( control( participants( and( PPA( syndromic( groups.( *( pFvalue( following( linear( regression(
comparing(PPA(syndromic(groups(with(controls(adjusting(for(age,(gender(and(disease(duration.(Data( is(
uncorrected(for(multiple(comparisons.(
6.6( Baseline( RD( values( and( estimated( mean( differences( within( white( matter( regions( of( interest(
comparing( control( participants( and( PPA( syndromic( groups.( *( pFvalue( following( linear( regression(
comparing(PPA(syndromic(groups(with(controls(adjusting(for(age,(gender(and(disease(duration.(Data( is(
uncorrected(for(multiple(comparisons.(
6.7( Baseline( AX( values( and( estimated( mean( differences( within( white( matter( regions( of( interest(
comparing( control( participants( and( PPA( syndromic( groups.( *( pFvalue( following( linear( regression(
comparing(PPA( syndromic(group(with( controls( adjusting( for( age,(gender( and(disease(duration.(Data( is(
uncorrected(for(multiple(comparisons.(
6.8( Estimated( percentage( per( year( difference( in( the( rate( of( change( for( each( DTI( metric( for( nonF










7.1(Overview(of(WM( tract( involvement( in( bvFTD( crossFsectionally( and( longitudinally( based(on( FA(data.(
CrossFsectional( data:( ++++( >50%( tract( involved,( +++( 25F50%,( ++( 10F25%,( +( 5F10%,( blank( minimal/no(
involvement.(Longitudinal(data:(+++(>10%/year(change,(++(5F10%/year(change(+,(2.5F5%/year(change,(blank(
<2.5%/year(change.(
7.2( Overview( of( WM( tract( involvement( in( PPA( crossFsectionally( and( longitudinally( based( on( FA( data.(
CrossFsectional( data:( ++++( >50%( tract( involved,( +++( 25F50%,( ++( 10F25%,( +( 5F10%,( blank( minimal/no(
involvement.(Longitudinal(data:(+++(>10%/year(change,(++(5F10%/year(change(+,(2.5F5%/year(change,(blank(
<2.5%/year(change.(Key:(ns,(not(studied(longitudinally.(
7.3( Overview( of( individual( DTI(metrics( performance( reflecting( potential( as( a( disease( biomarker.( Table(















direction( of( diffusion( in( each( direction.( The( ellipsoid( is( shown( in( relationship( to( the( normal( geometry(
within(the(scanner((x,(y(and(z).(
1.3( Representation( of( major( brain( networks/brain( regions( and( the( white( matter( connections( that( link(
them.(Green(circles(represent( the(Salience(network((ACC,(anterior(cingulate(cortex;(FrIns,(FrontFinsular(
cortex);( orange( circles( represent( the( default( mode( network( (PCC,( posterior( cingulate( cortex;( Prec,(
precuneus);(blue( circles( represents( the( frontoFparietal( control(network( (DLPFC,(dorsolateral(prefrontal(
cortex;(TPJ,(temporoFparietal(junction)(and(red(circle(represents(the(executive(control(network((DMPFC,(































DTI(metrics( (AX,(FA,(RD,(TR)(are( shown(separately.(The(colour( scale( indexes(P(values(after( familyFwise(
error(correction(for(multiple(comparisons(over(the(whole(brain.(
3.6(Patterns(of(white(matter(alteration( in( the(MAPT(and(C9ORF72(mutation(groups(compared(with( the(
healthy(control(group(and( the(AD(group,(after( correction( for(mean(global(diffusivity(value.(The(colour(
scale(indexes(P(values(after(familyFwise(error(correction(for(multiple(comparisons(over(the(whole(brain.(
3.7(ROC(curves(for(classification(of(individuals(to(the(bvFTD(group(and(healthy(control(group((left)(or(AD(
group( (right),( based( on( each( participant's( global(mean( diffusivity( data( (above)( and( each( participant's(
unadjusted(mean(diffusivity(data(within(a(tract(region(of(interest((below).(ROC(curves(for(particular(DTI(
metrics( (AX,( FA,( RD,( TR)( and(white(matter( tracts( of( interest( (CB,( CC,( UF)( are( shown( separately;( areaF
underFcurve(is(displayed(for(each(curve((areaFunderFcurve(=(1(corresponds(to(ideal(separation(of(groups).(
3.8(Maps(of(grey(matter((GM)(atrophy((light(blue)(and(regions(of(intersection(of(all(four(white(matter(DTI(
metrics( (adjusted( for( mean( global( diffusivity( value)( in( the( bvFTD( group( compared( with( the( healthy(
control(group.(Maps(are(overlaid(on( representative(coronal( sections(of( the(MNI152( template(brain;( the(
right(hemisphere((R)(is(shown(on(the(left.(The(diffusivity(tensor((DT)(metric(data(intersection(colour(scale(








4.2( Individual( trajectories( of( change( in( FA( over( time(within( right( and( left( uncinate( fasciculus.( The( red(
dashed(line(indicates(mean(trajectory.(
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4.3( Individual( trajectories( of( change( in( FA( over( time(within( the( body( of( the( corpus( callosum.( The( red(
dashed(line(indicates(mean(trajectory.(
(
5.( CrossFsectional( profiles( of( white( matter( pathology( in( the( primary( progressive(
aphasias.(
5.1.( Patterns( of( decreased( FA( in( PPA( groups( compared( with( controls.( Results( are( overlaid( on(








5.3.( Patterns( of( increased( TR( in( PPA( groups( compared( with( controls.( Results( are( overlaid( on(
representative( sections( derived( from( the( FA( skeleton.( For( coronal( and( axial( sections,( the( right(
hemisphere(is(shown(on(the(left.(The(colour(scale(indexes(P(values(after(familyFwise(error(correction(for(
multiple(comparisons(over(the(whole(brain.(
5.4.( Top( panel( shows( areas( of( altered( white( matter( in( svPPA( compared( with( AD( patients;( indicating(
profiles( of( increased( AX( (top),( RD( (middle)( and( TR( (bottom).( Results( are( overlaid( on( representative(
sections((MNI(coFordinates(shown(on( left)(derived(from(the(average(FA(skeleton.(For(coronal(and(axial(
sections,( the( right( hemisphere( is( shown( on( the( left.( The( colour( bar( (bottom)( codes( significance( (FWE(
corrected(pFvalue).((
5.5.(Patterns(of(altered(diffusivity((decreased(FA(and(increased(AX/RD/TR)(in(AD(compared(with(healthy(
controls.( Results( are( overlaid( on( representative( sections( derived( from( the( average( FA( skeleton.( For(













6.1( Individual( trajectories(of(change( in(FA( (yFaxis)(over( time( (xFaxis( in(years)(within(body(of( the(corpus(
callosum(in(each(PPA(syndrome.(The(red(dashed(line(indicates(mean(trajectory.((















































































































and" neuroimaging" phenotypes." FTLD," whilst" relatively" uncommon," results" in" a"
devastating" clinical" syndrome" causing" a" progressive" dementia," affecting" particularly"
those"under"the"age"of"sixtySfive"(Ratnavalli"et"al.,"2002),"and"is"increasingly"recognized"as"
a"cause"of"dementia"in"older"age"groups."Over"the"last"two"decades"a"substantial"body"of"
clinical," genetic," imaging" and" pathological" data" has" been" amassed," improving" our"
understanding"of" these"disorders."Despite" this" limited"data"exisits"on" the" role"of"white"
matter" pathology" in" FTLD." Understanding" the" profiles" of" white" matter" pathology" is"
important" in" further"unravelling" the" complex"neurobiology"of" these"disorders"and"may"
help" link" clinical" phenotypes" with" molecular" alterations" in" the" brains" of" patients" with"
FTLD."The"principle"aim"of" this"Thesis" is" to"provide"a"detailed"characterization"of"white"
matter" tract" pathology" across" the" spectrum" of" FTLD" using" both" crossSsectional" and"
longitudinal" diffusion" tensor" imaging" (DTI)." This" introductory" chapter" will" provide" an"
overview" of" the" clinical" syndromes" of" FTLD" and" outline" previous" major" neuroimaging"
studies."It"will"also"discuss"how"DTI"can"be"used"to"examine"WM"in"vivo"and"thus"provide"
an" understanding" of" changes" to" structural" brain" connectivity" in" neurodegenerative"
disorders."A"methodology" chapter"will" outline" the" inclusion" criteria" for" the" subsequent"
experiments" along" with" detailed" methods" on" imaging" data" acquisition" and" analysis."
Chapters" 3" and" 5" will" examine" crossSsectional" white" matter" pathology," first" in" the"
behavioural" variant" of" frontotemporal" dementia" (bvFTD)" and" then" in" the" primary"
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This"was" the" first"attempt" to"distinguish" relatively" focal"patterns"of"brain"atrophy" from"
the" more" generalised" brain" atrophy" of" senile" dementia." Whilst" these" reports" of" focal"
neurodegeneration" are" over" 100" years" old"we" still" do" not" understand" the"mechanisms"
that"lead"to"such"focal"patterns"of"brain"degeneration."Over"the"subsequent"decades"the"
pathology"of"these"conditions"was"differentiated"from"Alzheimer’s"disease"(AD),"with"the"
characteristic" spongiosis" and"Pick"bodies"being" identified" in" 1922" (Gans," 1922),"which" in"
fact"turned"out"to"be"just"one"pathological"subtype"of"this"diverse"group"of"diseases."In"
the" following" decades" psychologists" and" behavioural" neurologists" continued" to" refine"
the" clinical" phenotype" of" these" disorders." In" 1975" a" dementia" with" a" core" feature" of"




clinical"characterisation"of"bvFTD" led"to"the" first"consensus"criteria" (Neary"et"al.," 1998),"
which" aimed" to" improve" diagnosis" and" allowing" a" more" standardised" approach" to"
performing"research"in"this"area."Also"around"this"time"the"familial"aspect"of"FTLD"came"
under" close" scrutiny" with" several" families" identified" as" having" dementia" with"
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parkinsonism,"with"affected"family"members"having"linkage"on"chromosome"17"(Lynch"et"
al.," 1994)." These" individuals" would" latter" be" identified" as" having" a" mutation" in" the"
microtubule+ associated+ protein+ tau+ (MAPT)+ (Hutton" et" al.," 1998)." It" was" also" becoming"
clear" that"many" patients,"who" had" the" same" clinical" features," had" different" underlying"
pathologies."This" in" stark"contrast" to" the"vast"majority"of"patients"who"presented"with"
episodic" memory" problems," who" at" autopsy" had" the" hallmarks" of" AD," namely" betaS
amyloid"plaques" and" tau" tangles" (Braak" and"Braak," 1996)."Whilst" Pick’s" bodies" and" tau"
deposition"was"seen"in"many"patients"with"clinical"syndromes"of"bvFTD"and"PPA"a"large"
proportion" had" an" alternate," more" nonSspecific" proteinopathy," termed" ubiquitin." This"
included"patients"with"apparently"sporadic"and"familial"disease,"as"well"as"patients"with"
different" phenotypes" of" either" a" behavioural" led" (bvFTD)" or" language" lead" (PPA)"
dementia.""
"
With" the" increasing" availability" of"magnetic" resonance" imaging" (MRI)" in" the" 1990’s" the"
neuroimaging"phenotype"of"FTLD"associated"syndromes"began"to"emerge,"with"specific"
profiles"of"brain"atrophy"emerging"at"both"clinical"and"pathological" levels,"which"will"be"
discussed" in" the" subsequent" section." In" 2006" ubiquitin" was" identified" as" the" protein"
Transactive"Repeat"DNA"binding"protein"43"(TDP843)"(Neumann"et"al.,"2006)."It"was"also"




autosomal"dominant" fashion" (Rohrer"et" al.," 2009)," in" addition" this"data" suggested" that"
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other"genes"causing"FTLD"were"to"still"to"be"identified"(Vance"et"al.,"2006)."Most"recently"
the" third" major" genetic" cause" of" FTLD" has" been" identified," which" is" a" hexanucleotide"
repeat" expansion" located" on" chromosome" 9" open" reading" frame" 72," the" C9ORF72+
mutation"(DejesusSHernandez"et"al.,"2011;"Renton"et"al.,"2011)."This"genetic"discovery"has"
also"provided"molecular"validity"for"the"overlap"commonly"seen"between"motor"neurone"
disease" and" frontotemporal" dementia" (FTD)." The" degree" to" which" FTLD" might" be"
inherited" is" significant," as" presymptomatic" mutation" carriers" provide" a" population" in"
which" to" characterise" the" diseases" natural" history." This"may" allow" the" identification" of"
preclinical" disease" states" through" the" identification" of" clinical," chemical" or" radiological"
biomarkers," with" potential" therapeutic" implications" for" both" presymptomatic" and"
affected" individuals."More" recently" the" clinicoSpathological" criteria" for" FTLD" have" been"







Throughout" subsequent" chapters" the" term" biomarker" will" be" used," it" is" therefore"
important" to" provide" some" background" and" guidance" as" to" what" constitutes" an"
appropriate" biomarker." The$ term$ biomarker,$ or$ biological$ marker,$ has$ become$
commonplace$ in$medical$ literature$ and$ it$ broadly$ relates$ to$ a$means$with$which$one$ can$
detect$and$monitor$a$response$to$a$treatment$or$detect$a$particular$disease$state.$Prior$to$a$
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discussion$ on$ the$ role$ of$ potential$ novel$ biomarkers$ in$ FTLD$ it$ is$ important$ to$ provide$
further$ details$ on$ what$ constitutes$ a$ biomarker,$ and$ indeed$ what$ makes$ for$ a$ useful$
biomarker.$Early$definitions$of$a$biomarker$tended$to$focus$on$areas$of$drug$safety$and$drug$
discovery.$Over$time$the$concept$of$what$constitutes$a$biomarker$has$broadened.$ In$1993$
The$ World$ Health$ Organisation$ provided$ a$ definition$ of$ a$ biomarker$ as$ “any$ substance,$
structure,$ or$ process$ that$ can$ be$measured$ in$ the$ body$ or$ its$ products$ and$ influence$ or$
predict$the$incidence$of$outcome$or$disease”$and$more$broadly$$“almost$any$measurement$
reflecting$an$interaction$between$a$biological$system$and$a$potential$hazard”$(WHO,$1993).$$
More$ recently$ in$ 2001,$ a$ framework$ for$ the$ development$ of$ biomarkers$ was$ proposed$
(“Biomarkers$ and$ surrogate$ endpoints,”$ 2001).$ This$ framework$ provided$ a$ further$
expansion$of$the$concept$of$biomarkers$and$defined$a$biomarker$as$“a$characteristic$that$is$
objectively$ measured$ and$ evaluated$ as$ an$ indicator$ of$ normal$ biological$ processes,$
pathogenic$ processes,$ or$ pharmacologic$ responses$ to$ a$ therapeutic$ intervention.”$ In$
addition$ the$ role$ of$ biomarkers$ as$ a$ diagnostic$ tools,$ as$ a$ means$ to$ stage$ and$ provide$
prognostic$information$on$a$disease$state,$and$as$means$of$assessing$disease$response$to$a$
particular$intervention$has$also$been$emphasised.$From$a$pragmatic$standpoint$a$biomarker$
should$ be$ clinically$ relevant,$ reflecting$ how$ a$ patient$ feels$ or$ functions,$ it$ should$ be$
reproducible$ and$ it$ should$ be$ reasonably$ and$ safely$ accessible.$ With$ regards$ to$
neurodegenerative$ diseases$ biomarkers$ should$ reflect$ the$ clinical$ changes$ reported$ by$
patients$ and/or$ careers.$ Biomarkers$ should$ be$ able$ to$ reflect$ clinical$ endpoints,$ which$
characterised$in$the$most$finite$terms$would$be$reflect$either$a$patient$being$either$cured$or$
dying$ from$ a$ particular$ disease.$ In$ many$ diseases,$ particular$ in$ the$ area$ of$
neurodegeneration,$ these$ clinical$ endSpoints$ may$ be$ deemed$ unreasonable.$ The$ natural$
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history$of$most$neurodegenerative$diseases$is$one$of$insidious$progression$over$the$course$





biomarker,$ which$ substitutes$ for$ a$ clinical$ endpoint,$ but$ which$ is$ expected$ to$ predict$ a$
clinical$ response,$ based$ on$ robust$ scientific$ data.$ Over$ time$ it$ is$ import$ to$ validate$ the$
sensitivity$ and$ specificity$ of$ a$ particular$ biomarker$ in$ predicting$ a$ clinical$ endpoint.$More$
recently$the$use$of$biomarkers$has$been$proposed$to$enrich$clinical$populations$to$provide$
more$ optimum$ outcome$ measures,$ particular$ when$ dealing$ with$ smaller$ sample$ size$ or$
diseases$with$multiple$subStypes.$$$
Across$ neurodegenerative$ conditions$ a$ range$ of$ biomarkers$ are$ either$ in$ use$ clinically$ or$
have$ been$ proposed$ on$ a$ research$ basis$ (Ahmed$ et$ al.,$ 2014;$ Hampel$ et$ al.,$ 2010).$
Neuroimaging$ biomarkers$ are$ perhaps$ the$most$well$ established$ surrogate$ endpoints$ for$
trials,$with$structural$MRI$accounting$for$the$majority$of$studies$reported$(NoelSStorr$et$al.,$
2013).$CSF$biomarkers$are$also$in$common$use$with$protein$levels$such$as$betaSamyloid,$tau,$
phosphoralyted$ tau$ and$ 14S3S3$ protein$ having$ good$ sensitivity$ and$ specificity$ for$
Alzheimer’s$ disease$ and$ Prion$ disease$ respectively.$ As$mentioned$previously$ validation$ of$
individual$ biomarkers$ is$ important.$ Pathological$ confirmation$ of$ a$ predictive$ biomarker$ is$
key,$ with$ one$ metaSanalysis$ of$ known$ biomarkers$ (neuroimaging$ and$ CSF)$ finding$ an$
average$ sensitivity$ of$ 85%$ and$ specificity$ of$ 78%$ across$ studies$ with$ pathological$
confirmation$ of$ AD$ (Sandrine$ et$ al.,$ 2014).$ Future$ biomarkers$ will$ need$ to$ offer$ at$ least$
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similar$ levels$ of$ sensitivity$ and$ specific$ if$ not$ higher,$ in$ order$ to$ be$ adopted.$ Future$
biomarkers$ in$ neurodegeneration$ may$ include$ blood$ and$ urine$ measures,$ as$ well$ as$
additional$ CSF$ markers$ such$ as$ TDPS43$ and$ neurofilament$ light$ in$ FTD$ and$ βSsite$ APPS
cleaving$enzyme$1$in$AD.$New$imaging$techniques$such$as$tau$PET$imaging$and$DTI,$which$is$
proposed$as$a$potential$biomarker$in$this$thesis,$may$also$hold$promise.$$
A$ key$ issue$ in$ the$ development$ of$ biomarkers$ for$ frontotemporal$ dementias$ is$ the$
heterogeneity$ of$ the$ disease.$ Putative$ cognitive$ biomarkers,$ such$ as$ neuropsychological$
testing,$have$been$shown$to$be$unreliable$with$poor$pathological$specificity,$which$may$be$
due$ to$ issues$ as$ diverse$ as$ anatomical$ overlap$ between$pathologies$ resulting$ in$ common$
profiles$ of$ cognitive$ demise,$ the$disease$ stage$ the$patient$was$ tested$ at,$ or$ the$patient’s$
ability$ to$ engage$ in$ a$ particular$ task.$Of$ course$ this$ does$not$ limit$ the$potential$ role$of$ a$




Diagnosis$ of$ FTLD$ syndromes$ is$ aided$ by$ macroscopic$ patterns$ of$ brain$ atrophy$ and$ is$
incorporated$in$the$most$recent$consensus$criteria;$as$such$neuroimaging$would$seem$to$be$
a$ good$ candidate$ as$ a$ disease$ biomarker.$ Previously$ proposed$ imaging$ biomarkers,$ such$






based$ on$ patterns$ of$ brain$ atrophy$ seen$ at$ a$ group$ level$ across$ a$ particular$ clinical$
syndrome,$ however$ it$ is$worth$ noting$ the$ hetereogenetity$ of$ syndromes$ (see$ figure$ 1.1).$
This$ may$ result$ in$ large$ interSsubject$ variablitiy$ within$ a$ particular$ group,$ for$ example$
patients$with$C9ORF72$mutations$have$hugely$variable$patterns$of$brain$atrophy$(Mahoney$
et$ al.,$ 2012a).$ In$ the$ development$ of$ biomarkers$ for$ FTLD$ it$ seems$ increasing$ likely$ that$
there$will$be$a$need$to$use$sophisticated$methodologies.$Potential$biomarkers$will$need$to$
target$brain$changes$that$either$cut$across$the$clinicopathological$spectrum$or$that$adopt$a$
multimodal$ approach,$ combining$ multiple$ pieces$ of$ data$ (clinical,$ biochemical$ and$




The" most" recent" clinical" criteria" for" bvFTD" and" PPA" were" published" in" 2010" and" 2011"
respectively"(GornoSTempini"et"al.,"2011;"Rascovsky"et"al.,"2011)."The"current"pathological"
criteria"were" published" in" 2007" and" updated" in" 2010." These" criteria" form" the" basis" for"
inclusion"of"participants"within"the"current"study."The"hallmark"of"bvFTD"is"a"progressive"




consensus" criteria" attempted" to" adopt" a" flexible" approach" in" describing" the" clinical"
features" of" bvFTD," in" the" knowledge" that" some" patients" can" display" rather" discrepant"
clinical" features:" for"example" some"patients"may"suffer"with" severe"apathy"and" inertia,"
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whilst" others" may" have" more" florid" disinhibition." In" addition" these" criteria" adopt" a"




Patients"with"possible"bvFTD"are"classified"based"on"clinical" features"solely," resulting" in"
86%"sensitivity."Patients"with"probable"bvFTD"are"those"with"neuroimaging"features,"such"
as" focal" atrophy" or" hypometabolism," for" which" the" current" criteria" claim" a" lower"
sensitivity"of"76%,"although"these"individuals"will"have"a"greater"specificity"(i.e."certainty"
































































logopenic" variant" (lvPPA)." The" authors" stress" that" PPA" is" a" clinical" entity" and" to"
distinguish" it" from" other" neurodegenerative" syndromes" they" exclude" patients" with"





assuming" that" these" individuals" may" benefit" the" most" from" disease" modifying"
treatments." The" current" criteria" recognise" that" some"patients" have" clinical" features" sui+





However," unlike" the" bvFTD" criteria," the" authors" did" not" state" that" the" presence" of"
biomarkers" (e.g." CSF" Beta" Amyloid" levels)" consistent" with" AD" or" another" nonSFTLD"







































































































































maintaining" cell" structure"and"aiding" intracellular" transport," and"TDPS43" (FTLDSTDPS43),"
the"major" role"of"which" is" thought" to"be" in"RNA" regulation" and"managing" intracellular"
stresses" (Lee" et" al.," 2011)." Approximately" 10%" of" FTLD" is" made" up" of" uncommon"
pathological"subtypes,"such"as"the"protein"fused"in"sarcoma"(FTLDSFUS)"characterized"by"
neuronal" cytoplasmic" inclusions"which" stain" for" FUS" and" ubiquitin" proteasome" system"
(FTLDSUPS),"which"stain"for"ubiquitin"or"p62"but"not"for"FUS,"and"are"almost"exclusively"
associated"with"a"rare"mutations" in"the"CHMP2B+gene"(Cairns"et"al.,"2007;"Mackenzie"et"










of" TDPS43" (types" ASD)" are" recognized" based" on" the" morphology" and" anatomical"
distribution" of" TDPS43" cortical" inclusions" (Mackenzie" et" al.," 2011)." " Many" studies" have"
reported" that" patients" have" specific" clinical" and" radiological" features" which" can" help"
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predict"the"underlying"neuropathological"syndrome"(Grossman,"2010;"Knibb"et"al.,"2006;"
Pereira"et" al.," 2009a;"Rohrer" et" al.," 2011)." Semantic" variant"primary"progressive"aphasia"
(svPPA)"has"a"strong"association"with"TDPS43"type"C"pathology;"patients"with"bvFTD"and"
features"of"motor"neuron"disease"most"typically"have"TDP"type"B"pathology"and"patients"




overlap" in" terms" of" clinical" and" histopathological" features." Figure" 1.1" provides" an"
illustration"of"the" incidence"and"overlap"of"clinical"syndromes"with"neuropathology"and"
gene" mutations" based" on" previously" published" data" relating" to" clinicopathological"
correlations"and"pathological" frequency"(Grossman,"2010;"Lashley"et"al.,"2011;"Rohrer"et"
al.,"2011;"Rohrer"et"al.,"2010;"Snowden"et"al.,"2011);"for"example"this"figure"illustrates"the"
fact" that" patients" with" bvFTD" can" have" either" tau," TDPS43" or" AD" pathology" at" postS





present" little" is" known" about" associations" between" white" matter" pathology" and" the"
clinical"syndromes"associated"with"FTLD."Despite"the" lack"of"neuroimaging"data"on"this"
subject"there"is"a"substantial"amount"of"histopathological"data"implicating"white"matter"
structures" in" FTLD," and" this" was" a" major" impetus" for" the" subsequent" studies." With"
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regards"to"the"tauopathies"in"those"with"CBD"pathology"a"hallmark"of"the"diagnosis"is"the"




of" 4Srepeat" tau" fibrillary" structures" and" coiled" bodies" throughout" subcortical" frontal"
white"matter"(Piao"et"al.,"2005;"Sakai"et"al.,"2006)."In"PSP"oligodendroglial"inclusions"are"
commonly" reported" within" frontal," tegmental" and" cerebellar" white" matter" tracts"
(Armstrong"and"Cairns,"2013)."One"report" in"PSP"patients"suggests" that"70%"of"subjects"
have"a"greater"burden"of"tau"inclusions"within"frontal"white"matter"compared"with"grey"
matter," as" measured" using" a" quantitative" western" blot" technique" (Zhukareva" et" al.,"
2006)." More" recently" a" set" of" tauopathies" with" prominent" white" matter" pathology,"
termed"globular"glial" tauopathies,"have"also"been"reported."These"are"characterised"by"
the" presence" of" globular" oligodendroglial" inclusions" and" encompass" a" wide" clinical"
spectrum"from"PSP"and"CBS"to"bvFTD"and"even"a"motorSneuron"phenotype"(Ahmed"et"
al.,"2013)."
The" other" major" pathological" protein" in" FTLD" is" TDPS43." The" number" of" publications"
documenting" the" profiles" of" white" matter" pathology" in" this" proteinopathy" is" fewer"
compared"to"tau,"perhaps"owing"to"its"more"recent"identification,"however"there"remains"
substantial" evidence" that" this" protein" is" implicated" in" white" matter" degeneration."
Neumann" and" colleagues" first" noted" this" association" in" 2007," shortly" after" this" protein"





including" “coiled" bodySlike" comma" shaped”" inclusions," astrocytic" inclusions" and" axonal"
swellings."SubScortical"deposition"was"extensive"with"only"visual"cortex,"cerebellum"and"
anterior"and"posterior"spinal"roots"spared"(Brandmeir"et"al.,"2008)."Further"pathological"
studies" by" Hiji" and" colleagues" in" patients" within" the" FTLDSMND" spectrum" identified"
numerous"threadSlike"white"matter"inclusions,"which"were"found"to"be"TDPS43"positive."In"




key" role" in" the" regulation" of" mRNA" levels" with" increasing" evidence" that" it" has" an"
important"role"in"stress"responses"(LiuSYesucevitz"et"al.,"2010)."
A" number"of" other" clinical" observations"provide" further" evidence" for" the" role"of"white"
matter"pathology"in"FTLD."For"example"severe"white"matter"hyperSintensities"on"MRI"has"
been" reported" in" patients" with" GRN+ mutations" (Caroppo" et" al.," 2014)," " increased"




















outcome"measure" owing" to" its" wide" availability" and" relative" ease" of" use." The" earliest"
neuroimaging" studies" involved" calculation" of" changes" in" whole" brain" and" regional"
volumes"by"drawing"around"brain"structures."More"recently,"techniques"including"voxelS
based" morphometry" (VBM)" have" emerged" allowing" the" study" of" alterations" in" grey"
matter" (GM)" in" larger" patient" groups" by" using" automated" brain" segmentation" and"
registration" techniques." Two" recent" metaSanalysis" utilizing" data" from" structural" and"





of" connections" between" thalamus" and" frontal" lobes" (Barbas," 2000)." Despite" these"
relatively" specific" anatomical" findings" it" is" clear" from" other" individual" studies" that" the"
patterns" of" atrophy" in" bvFTD" are" quite" variable" and"may" even" include" involvement" of"
structures,"outside"regions"of"atrophy"considered"‘typical’"for"bvFTD,"such"as"parietal"and"
occipital" lobes"and"cerebellum"(Grossman"et"al.,"2007;"Hartikainen"et"al.,"2012;"Mahoney"
et" al.," 2012a)." Other" recent" studies" have" attempted" to" characterise" profiles" of" atrophy"
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along" clinical" grounds."One" such" study" examined" cases" of" bvFTD"with" prominent" right"
temporal"lobe"and"suggested"that"these"individuals"had"specific"clinical"features"including"
prosopagnosia," memory" impairment" and" visual" and" somatic" hallucinosis" (Chan" et" al.,"
2009)."Another"study"identified"multiple"subtypes"of"bvFTD"on"imaging"grounds"using"a"
cluster" analysis" of"MRI" data" from" sixtySsix" subjects" (Whitwell" et" al.," 2009)." These" data"
suggest" a" frontal" dominant" subtype" with" predominant" executive" and" behavioural"
dysfunction;" a" frontotemporal" subtype" with" additional" memory" and" language"
dysfunction;" a" temporoSfrontoSparietal" subtype"with"more"global" cognitive"dysfunction"
and" a" temporal" dominant" subtype" with" mainly" memory" and" language" deficits." More"
recent" imaging" techniques" including" postitron" emission" tomography" (PET)" and" resting"
state" functional"MRI" (fMRI)" have" continued" to" support" the" notion" of" greatest" disease"
burden" being" located" in" frontotemporal" brain" regions" in" bvFTD." In" addition" these"
techniques"allow"us"to"better"understand"dynamic"brain"changes,"in+vivo,"through"the"use"
of" activation" paradigms" and" resting" state" fMRI." A" significant" finding" has" been" the"
identification" of" dysfunction" within" a" soScalled" ‘Salience" Network’," comprising" ventral"
frontal," insular" and" anterior" cingulate" cortex," areas" important" in" external" event"
monitoring"and"other"aspects"of"social"cognition"(Seeley"et"al.,"2009;"Zhou"et"al.,"2010)."It"
has" been" suggested" that" this" finding"may" be" useful" biomarker" in" distinguishing" bvFTD"




metabolic" and" structural" imaging" studies" have" shown" relative" concordance." SvPPA" is"
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consistently"associated"with"atrophy"and"hypometabolism"of"the"anterior"temporal"lobe,"
most" typically" on" the" left" side," including" the" fusiform" gyrus" and" amygdala" (AcostaS
Cabronero"et"al.,"2011;"Mummery"et"al.,"2000)."Longitudinally"there"is"progressive"atrophy"
in" these" regions" as" well" as" within" the" contralateral" anterior" temporal" lobe" and"
orbitofrontal" cortex" (Rohrer" et" al.," 2008)." In" those" with" nvPPA" a" largely" consistent"
pattern"of" atrophy" and"hypometabolism"within" the" frontal" lobe," typically" the" left" side,"
involving" Broca’s" area," insular" and" premotor" cortex" has" been" reported" across" studies"
(Grossman," 2010;" Nestor" et" al.," 2003;" Rohrer" et" al.," 2009)." Longitudinally" atrophy"
progresses" superiorly" and" medially" to" further" involve" frontal" lobe" and" temporal" lobe"
structures."Atrophy"also"appears"to"track"posteriorly"along"the"Sylvian"fissure"to"include"
the"parietal"lobe"(Rogalski"et"al.,"2011)."Finally"those"with"lvPPA"have"a"pattern"of"atrophy"
involving"more"posterior" temporal" lobe" and"parietal" regions," and" again" like" svPPA" and"
nvPPA" this" tends" to" be" asymmetric," with" greater" involvement" of" the" left" hemisphere"
(Henry" and" GornoSTempini," 2010)." Longitudinally" those" with" lvPPA" have" progressive"
atrophy"of" these" regions"as"well"as" rightSsided"temporoSparietal" frontal"and"subcortical"
atrophy"(Rohrer"et"al.,"2013)."
"
Beyond" defining" the" neuroimaging" signatures" for" clinical" syndromes" more" recent"
attempts" have" been" made" to" identify" molecular" neuroimaging" signatures," by" using"
histopathological"and"genetic"data."This" is" important"given"that"future"drug"treatments"
are" likely" to" target" specific"molecular"disorders."Much" like" the" clinical" heterogeneity"of"
FTLD," there" is" also" substantial" pathologically" heterogeneity." The" most" common"




MAPT+mutations" are" associated"with"mainly" temporal" lobe" atrophy," and" often" striking"
bilateral" medial" temporal" lobe" atrophy" (Janssen" et" al.," 2002;" Rohrer" et" al.," 2011),"
additionally" there" may" be" inferior" temporal" lobe" and" orbitofrontal" cortex" atrophy." In"
cases"of" CBD"and"PSP,"most" commonly"presenting" as" either" nvPPA"or"bvFTD" clinically,"
atrophy"can"be"quite"focal;" in"CBD"atrophy" is"perhaps"somewhat"more"widespread"and"
more" apparent" on" individual" imaging"with" focal" atrophy" often" reported" in" the" parietal"
lobes" (Josephs" et" al.," 2008)." Other" studies" have" reported" relatively" symmetrical"
dorsolateral" frontal" lobe" atrophy" (Rohrer" et" al.," 2011)." In" PSP" atrophy" of" the" superior"
cerebellar"peduncle"and"midbrain"are"common"(Josephs"et"al.,"2008;"Paviour"et"al.,"2006)."
It" should"be"pointed"out" that"whilst" these"pathologies" can"present"as"bvFTD"or"nvPPA"
clinically,"they"typically"present"as"corticobasal"syndrome"or"clinical"PSP"and"as"such"the"
neuroimaging"hallmarks"of"these"pathologies"presenting"as"bvFTD"or"nvPPA"are"relatively"
unknown." In" the"case"of"TDP"pathology" there"have"been"several" studies"attempting" to"
identify" profiles" of" atrophy" specific" to" TDP" subtypes" (Rohrer" et" al.," 2011;" Rohrer" et" al.,"
2010;"Whitwell" and" Josephs," 2012)." TDP" type" A" pathology" has" a" rather" heterogeneous"
profile"of"brain"atrophy"often"involving"frontal,"temporal"and"parietal"lobes."The"degree"
of" atrophy" can" be" significant" and" highly" asymmetric" as" in" cases" associated" with" GRN"
mutations"(Beck"et"al.,"2008)."However"in"those"with"C9ORF72+mutations"there"appears"to"
be" significant" variation" in" the" patterns" of" atrophy" despite" individuals" having" the" same"


















examples" are" in" AD"where" reduced" activity" is" observed" in" the" ‘default"mode" network’"
(Greicius" et" al.," 2004)," and" more" recently" in" bvFTD" where" reduced" connectivity" is"
observed"within"the"‘salience"network’."These"findings"have"been"repeated"by"others"and"
also" show" a" divergence" in" functional" connectivity" between" bvFTD" and" patients" with"
Alzheimer’s" disease," making" fMRI" a" potentially" useful" clinical" biomarker" (Filippi" et" al.,"
2013)." fMRI" studies" in" those" with" PPA" are" fewer" and" typically" involve" activation"
paradigms" aimed" at" better" understanding" the" neural" basis" of" semantic" categorization,"
language"and"memory"(Binney"et"al.,"2010;"Goll"et"al.,"2012;"Wilson"et"al.,"2011).""
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Other"techniques"to" image"neuropathology" in+vivo+show"promise"with"amyloid" imaging"
now"readily"available"to"detect"AD"pathology"(Klunk"et"al.,"2004),"and"several"tau"based"
ligands" in" development" and" showing" early" promise" (Maruyama" et" al.," 2013)." These"
techniques"provide"additional"tools"for"understanding"the"neurobiology"of"FTLD"and"will"







functional" alteration," and" whilst" these" forms" of" imaging" remain" important," they" are"
associated"with"a"number"of"limitations."Firstly"techniques"such"as"whole"brain"atrophy"or"
fMRI"may"lack"in"either"sensitivity"or"practicality"to"detected"the"earliest"disease"related"
changes." Secondly" grey"matter" analysis" tends" to" indirectly" assess" network" breakdown"
often"making"inferences"about"associations"between"atrophy,"reduced"functional"activity"




vivo" has" become" possible" with" more" advanced" neuroimaging" such" as" DTI," whilst" still"
maintaining" the"practicalities" and" convenience"of"MRI." This" has" allowed" researchers" to"
provide" more" detailed" maps" of" changes" to" white" matter" architecture" in" many"
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neurological"diseases" (Ciccarelli" et" al.," 2008)."Diffusion"weighted" imaging" (DWI)"utilises"
the" principle" of" Brownian" motion," to" detect" the" movement" (or" restriction)" of" water"
molecules"within" brain" structures" and" has" been" an" invaluable" tool" in" the" detection" of"
acute" cerebral" ischaemia" for" many" years." DTI" is" a" further" advance" on" DWI," applying"
diffusion" gradients" in" multiple" (six" or" more)" directions." The" study" of" cerebral" white"
matter" is"particularly"well"suited"to"DTI"as" it"displays"high"anisotropy"due"to"myelinated"
axons." In" healthy" white" matter" water" tends" to" diffuse" along" a" parallel" gradient" with"
limited"diffusion"perpendicularly"(Figure"1.2A)."This"normal"gradient"of"diffusion"tends"to"
alter"in"many"neurological"diseases."A"mathematical"model"to"describe"this"process"was"









diffusion( gradients.( B),( Diffusion( ellipsoid( characterised( by( its( three( eigenvalues( (λ1,( λ2( and( λ3),(




another" (i.e."λ1≈λ2≈λ3);"when"an"object" is"highly"anisotropic" (e.g."a"white"matter" tract)"





anisotropy" (FA)," which" describes" the" degree" of" directionality" of" diffusion" and" is"
calculated"as"follows:"
"
!" = !! !! − !!! ! + ! !! − !!! ! + ! !! − !!! !!!!! + !!!! + !!!! "
"
Other" scalars" better" represent" the"magnitude" of" diffusion" and" include" trace" diffusivity"
(TR)"and"its"average"mean"diffusivity"(MD):""
" !" = !!! + !!! + !!!"
"
!" = ! !! + !!! + !!!3 "
"
"Axial" diffusivity" (AX)" is" a" measure" of" the" magnitude" of" diffusion" parallel" to" the"
orientation" of" the" white" matter" tract" being" studied," which" should" be" the" dominate"
direction,"as"diffusion"of"water"in"this"direction"should"be"relatively"unimpeded"given"the"
orientation"of"the"structure:"" !" = !!!"
Radial"diffusivity"RD,"which"is"a"measure"of"the"magnitude"of"diffusion"perpendicular"to"
the" orientation" of" the" white" matter" tract" being" studied," should" detect" only" minor"
diffusion,"as"the"movement"of"water"molecules"in"this"direction"is"more"impeded"by"tract"
fibres:"
!" = ! !! + !!!2 "
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It" is"possible" to"obtain"measurements" for"each"DTI"metric" (FA,"MD,"AX"and"RD)"within"
each" brain" voxel" during" one" scan," yielding" large" amounts" of" data" for" each" subject." At"
present," FA" remains" the" most" commonly" reported" metric" within" the" literature." It" is" a"
useful"metric,"which"reflects"the"overall"integrity"of"a"white"matter"tract"by"reporting"the"
degree"of"isotropy"within"it,"whereby"a"value"approaching"one"signifies"highly"anisotropic"
diffusion" of"water," often" associated"with" a" tract" being"more" structurally" intact," whilst"












FA," the"most"widely" reported"DTI"metric,"with" lower"FA"values"being"associated"with"a"
range" of" neurological" and" psychiatric" conditions" (Ciccarelli" et" al.," 2008;" Thomason" and"
Thompson,"2011)."However"as"alluded"to"changes"in"FA"are"driven"by"changes"in"either"AX"




in"mouse"models" of" demyelination" has" shown" that" RD"was" higher" in" animals" with" no"
myelin"whilst"AX"was"unchanged"(Song"et"al.,"2002),"suggesting"that"RD"may"be"a"useful"
measure" of" demyelination" but" not" axonal" loss," and" in" fact" this" has" been" repeated" by"
others"(Harsan"et"al.,"2006;"Tyszka"et"al.,"2006)."Change"in"AX"has"been"reported"in"the"
context"of"axonal"damage,"with"decreased"AX"reported"following"an"acute"axonal"injury"
(Liu"et"al.," 2013;"Sun"et"al.," 2006)."However" changes" in" the"magnitude"of"diffusion"also"
appear" to"be"variable" and"dynamic"with" initial" decreases" in"AX"and"RD" reported" in" the"
context"of"acute"injury,"such"as"nerve"transection"or"acute"inflammation,"followed"by"an"
increase" in" both" these" metrics," felt" to" be" compatible" with" more" chronic"
neuropathological"processes"(AcostaSCabronero"et"al.,"2012;"Brennan"et"al.,"2013;"Fox"et"
al.,"2010;"Liu"et"al.,"2013)."These"dynamic"changes"may"be"explained"by"multiple"phases"of"
change" within" the" milieu" of" the" white" matter" axon," with" an" initial" phase" of"
dysmyelinationSremyelination" and" cellular" oedema" as" part" of" an" acute" inflammatory"
processes," followed" by" a" more" chronic" process" of" demyelination," failure" of" axonal"
transport,"axonal"degeneration"and"neuronal"death."This"is"certainly"plausible"given"that"
most"of"the"variability"in"these"metrics"have"been"reported"in"conditions"associated"with"
inflammation," such" as" multiple" sclerosis." Whilst" some" variability" has" been" reported" in"
some"neurodegenerative"conditions,"there"appears"to"be"relatively"more"consistency" in"
the"direction"of"change"for"each"metric,"particular"FA,"RD"and"MD"(AcostaSCabronero"et"
al.," 2012," 2010)," most" likely" due" to" these" processes" being" a" more" insidious" and"
unidirectional"process"of"neuronal"decline." In"one"recent"study" in"AD,"AX"and"MD"were"
reported" to" be" a" more" sensitive" metric" crossSsectionally," whilst" FA" was" better" at"
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are" also" a" number" of" limitations" with" DTI" in" the" areas" such" as" scan" acquisition," data"
analysis" and" interpretation" (Jones" et" al.," 2013)." From" a" technical" point" of" view" the"
resolution" used" to" acquire" data" is" typically" quite" large" in" comparison" to" the" size" of" an"
individual"axon,"with"a"typical"voxel"sizes"being"2S3mm"in"size."This"relatively"low"spatial"
resolution" limits" are" ability" to" capture" changes" in" smaller" white" matter" structures,"
particularly"as"they" interface"with"cortex."This"may"also"result" in"partial"volume"effects,"
with"may" result" in" a" combination" of"misSregistration" between"white"matter" structures"
and"contamination"between"white"and"grey"matter,"and"cerebrospinal"fluid"(CSF)."With"
improvements"in"scanner"field"strength"it"is"possible"to"improve"the"resolution,"however"
this" must" be" balanced" with" scan" time" and" safety," a" particular" issue" for" patients" with"
behavioural" problems." Other" issues" such" as" artefacts" due" to" eddy" currents," head"
movement" and" susceptibility," particularly" at" air/brain" boundaries" can" be" a" problem,"
although" improved" algorithms" for" preSprocessing" of" diffusionSweighted" data" have"
reduced" these" problems" somewhat." Having" good" anatomical" specificity" for" particular"
white" matter" structures" can" be" problematic" due" to" close" proximity" of" tracts" to" one"
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another" or" due" to" crossing" fibres." For" example" a" structure" like" the" cingulum" bundle,"
which" runs" anteroSposteriorly" in" near" isolation" from" other" tracts," is" relatively" easy" to"
isolate" for" regionSofSinterest" (ROI)" analysis," whilst" the" superior" longitudinal" fasciculus"
crosses"or"neighbours"many"white"matter"tracts."Much"of"the"processing"of"DTI"data" is"
based"on"certain"mathematical"and"physical"assumptions"of"water"diffusion,"for"example"
an"ellipsoid" is"viewed"as"the"best"way"of"characterizing"diffusion" in"the"healthy"brain." It"
may"be" true" to"say" that"many"of" these"assumptions"are"valid" in"healthy" individuals"but"
changes" to" the" microstructures" of" individuals" with" neurodegenerative" conditions" may"
cause"some"of"these"assumptions"to"become"less"valid."One"extreme"example"may"occur"
during" the" registration" of" DTI" images" to" one" another." Current" registration" techniques"
tend" to" rely" on" a" process" that" involves" warping" a" diseased" brain" to" one" of" a" young"
healthy" individual," which" can" result" in" misalignment" and" excessive" warping" of" the"
patient’s" brain." In" addition" registration" and" analysis" techniques" in" DTI" are" often"












Previous" sections" have" highlighted" the" substantial" evidence" amassed" regarding" the"
prevalence" of" white" matter" histopathology" in" FTLD." Further," the" potential" of" DTI" in"
assessing" the"microstructural" changes"within"white"matter,"by"measuring"alterations" in"
diffusion" within" axons," has" been" discussed." Whilst" accumulation" of" potentially" toxic"
proteins"has"been"observed"within"cells"at"postSmortem"it"is"likely"that"a"number"of"steps"
precede" this;" for" example" firstly" failures" in" axonal" transport" and" axonal" degeneration"
leading"to"some"of"the"changes"which"DTI"may"be"detecting.""
Axonal"degeneration"occurs"in"health"and"is"a"tightly"regulated"and"efficient"process"that"
contributes" to" the" development" of" the" normal" brain," ensuring" that" healthy" functional"
neural"circuits"develop"(ChevalierSLarsen"and"Holzbaur,"2006;"Saxena"and"Caroni,"2007)."





protective" proteins" such" as" slow"Wallerian" degeneration" protein" guide" the" process" of"
axonal" degeneration" (Saxena" and" Caroni," 2007)." Pathological" axonal" degeneration" has"
been" implicated" in" a" range" of" neurodegenerative" disorders;" mutations" in" Amyloid"







a" mutant" P301S" tau" transgenic" mouse" model" axonal" swellings" were" observed" which"
contained" neurofilament," which" occurred" prior" to" the" development" of" neurofibrillary"
tangles." The" same" study" also" identified" that" these" neurofilament" containing" axonal"
swellings"were"also"present"in"postSmortem"brains"of"patients"with"FTLDStau"(van"Eersel"
et"al.,"2015)."Neurofilament"in"its"normal"state"provides"structural"support"for"axons,"and"
it"would" be" reasonable" to" conclude" that" abnormal" aggregations" of" neurofilament"may"
contribute" to"axonal"degeneration." Indeed" it" is"possible" to"measure"abnormal" forms" in"
CSF." Termed" neurofilament" light," these" proteins" have" been" associated" with"
neurodegenerative"pathologies"as"well"as"white"matter"lesion"load"on"MRI"(Sjögren"et"al.,"
2001)."The"role"of"the"other"major"pathology" in"FTLD,"TDPS43," in"contributing"to"axonal"








regulates" the" ubiquitinSproteasome" system," which" in" turn" provides" a" mechanism" for"
ordered"cell"degeneration"(Kimonis"et"al.,"2008)."Mutations"in"this"gene"results"in"bvFTD,"




may" directly" contribute" to" axonal" degeneration" (Beirowski" et" al.," 2010)." Another" rare"
syndrome,"which"may"present"as"bvFTD,"along"with"respiratory"failure"and"Parkinsonism,"
is"Perry"syndrome."This"syndrome" is"a" result"of"mutations" in" the"Dynactin"gene,"a"gene"
which" codes" for" dynactin," a" protein" which" is" a" constituent" of" the" dyneninSdynactin"






along" with" deposition" of" toxic" protein" species" within" axons" that" a" process" of" axonal"
degeneration"is" initiated"with"a"subsequent"gradual" ‘dyingSback’"process"whereby"more"
proximal" neurons" and" synapses" become" dysfunctional" (ChevalierSLarsen" and"Holzbaur,"
2006;" Simons" et" al.," 2014)." Beyond" just" axonal" degeneration" the" extensive"
histopathological"suggest"that"axonal"degeneration"and"failures"in"myelination"combine,"















callosum," often" with" complete" absence" of" myelin," extensive" axonal" damage" and" the"
presence"of"axonal"spheroids"(Freeman"et"al.,"2009)."Beyond"FTLD"large"epidemiological"
studies" of" the" aging" population," such" as" the" Rotterdam" Study," also" provide" robust"
evidence"that"progression"in"white"matter"lesion"load,"in"this"case"presumed"to"be"due"to"
vascular" disease," correlates" strongly" with" deteriorating" memory" and" speed" of"
information"processing" (Cees"De"Groot"et"al.," 2000)." Indeed"some"studies"suggest" that"
the"degree"of"white"matter"pathology"in"small"vessel"disease"may"directly" influence"the"
profiles"of"cortical"atrophy"(Du"et"al.,"2005)."Multiple"sclerosis"is"perhaps"the"most"widely"
studied" disease" of" white"matter," and"whilst" commonly" referred" to" as" a" demyelinating"






Scaling" intraSaxonal" pathophysiology" up" to" explain" clinical" syndromes" is" a" more"
challenging"concept,"particularly"given"that"neurodegeneration"encompasses"both"white"
and" grey" matter," making" examination" of" changes" in" isolation" difficult." A" number" of"
animal" models" and" human" disease" processes" highlight" that" relatively" selective" white"
matter"pathology"can"induce"clinical"deficits."In"aged"nonShuman"primates"a"linear"decline"
in" the" density" of"myelinated" axons" and" increasing" axonal" degeneration" is" observed" in"
structures" such" as" the" anterior" commissure," with" a" direct" correlation" between" the"
number"of"healthy"of"nerve"fibres"and"cognitive"performance"(Sandell"and"Peters,"2003)."
A" number" of" selective" white" matter" lesion" studies" have" also" shown" that" monkeys"
develop"syndromes"compatible"with"bvFTD"(Horel"and"Misantone,"1974),"whilst"lesions"of"
amygdalofugal" tracts" result" in" severe" impairment" of" visual"memory" (Bachevalier" et" al.,"
1985)." Lesion" studies" have" also" provided" insights" on" the" trajectory" of" axonal"
degeneration," for" example" targeted" lesions" within" tracts" connecting" the" fornix" and"








Classical" neuroSanatomists" believed" that" brain" functions" were" compartmentalised" to"
particular"brain"regions"and"gyri"and"whilst"this"can"be"said"to"be"true"for"certain"primary"
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functions" such" as" the" motor" cortex," it" is" increasingly" recognised" that" many" higher"
cognitive" functions" are" a" result" of" anatomically" distributed" brain" regions" working" in"
synchrony"as"a" functional"network."Early" ideas"on"how"higher"cognitive" functions"were"
distributed" are" exemplified" in" the"work" of" Geschwind," who" gave" a" detiled" account" of"
disconnection" syndromes," for" example" the" interruption" of" the" structural" connections"
between" two"cortical" language" regions" resulted" in" the"clinical" syndrome"of" conduction"
aphasia" (Benson"et"al.," 1973)."With"new"techniques" to"study"structural" connections" the"
concept" of" hodology" –" the" pattern" of" white" matter" connections" between" cortical"
regions," has" once" again" become" an" important" concept" in" integrating" function" with"
anatomy"(Catani"and"ffytche,"2005)."Beyond"these"‘direct’"structural"brain"connections"it"
has"also"been"established,"mainly"through"the"use"of"fMRI,"that"brain"regions"can"work"in"
synchrony" through" both" direct" and" indirect" connections," for" example" via" subcortical"
structures" such" as" the" thalamus." Examples" of" functional" brain" networks" include" the"
default" mode" network," which" includes" ventromedial" prefrontal" cortex" and" posterior"
cingulate" cortex" and" is" active" during" internally" orientated" tasks" (Buckner" et" al.," 2008);"
Salience" network," composed" of" anterior" cingulate" and" insular" cortex" and" activated"
during" detection" of" external" and" internal" salient" events" and" important" in" modulating"
behavioural" responses" to" these" stimuli" (Seeley" et" al.," 2007);" FrontoSparietal" control"
network,"composed"of"lateral"prefrontal"and"inferior"parietal"cortex"and"activated"when"
performing"a"goal"directed"task" (Vincent"et"al.,"2008);" linguistic"networks"composed"of"
mainly" left" side" frontoStemporoSparietal" regions" for" speech"generation" (Geranmayeh"et"
al.,"2014),"and"ventral"prefrontal"and"temporal"regions"for"semantic"processing"(Noonan"
et" al.," 2013)." These" large" scale" cognitive" networks" are" distributed" across" brain" regions"
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nodes," which" carry" out" even" more" subSordinate" tasks." Advances" in" imaging" the"
physiology" of" brain" networks," through" the" use" of" technologies" such" as" the" use" of"
optogenetics," allows" us" to" resolve" the" basic" constituents" of" brain" networks" down" to"




nodes" or" over" longer" range" between"modules." In" addition" some" nodes"may" be" highly"
interconnected" to" allow" rapid" integration" of" information" across" multiple" modules," soS
called" rich8club+ nodes+ (van" den" Heuvel" and" Sporns," 2011)." Some" nodes" may" have" high"





link( them.( Green( circles( represent( the( Salience( network( (ACC,( anterior( cingulate( cortex;( FrIns,( FrontF
insular(cortex);(orange(circles(represent(the(default(mode(network((PCC,(posterior(cingulate(cortex;(Prec,(
precuneus);(blue( circles( represents( the( frontoFparietal( control(network( (DLPFC,(dorsolateral(prefrontal(
cortex;(TPJ,(temporoFparietal(junction)(and(red(circle(represents(the(executive(control(network((DMPFC,(







(modules)" represented" by" coloured" circles" and" structural" connections" (edges)"
represented"by"filled"and"dashed"lines."
With" improvements" in" neuroimaging" we" can" now" image" many" of" the" components" of"
these"brain"networks"in+vivo,"whilst"acknowledging"the"lack"the"resolution"to"fully"resolve"
subSvoxel" components" of" brain" networks." The" availability" of" these" techniques" was" a"
major"motivation" for" the" current" undertaking," coupled"with" the" increasing" recognition"
that" neurodegenerative" conditions"may" target" specific" aspects" of" both" functional" and"
structural" brain" networks." This" concept" of" neurodegeneration" across" specific" brain"
networks," network8led+ degeneration," may" provide" a" common" framework" for"




been" known" for" some" time" that" specific" brain" networks" and" their" components" are"
vulnerable" in" neurodegenerative" diseases." For" example" reduced" intrinsic" connectivity"
within" the" defaultSmode" network" has" been" repeatedly" demonstrated" in" Alzheimer’s"
disease," and" not" just" in" symptomatic" individuals" but" also" in" preSsymptomatic" familial"
Alzheimer’s"disease"mutation"carriers" (Chhatwal"et"al.,"2013)."More"recently"changes"to"
structural" connections" have" also" been" shown" in" presymptomatic" frontotemporal"
dementia" patients"who" harbour" both"PGRN+ and"MAPT+mutations" (Borroni" et" al.," 2008;"
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Dopper"et"al.,"2013)."As"mentioned"previously"the"Salience+network"has"shown"selective"
vulnerability" in" patients" with" frontotemporal" dementia" (Zhou" et" al.," 2010)." One" can"
imagine"that"there"are"specific"features"of"these"networks,"which"make"them"particularly"
vulnerable"to"degeneration"(Pievani"et"al.,"2011)."This"could"be"one"of,"or"a"combination"of"
the" following:" abnormal" development," exposures" to" specific" environmental" triggers,"
genetic"modifiers"conferring"greater" risks"of"degeneration" to"specific"networks."With"a"
network" in" a" vulnerable" state" a" second" hit"with" a" toxic" protein," for" example" tau,"may"
instigate"further"damage"to"the"network"resulting"in"nodal"stress"with"downstream"loss"
of" synapses" and" more" widespread" network" failure" due" to" loss" of" trophic" support,"
perhaps" through" failure" of" axonal" transport" (Goedert" et" al.," 2014)." The" speed" and"
propagation" of" network" degeneration" may" depend" upon" the" configuration" of" the"
network"under"attack,"with"a"more"focal"contiguous"degeneration"within"networks"with"
composed" of" shortSrange" connections" between" nodes" and" modules," and" largeSscale"
degeneration" in" network" with" higher" numbers" of" rich8club+ nodes" or" with" longSrange"




in" quite" focal" cognitive" deficits." However" over" time" other" networks"may" also" become"
affected,"noting"the"longSrange"association"fibres"linking"the"salience"network"with"other"
brain" networks." Alternatively" if" a" highly" interconnected" network," such" as" the"




those" with" genetic" forms" of" bvFTD," despite" every" neuron" harbouring" a" pathogenic"
mutation," global" simultaneous" brain" degeneration" does" not" occur," instead" a" specific,"
almost" programmed," pattern" of" degeneration" occurs." For" example" in" figure" 1.4" an"
individual" who" was" initially" clinically" unaffected" with" bvFTD" had" serial" volumetric"MRI"
scans"over"a"tenSyear"period." "This" individual"harboured"a"MAPT"mutation"(exon"10"+16)"
and"exhibits"the"commonly"reported"radiological"findings"of"focal"medial"temporal" lobe"
atrophy"with" subsequent" orbitofrontal" atrophy." This" pattern" suggests" that" these" brain"
regions" have" a" selective" vulnerability.+These" important" genetic" cases" also" suggest" that"
specific" proteins"may" also" determine" how" network" degeneration" proceeds." Increasing"
evidence"suggests" that" tau"exhibits"prionSlike"properties"with" intracellular," transynaptic"
and"transaxonal"spread"of"this"protein"observed"in"cell"and"animal"models"of"tauopathy"
(Clavaguera" et" al.," 2013;" Goedert" et" al.," 2014;" Nussbaum" et" al.," 2012)" and" it" has" been"
postulated"that"brain"networks"are"the"vehicle"through"which"tau"species"(and"perhaps"
other" proteins)" preferentially" disperse." Brain" networks" may" also" be" targets" for"
deficiencies" in" normal" cell" repair" and" metabolism." For" example" in" GRN+ mutations," a"
haploinsufficeny" resulting" in" 50%" less" granulin+ 8+ an" important" cell" repair" protein," may"
result"in"damage"to"key"functional"nodes"with"downstream"damage"to"distant"nodes"due"





In" summary" there" is" growing" evidence" that" neurodegenerative" diseases" target" specific"
brain"networks"(Warren"et"al.,"2013)."Elements"of"these"networks,"such"as"their"structural"













Whilst" our" knowledge" of" nonSAlzheimer’s" dementia," originally" described" by" Pick,"
stretches"back"over"one"hundred"years,"it"is"in"the"last"two"decades"that"real"progress"has"
been"made" in"refining"the"clinical," radiological"and"neuropathological"phenotype"of"the"
nonSAlzheimer’s" dementia," or" specifically" in" FTLD." " There" has" been" multiple" imaging"
studies" performed" to" establish" the" patterns" of" grey"matter" atrophy" in" FTLD," however"
these"studies,"alone,"have"a"number"of" limitations."Firstly," increasing"evidence"suggests"
that" macroscopic" brain" atrophy" is" a" terminal" process" in" the" evolution" of" FTLD," and"
therefore" may" not" be" sufficiently" sensitive" to" capture" the" earliest" features." Secondly,"
grey" matter" studies" cannot" fully" explain" the" variability" on" both" imaging" and" clinical"
grounds" seen" in" FTLD," in"particular" it"does"not"explain"why" some" individuals"with" little"




techniques," in" this" case"DTI" as" the" imaging"modality" best" suited" to" capture" changes" in"
structural" pathway" connections" that" bind" networks" together." Increasing" evidence"
suggests"that"certain"brain"networks"may"exhibit"specific"vulnerabilities"and"it"has"been"













4 Establish"the"sensitivity"and"specificity"of" individual"DTI"metrics" in"the"monitoring"of"
FTLD."
"
Chapter" 2" sets" out" the" clinical" assessments" and" imaging" techniques" used" in" the"
subsequent"chapters."
Chapter"3"will"test"the"hypothesis"that"there"are"clinically"and"moleculary"defined"profiles"
of" white"matter" pathology" in" bvFTD." Using" a" a" well" defined" patient" cohort" key" white"
matter"tracts"are"examined"crossSsectionally,"using"a"number"of"DTI"metrics,"to"establish"
the" extent" of" white" matter" tract" pathology." DTI" metrics" are" also" compared" with" one"
another" to" establish" optimal" DTI" metrics." Grey" matter" is" also" studied" using" VBM" and"
compared"with"the"profiles"of"white"matter"tract"pathology."
Chapter"4"will" test" the"hyptothesis" that" longitudinal"DTI" can"be"applied" to" study"white"
matter" tract" changes" in" bvFTD." Previously" longitudinal" DTI" has" been" a" technically"
challenging"methodlogy"to"apply."This"chapter"aims"to"establish"it"as"a"useful"measure"of"
disease" pathology." Furhtermore" this" chapter"will" test" the" hyptothesis" that" functionally"
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relevant"white"matter"tracts"show"evidence"of"progressive"disease"pathology"in"line"with"
the" syndromic" evolution." Patients" with" bvFTD" will" undergo" serial" clinical" and" imaging"







and" lvPPA" key" white" matter" tracts" are" examined" using" a" number" of" DTI" metrics" to"
establish"the"extent"of"white"matter"tract"pathology."DTI"metrics"are"compared"with"one"

















had" a" clinical" diagnosis," which" was" only" possibly+ consistent" with" bvFTD," i.e." potential"
phenocopies,"or"if"their"PPA"syndrome"was"unclassifiable."Patients"were"also"excluded"if"
they"were"unable"to"tolerate"MRI"scanning,"had"white"matter"pathology"consistent"with"




of" recruited" patients." Were" possible" spouses/partners" were" recruited." Controls" were"
included" only" after" completing" a" detailed" clinical" assessment" and" neurological"
examination" to" ensure" they" did" not" have" a" diagnosis" of" a" neurodegenerative" or"
psychiatric" disorder," or" excessive" vascular" risk" factors" (e.g." poorly" controlled"
hypertension,"diabetes"or"known"cardioS"or"cerebrovascular"disease).""
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Ethical"approval" for"the"all"studies"contained" in"this"Thesis"was"obtained"from"the" local"





patients" and" healthy" participants." This" captured" basic" demographics" such" as" age,"
handedness,"occupation"and"years"of"education;"clinical"history"including,"first"symptoms,"
estimated" year" of" disease" onset," current" symptoms," prior"medical" history" and" current"
medications." A" standardized" physical" and" neurological" examination" was" carried" out"
which"included"bedside"assessment"of"praxis."All"patients"and"controls"underwent"a"miniS
mental"state"examination"(MMSE)."Blood"samples"where"obtained"for"DNA"analysis,"with"
additional" blood" samples" archived," were" consent" was" given." In" addition" a" subset" of"
patients"had"cerebrospinal"fluid"(CSF)"analysed"for"total"tau"and"betaSamyloid"1S42,"where"
clinically"indicated"to"determine"the"likelihood"of"AD"pathology."Total"CSF"tau"(a"measure"
of" neuronal" loss," as" a" nonSspecific" accompaniment" of" neurodegeneration)" and" CSF"
amyloidSbeta1S42"(Aß1S42);"a"measure"of"amyloid"deposition"specific"for"AD"pathology)"were"
measured" (Innotest" platforms," Innogenetics," Ghent," Belgium)." " Local" reference" ranges"






intellect" (IQ)" was" assessed" using" the" Wechsler" Abbreviated" Scale" of" intelligence"
(Wechsler," 1999)."Recognition"memory"was"tested"using"The"Recognition"Memory"Test"
for" faces" (Warrington," 1984),"which" presents" 50" faces"with" an" orienting" question." The"
participant"is"then"presented"with"the"target"paired"with"an"unfamiliar"face"and"asked"to"
judge" that" they" have" seen" before." The" same" procedure" is" used" for" the" Recognition"
Memory" Test" for" words." SingleSword" comprehension" was" assessed" using" The" British"
Picture" Vocabulary" Scale" (Dunn," Dunn" &" Whetton," 1982)" whereby" participants" must"
match"one"of"four"pictures"to"a"target"word"of"increasing"difficulty."Formal"naming"was"
assessed" using" The" Graded"Naming" Test" (McKenna"&"Warrington," 1983)." This" requires"
participants"to"name"line"drawings"that"become"increasingly"less"common."Mathematical"
ability"was"assessed"using"The"Graded"Difficulty"Arithmetic"Test"(Jackson"&"Warrington,"
1986)," which" allows" participants" 10" seconds" to" perform" increasingly" difficult" mental"
arithmetic"sums."Perceptual"skills"were"assessed"using"the"Object"Decision"subtest"of"the"
Visual" Object" and" Space" Perception" battery" (Warrington" &" James," 1991)." This" requires"
participants" to" identify" the" silhouette" of" a" 75" degree" rotated" real" object" from" three"
nonsense"silhouettes"of"similar"complexity."Finally"executive"function"was"assessed"using"
The" DelisSKaplan" Executive" function" system" (Delis" et" al.," 2001)." The" colourSword"
Interference" test" assesses" executive" function" using" a" progressively" challenging" set" of"
tests,"first"requiring"subjects"to"name"consecutive"coloured"rectangles,"then"read"aloud"
printed" colour" names" and" finally" identify" the" ink" colour" where" colour" words" are"
presented" in" a" conflicting" colour." Additional" neurolingustic" tests" were" performed" in"
those"with"suspected"PPA."This"included"repetition"of"30"single"words,"with"progressively"
!68!####
more" syllables," repetition" of" 10" phrases" of" 3S10"words" in" length" and" an" assessment" of"
receptive" grammar," which" involved" a" description" of" a" scenario" and" forced" choice"
selection"of"this"scenario"from"four"pictures"(Kay,"1992)."When"participants"were"unable"
to"attempt"a"test"after"prompting"or"were"unable"to"complete"a"trial"they"were"assigned"
either" the" chance" or" floor" score" for" that" particular" test." Each" patient’s" clinical" history,"
examination"and"neuropsychological"profile"along"with"standard"clinical"MRI"sequences"





Given" the" high" prevalence" of" genetic" associated" bvFTD" (and" less" so" PPA)" all" subjects"
were" requested" to" provide" a" blood" sample" for" DNA" analysis" for" commonly" associated"
genetic"mutations."In"rare"instances"participants"declined"to"provide"a"sample,"although"
this" was" not" an" exclusion" criterion" for" the" study," and" 93%" of" those" with" bvFTD" were"
screened." Following" obtainment" of" consent" genetic" analysis" was" carried" out" to"
determine" if" mutations" in" MAPT,+ PGRN+ or+ C9ORF72+ were" present" using" either" direct"
Sanger" sequencing" or" with" next" generation" sequencing" technology" using" Life"
Technology’s" Ion" Torrent" Personal" Genome" Machine" sequencing;" which" additionally"
screened" for" mutations" within" fusedSinSsarcoma," valosinScontaining" protein," charged"
multivesicular"body"protein" 2B,"prion"protein," TAR"DNASbinding"protein"43,"presenilin" 1"





All"MRI" scans"were" acquired" on" the" same" Siemens" Trio" Tim" 3STesla" scanner" (Siemens,"
Erlangen)"using"a"32Schannel"headScoil."The"image"protocol"consisted"of"a"3SD"volumetric"













value:" 1000" s/mm2)," augmented" with" parallel" imaging" acceleration" to" reduce"







Whole" brain" measurement" was" carried" out" using" a" semiSautomated" process" of" brain"
segmentation"with" initial" threseholding" of" the"MRI" brain" and" a" subsequent" process" of"
multiple" erosions" and" dilations," using" MIDAS" software" (Freeborough" et" al.," 1997)," to"
result"in"a"brain"region"separated"from"dura"and"skull,"and"yielding"a"whole"brain"volume."
Longitudinal"whole"brain"volume"changes"were"derived"as"follows:"baseline"and"followS
up" scans" were" spatially" aligned" to" standard" space" and" then" underwent" an" affine"
registration" (12" degrees" of" freedom)" to" align" the" followSup" scan" to" the" baseline" scan."
Change" in"brain"volume"was"calculated"using" the"boundary" shift" integral" (Freeborough"








using" voxelSbased" morphometry" (VBM)," which" assesses" differences" in" voxel" density"
across" a" series" of" structurally" aligned" volumetric" MRI" scans." " For" all" VBM" analyses"
Statistical" Parametric" Mapping" (SPM)" version" 8" (http://www.fil.ion.ucl.ac.uk/spm)" was"
used" running" the" DARTEL" toolbox" (Ashburner," 2007)." DARTEL" improves" interSsubject"
alignment" by" generating" forward" and" backward" deformations." From" the" initial"
segmentations" each" tissue" class" undergoes" rigid" transformation" to" approximate"
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alignments."Both"grey"and"white"matter" is"then"simultaneously"registered"producing"an"
initial"groupSwise"template,"which" is"then" iteratively"refined,"and" individual"subject"data"








both" native" space" and" “DARTEL" imported”" space." Segmentations" are" visually"
inspected"to"ensure"tissue"classes"are"not"contaminated"or"degraded."
3. DARTEL"grey" and"white"matter"output" images" are" Jacobian" scaled" and" spatially"
normalized"to"Montreal"neuroimaging"template"(MNI)"space"using"the"‘Normalise+
to+ MNI+ space’+module" in" SPM" 8" using" default" parameters." To" provide" normally"
distributed"data" for" statistical" analysis" images"undergo" smoothing"using" a"6mm"
kernel"size.+-
4. Total"intracranial"volume"(TIV),"reported"in"millilitres,"were"calculated"by"summing"




disease" duration" (as" a" marker" of" disease" severity)" included" as" nuisance" coS
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variants."In"line"with"DTI"analysis"regional"differences"in"grey"matter"volume"were"
assessed" using" voxelSwise" nonSparametric" permutation" testing" (n=10,000"
permutations)." Results" underwent" correction" for" multiple" comparisons" using"
familySwise"error"(p<0.05)"and"threshold"free"cluster"enhancement.""-




Following" acquisition" each" diffusionSweighted" sequence" is" visually" inspected" to" ensure"
adequate" brain" coverage" and" to" identify" any" artefacts" (e.g." excessive" movement"
resulting" in" checkerSboarding," field" distortions)." If" an" abnormality" is" detected," were"
possible,"the"participant"is"recalled"for"repeat"scanning"as"soon"as"possible."The"presence"
of"persistent" image"artefacts" is"considered"an"exclusion"criterion" from"the"study"and" is"
indicated"in"the"subsequent"studies."All"images"were"motion"and"eddy"current"corrected"
by"registering"each"diffusionSweighted"imaged"to"the"first"b"="0"image"using"12"degrees"of"
freedom" FLIRT" (Jenkinson" and" Smith," 2001)." Tensor" fitting" was" performed" using" the"





An" overview" of" the" imaging" pipeline" described" below" is" found" in" Figure" 2.1." Following"





It" attempts" to" address" the" issue" of" misSalignment" of" white" matter" structures" by"
generating" a" white" matter" tract" skeleton" which" is" common" to" each" subject" and" then"
projecting" each" individual" subject’s" FA" data" onto" a" mean" FA" tract" skeleton" before"
carrying"out"voxelSwise"statistics"to"assess"for"differences"between"groups."Each"step"is"
outlined"below:"
1. Each" subject’s" FA" image" is" slightly" eroded" to" remove"outlier" data" from" the" raw"
diffusion"tensor"image."
2. All"FA" images"undergo"an" initial"affine"registration"and"then"nonlinear"alignment"
to"a"standard"study"specific"space."To"minimise"the"effect"of"excessive"warping,"
the" FA" image" that" is"most" representative"of" the"group" is" selected" as" the" target"






4. All" study" subject’s" FA" images" are" then" averaged" to" create" a" mean" FA" image"
combined"into"a"single"4SD"image"file."The"white"matter"tracts"undergo"a"process"
of"skeletisation."This"aims"to"identify"white"matter"tracts,"which"are"common"to"all"
study"subjects."These"are" represented"as"a"contiguous" line,"which" runs"along"an"
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approximate"centre"line"of"each"tract."The"voxels"that"comprise"the"skeleton"are"
chosen"after"a"search"of"each"voxel" to"determine" the"voxel"with" the"highest"FA"
value," and" this" voxel" is" then" labelled" as" being" at" the" centre" of" the" tract." To"
determine"the"orientation"of"the"tract"the"vectors"perpendicular"to"the"centre"of"











7. The" aligned" data" are" now" ready" to" be" feed" into" a" voxelwise" statistical" analysis"
pipeline." Carrying" out" statistical" analysis" on" only+ the" skeletonised" data" has" an"
advantage"of"reducing"the"total"number"of"statistical"tests"by"limiting"analysis"to"
only" the"voxels"within" the" skeleton."This" reduces" the" likelihood"of" false"positive"
results.""






distribution"using" FSL’s" randomise+module" (Winkler" et" al.," 2014)," and" controlling"
for"multiple"comparison"using"familySwise"error"rate"p<0.05."
10. The" test" statistic" is" generated" using" ThresholdSfree" cluster" enhancement" (TFCE)"
(Smith" and" Nichols," 2009)." This" method" finds" clusters" (i.e." voxels" with" some"
spatial"contiguity)"and"then"enhances"them,"rather"than"performing"single"voxelS
wise" threseholding." " Normal" cluster" based" threseholding" requires" an" arbitrary"
initial"cluster"to"be"defined."TFCE"finds"clusters"based"on"the"presence"of"clusterS








were" selected" from" a" probabilistic" atlas" (Mori" et" al.," 2004)," and" to" adjust" for"
anatomical" variability" of" the" tract" thresholded" at" a" likelihood" of" overSlap" across"
individuals" of" 20%," this" moderately" stringent" threshold" is" also" likely" to" reduce"
contamination"within" regionsSofSinterest" by" reducing" partial" volume" effects" and"
erroneous"inclusion"of"grey"matter."This"figure"was"chosen"following"a"review"of"
varying" thresholds." This" threshold" was" deemed" to" be" appropriate" as" it"
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consistently" included" core" parts" of" the" tract" (i.e." provided" high" anatomical"
specificity),"whilst"excluding"neighbouring"tracts,"CSF"or"grey"matter.""
13. Information" on" statistical" differences"within" the"mask"were" explored" using" the"




within" each" tract" limited" to" within" the" skeleton." The" decision" to" express" tract"












subjects" images" are" transformed" to" the" same"MNI" 152" space" as" the" FA" images"







Chapters" 4" and" 6"will" deal"with" longitudinal" analysis" of"DTI" data," little" is" known" about"
longitudinal" TBSS" analysis," and" in" particular" issues" surrounding" registration" of"
longitudinal" data." For" this" reason" an" inShouse" pipeline" was" developed" to" deal" with"
longitudinal" DTI" data." This" pipeline" primarily" uses" DTISTK" version" 2.2" software" package"
(Zhang"et"al.,"2006),"which"was"specifically"developed"to"deal"with"DTI"registration"and"
has" been" shown" to" have" the" best" performance" in" terms" of" registration" compared" to"
other"methods" (Wang"et"al.," 2011)."Another"major" factor" in"choosing" this" software"was"
that" it"has"good" reproducibility"between"subjects" scanned"backStoSback"as"evidence"by"
low"variability"(Keihaninejad"et"al.,"2013)."Unlike"registration"of"volumetric"MRI,"which"is"
driven" by" simple" scalar" measurements," DTI" is" multidimensional" (i.e." multiple" tensor"
orientations)," making" registration" of" images" more" complex." However" DTISTK" offers" a"
robust" spatial" normalisation" module" ensuring" this" high" dimensionality" is" maintained"
during" registration" of" images." DTISTK" allows" use" of" whole" tensor" information" by"
incorporating"tensor"orientation"and"tract"similarity"measures"(rather"than"using"a"simple"




2. A"withinSsubject" template" is"generated" from"baseline"and" followSup" scanning" to"





4. A"groupSwise" template" is" then"created" from"each"subject’s"average" image"using"
iterative"linear"and"nonSlinear"registration."





7. To" allow" a" regionS0fSinterest" analysis" the" FA" map" (in" groupSwise" space)" is"
segmented" using" locally" adaptive" tool" (LoAd)," part" of" the" NiftySeg" software"
package" (Cardoso,"2011)."A"binary"mask"of"white"matter" tracks"was"created"and"
matter"mater"structures"were"identified"using"the"ICBMSDTIS81"atlas"(Mori,"2005).""
8. The" ICBMSDTIS81" atlas" is" then" linearly" and" nonSlinearly" registered" to" the" final"
template"FA"image."
9. Binary"masks"of"each"regionSofSinterest"were"generated"using"a"threshold"of"50%"
on" the" white" matter" probability" map" with" a" further" 1mm" erosion" around" the"
boundary"of"each"mask" to"provide"high"anatomical" specificity" (unless"otherwise"
specified)."
10. DTI"metric" data" including"mean" value" and" standard" deviation" are" then" selected"
from"each"regionSofSinterest."











3.( CrossFsectional( profiles( of( white( matter( pathology( in(
behavioural(variant(frontotemporal(dementia(
3.1(Introduction(
Network" disintegration" in" bvFTD" has" been" demonstrated" using" functional" MRI" and"
distributed" grey" matter" changes" compatible" with" network" breakdown" have" been"
established"(Rohrer"et"al.,"2011;"Seeley"et"al.,"2009;"Whitwell"et"al.,"2005)."As"mentioned"in"
the" introduction" the" anteriorly" directed" ‘salience’" processing" network" appears" to" be" a"
key"network"which"shows"selective"vulnerability"in"bvFTD"(Seeley"et"al.,"2009)."Despite"a"
vast"literature"on"functional"and"volumetric"imaging"in"the"area"of"bvFTD,"there"remains"a"
paucity" of" information" on" the" changes" occurring" within" white" matter" tracts." This" is"
significant" as" these" structures" provide" the" structural" connectivity" underpinning" largeS
scale"brain"networks"by"binding"together"cortical"and"subcortical"regions."Furthermore,"
besides" common" syndromic" profiles" of" network" damage" there" may" be" distinct"
neuroanatomical" subgroups" within" the" bvFTD" spectrum" with" relative" specificity" for"
particular"molecular"pathologies"(Warren"et"al.,"2012)."Identifying"profiles"of"white"matter"





DTI"may" allow" such"white"matter" tract" profiles" to"be"delineated" in" bvFTD."A"particular"
potential" strength" of" DTI" is" the" generation" of" multiple" quantitative" metrics" of" white"
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matter"alteration"(diffusivity)"during"a"single"acquisition."The"neurobiological"significance"
of" these" metrics" remains" relatively" little" explored," particular" in" bvFTD," and" whilst"
fractional" anisotropy" (FA)" is" the" most" widely" cited" metric," more" recent" studies" have"
suggested"that"use"of"the"individual"parameters"of"diffusion"may"be"more"appropriate"in"
neurodegeneration"(AcostaSCabronero"et"al.,"2010)."The"primary"aim"of"this"chapter"is"to"
apply" DTI" as" a"means" of" characterising" profiles" of"white"matter" tract" pathology" crossS
sectionally," in" a" clinically" and"molecularly" characterised" cohort" of" patients"with" bvFTD."
Secondly" this" study" aims" to" explore" and" compare" multiple" DTI" metrics" to" establish" if"




Whilst" the"number"of" studies"using"DTI" to" study"bvFTD" remains" comparatively" small" in"








Although"this"was"a"wellSpowered"study" it"did"not"attempt"robust"DTI" registration," it" is"
also" unclear" how" the" subSgroups"were" defined," as" if" defined" on" imaging" grounds" this"
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could"lead"to"some"circularity"in"the"findings."A"number"of"other"studies"followed,"which"




2010;" Zhang" et" al.," 2009)." These" studies" identified" pathological" changes" in" uncinate"
fasciculus"and"anterior"cingulum"across"a"number"of"different"DTI"metrics."Furthermore"
these"studies"also"suggested"that"some"DTI"metrics"such"as"RD"might"be"more"sensitive"
than" others," identifying" a" wider" anatomical" profile" of" pathology" compared" to" more"
traditional"metrics" such" as" FA." Zhang" and" colleagues" also" reported" the" first" profiles" of"





the" time" of"writing" this" has" been" citied" in" over" 300" publications" as" a"methodology" of"
choice," across" a" range" of" disorders" from" neurodegenerative" conditions" to" neuroS
inflammatory,"psychiatric"disorders"and"neonatal"brain"disorders."This"robustness"was"a"
major" factor" in" the"decision" to"use" this" pipeline" for" this" crossSsectional" study." The" first"
study"of"white"matter" in"bvFTD"using"TBSS"was"published" in"2011"and" like" the"previous"
studies" showed" the" most" striking" changes" in" white" matter" tracts" occurred" within" the"
uncinate" fasciculus," corpus" callosum" and" cingulum" as" well" as" the" parahippocampus"
(Agosta" et" al.," 2011)." This" study" additionally" revealed" that" white"matter" changes" were"
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very" extensive," occurring" in" posterior" regions," often" thought" more" consistent" with"
Alzheimer’s"disease" (AcostaSCabronero"et" al.," 2010)," and"extending"beyond" the" limit"of"
maximal"grey"matter"atrophy."More" recent" studies"have"attempted" to" study"a"broader"
clinical"phenotype" including"patients"within" the"motorSneuron"disease" spectrum,"which"
overlaps" with" bvFTD" (Lillo" et" al.," 2012)," as" well" as" attempting" to" improve" the"






biomarker" evidence" of" neurodegeneration," meaning" that" patients" with" the" soScalled"
phenocopy" syndrome" (Kipps" et" al.," 2010)" or" psychiatric" diagnosis" may" have" been"
included." Furthermore" each" study" fails" to" include" individuals" with" molecularly" defined"
syndromes," i.e." those" with" genetic" or" pathological" confirmation" of" diagnosis." Imaging"
methods" are" also" subSoptimal;" many" early" studies" use" only" regionSofSinterest" based"
approaches"to"study"white"matter,"which"leads"to"a"bias"in"reporting."Large"differences"in"
the" degree" and" area" of" brain" atrophy" in" bvFTD" may" result" in" misalignment" between"
structures" during" registration," making" it" difficult" to" ensure" accurate" comparisons"




The"aim"of" this" study" is" to"establish" if" clinically"and"molecular"defined"profiles"of"white"
matter"pathology"occur."To"establish"this"hypothesis"the"current"study"will"also"address"
many"of" these" limitations"of"previous"studies"by" improving"on"selection"criteria,"having"
higher" quality" DTI" acquisitions" (in" this" case" using" 64" directions" and" backStoSback"































































































































TwentySseven" consecutive" patients" who" fulfilled" a" diagnosis" of" probable" or" definite"
bvFTD"based"on"current"consensus"criteria"were"recruited"from"the"Specialist"Cognitive"
Disorders" Clinic" at" the" National" Hospital" for" Neurology" and" Neurosurgery." The" bvFTD"









declined" and"one"patient" later"withdrew" consent" for" testing;" neither" of" these"patients"
had" a" family" history" and" were" therefore" considered" to" have" sporadic" disease." The"
remaining" 25" patients" underwent" genetic" sequencing" of"MAPT,+ PGRN+ or+ C9ORF72+ and"
other"genes"as"previously"specified"(see"section"2.1.3."for"details)"
"
All" subjects" underwent" MRI" acquisition" with" both" volumetric" and" diffusion" weighted"
imaging" acquired" and" underwent" preSprocessing" as" specified" previously" " (see" section"
chapter" 2," section" 2.2.1" for" details" on" image" acquisition)." " As" there" is" significant"
heterogeneity" in" the" imaging"phenotype"of" bvFTD" (i.e." some"have" right" temporal" lobe"





of" this" groupSwise" skeleton" followed" a" previously" published" pipeline" which" can" be"
incorporated" as" part" of" the" existing" TBSS" pipeline" (Keihaninejad" et" al.," 2012)." This"
methodology" aims" to" improve" the" quality" of" image" registration" in" neurodegenerative"
conditions"by"minimising"the"effects"of"stretch"and"distortion"seen"when"attempting"to"
warp" a" brain" affected" by" significant" neurodegeneration" onto" the" standard" FMRIB58"
image" (which" is" based" on" 58" scans" of" healthy" individuals" aged" 20S50" years)." It" also"
reduces" image" distortion" in" regions" affected" by" severe" atrophy" and" provides" greater"
detail"on"more"distal"sections"of"white"matter"tracts"compared"with"the"standard"TBSS"
pipeline"(compare"images"generated"using"this"customised"method"versus"standard"TBSS"
in" Figure" 3.1)." The" volumetric" images" were" analysed" within" SPM" using" the" DARTEL"











with"disease"group"membership"as" the" factor"of" interest"and"age,"gender," and"disease"
duration" included"as"nuisance"covariates."Each"metric"(AX/RD/TR/FA)"was"analysed"with"
the" above"model," and" additionally"with" a"model" that" included" the"overall"mean"of" the"
metric" under" study" as" an" additional" covariate." The" latter"model" reveals" areas" that" are"
specifically" affected" after" adjusting" for" widespread" global" differences," analogous" to"




healthy" individuals," the" AD" disease" group" and" with" each" other" using" the" same"model"
design."Statistical"analyses"were"carried"out"as"specified"previously"(see"section"2.6." for"
details)."Significant"results"were"projected"onto"a"studySspecific"average"brain"registered"
to" standard" (MNI)" space." To" provide" accurate" anatomic" localisation" a" series" of" tractS
specific"masks"were" applied" to" the" significant"whole" brain" results" using" a" probabilistic"
atlas" (Mori" et" al.," 2004)," and" chosen" based" on" apriori" hypothesis" of" involvement" or"
previously" published" imaging" data." " A" total" of" 14" binary"masks"were" created," covering"
major"white"matter"pathways"including"right"and"left"inferior"longitudinal"fasciculus"(ILF),"
superior" longitudinal" fasciculus" (SLF)," uncinate" fasciculus" (UF)," anterior" thalamic"
radiation" (ATR)," cingulum"bundle" (CB)," corticospinal" tract" (CST)," corpus" callosum" (CC),"
and" fornix." To" adjust" for" the" anatomical" variability" additional" masking" of" tracts" was"
carried" out" as" previously" specified" and" data" from" each" masked" tract" extracted" for"
analysis"(see"section"2.6).""
"
To" determine" the" sensitivity" and" specificity" of" different" DTI" metrics" in" classifying"
individual" participants" into" separate" groups" (bvFTD/healthy" individual/AD)" receiver"
operating" characteristic" (ROC)" curves" were" constructed" and" areasSunderScurve" (AUC)"
were"calculated."Two"approaches"were"used"for"the"classification,"assessing"respectively"
the" mean" of" each" individual" metric" (FA," AX," RD," MD)" across" the" whole" white" matter"
skeleton"and"the"mean"values"within"individual"tracts"identified"as"prominently"involved"







Subjects’" demographics," clinical" and" neuropsychological" characteristics" are" detailed" in"
table"3.2."27"patients"with"bvFTD"were"identified"(mean"age"62.5"±"9.0"years;"male=20);"14"





four" had"mutations" in" C9ORF72" and" one" patient" who" subsequently" died"was" found" to"
have"Pick’s"disease"pathology"at"postSmortem."In"addition"to"meeting"diagnostic"criteria"
for" bvFTD," 2" patients" had" symptoms" compatible" with" Progressive" Supranuclear" Palsy"
(both"having"sporadic"bvFTD)," 2"had"symptoms"compatible"with"motor"neuron"disease"







































63.1" 5.2+ 64.5" 4.5+ ns" ns" ns"





























" + " " "
Neuropsychological*( (
VIQ" 81.2" 23.4+ 90.6" 19.4+ 123.3" 9.6+ <0.001( ns" <0.001(
PIQ" 88.6" 19.1+ 83.3" 18.7+ 118.1" 10.9+ <0.001( ns" <0.001(
Recognition"Memory:""Words"(/50)" 33.3" 10.1+ 29.4" 7.8+ 48.1" 2.3+ <0.001( 0.08" <0.001(
Recognition"Memory":"Faces"(/50)" 32.8" 6.8+ 33.7" 6.3+ 41.9" 4.7+ <0.001( ns" <0.001(
Digit"Span:"Forward(/12)" 7.1" 2.2+ 6.3" 2.2+ 9.1" 1.4+ 0.002( ns" <0.001(
Digit"Span:"Reverse(/12)" 5.5" 2.7+ 4.3" 3.0+ 6.8" 1.8+ ns" 0.09" 0.002(
BPVS"(/150)" 116.5" 38.0+ 132.5" 24.3+ 147.9" 1.5+ <0.001( 0.02( <0.001(
Graded"Naming"Test"(/30)" 10.8" 9.1+ 13.9" 8.4+ 26.0" 2.1+ <0.001( ns" <0.001(
Graded"Arithmetic"Test"(/24)" 12.1" 6.9+ 5.3" 4.0+ 14.1" 5.4+ 0.4" <0.001( <0.001(
VOSP"(/20)" 15.7" 3.2+ 15.0" 3.3+ 18.8" 1.1+ <0.001( ns" <0.001(
DKEFS":"Colour"Naming"(max"90"secs)" 45.6" 22.9+ 55.0" 18.7+ 31.2" 4.7+ 0.03( 0.03( <0.001(
DKEFS:"Word"Naming"(max"90"secs)" 35.1" 23.6+ 36.6" 15.3+ 21.5" 3.4+ 0.02( 0.1( <0.001(








All" AD" patients" had" a" typical" memorySled" presentation." The" healthy" control" and" AD"
groups"were"comparable"in"age"and"gender"characteristics"(healthy"control"group"mean"
age"64.5"±"4.5"years,"male=13/20;"AD"group"mean"age"63.1"±5.2"years;"male=17/25)." "CSF"
data" was" available" on" 13/27" bvFTD" patients;" all" had" profiles" compatible" with" nonS
Alzheimer’s" pathology" (normal" Abeta1S42" and" normal" or" elevated" total" tau)," although"
one"subject"had"low"Abeta1S42"and"low/normal"tau,"which"was"felt"to"be"consistent"with"a"
handling"error."CSF"data"was"available"on" 11/25"AD"patients;"all"had"profiles"compatible"
with" AD" pathology" (low" Abeta1S42," elevated" total" tau)." A" detailed" general"
neuropsychological" assessment"was" completed" in" 69/72" participants" (one" patient"with"
bvFTD"and"two"with"AD"were"unable"to"comply"with"testing)."Profiles"of"performance"in"
the"patient"groups"were"in"keeping"with"clinical"syndromes:"both"disease"groups"showed"
widespread" deficits" compared"with" the" healthy" control" group," however" the" AD" group"
performed" inferiorly" to" the" bvFTD" group" on" tests" of" arithmetic" and" general" executive"




Widespread" white" matter" tract" pathology" was" identified" in" the" bvFTD" group"
compared"with"both"the"healthy"control"group"and"the"AD"group"(Figures"3.2"and"
3.3).""














Tract" pSvalue" Voxels" %"Voxels" Tract" pSvalue" Voxels" %"Voxels"
R"UF" 0.001" 390" 99.5" R"UF" 0.002" 389" 99.2"
L"UF" 0.002" 623" 95.3" L"UF" 0.002" 605" 92.5"
R"CB" 0.003" 151" 82.5" R"CB" 0.01" 121" 66.1"
L"CB" 0.004" 634" 74.8" CC" 0.005" 9818" 66"
CC" 0.004" 9700" 65.2" L"CB" 0.007" 525" 61.9"
L"ILF" 0.01" 1069" 40.6" L"ILF" 0.01" 1093" 41.5"
R"SLF" 0.02" 899" 37.8" R"ILF" 0.02" 750" 40.3"
R"ILF" 0.007" 542" 29.1" R"SLF" 0.01" 845" 35.5"
L"SLF" 0.02" 751" 27.6" L"SLF" 0.03" 882" 32.4"
R"ATR" 0.004" 316" 25.5" L"ATR" 0.003" 395" 25.3"
L"ATR" 0.003" 389" 24.9" R"ATR" 0.003" 313" 25.2"
Fornix" 0.001" 112" 20" Fornix" 0.001" 112" 20"
R"CST" 0.01" 213" 3.2" R"CST" 0.02" 269" 4"
L"CST" 0.006" 94" 1.3" L"CST" 0.008" 197" 2.7"
AX(bvFTD>Controls( FA(bvFTD<Controls(
Tract" pSvalue" Voxels" %"Voxels" Tract" pSvalue" Voxels" %"Voxels"
R"UF" 0.004" 269" 68.6" R"UF" 0.003" 349" 89"
L"UF" 0.002" 407" 62.2" R"CB" 0.007" 152" 83.1"
CC" 0.006" 6717" 45.1" L"CB" 0.004" 669" 78.9"
R"ILF" 0.01" 580" 31.1" L"UF" 0.003" 500" 76.5"
R"SLF" 0.008" 598" 25.1" CC" 0.005" 9470" 63.6"
R"CB" 0.01" 45" 24.6" R"SLF" 0.03" 893" 37.5"
R"ATR" 0.007" 271" 21.9" L"ILF" 0.01" 875" 33.2"
L"ATR" 0.004" 331" 21.2" L"SLF" 0.02" 784" 28.8"
Fornix" 0.002" 112" 20" R"ILF" 0.01" 490" 26.3"
L"CB" 0.009" 141" 16.6" L"ATR" 0.01" 306" 19.6"
L"SLF" 0.01" 262" 9.6" R"ATR" 0.008" 219" 17.7"
R"CST" 0.005" 316" 4.7" R"CST" 0.008" 343" 5.1"
L"CST" 0.006" 293" 4" L"CST" 0.009" 171" 2.3"
Table& 3.3& Summary& of& unadjusted& diffusivity& data& by& diffusivity& metric& and& region& of& interest&
comparing&bvFTD&with&healthy&controls.&&Results&are&ordered&by&%&of&tract&involvement.&
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metrics" (increased" AX/RD/TR," decreased" FA" in" bvFTD)" in" bilateral" uncinate"




Figure(3.3(Unadjusted(white(matter( tract(data:(Patterns(of(white(matter(alteration( in( the(bvFTD(





showed" most" significant" and" consistent" white" matter" pathology" across" metrics"
(increased"RD/TR,"decreased"FA"in"bvFTD)"in"bilateral"uncinate"fasciculus,"cingulum"
bundle" and" corpus" callosum," and" somewhat" less" prominently" in" superior"






















Tract" pSvalue" Voxels" %"Voxels" Tract" pSvalue" Voxels" %"Voxels"
R"UF" 0.002" 370" 94.4" R"UF" 0.006" 338" 86.2"
L"UF" 0.003" 588" 89.9" L"UF" 0.006" 550" 84.1"
L"CB" 0.003" 524" 61.8" R"CB" 0.008" 417" 49.2"
CC" 0.007" 7588" 51" CC" 0.008" 74" 40.4"
R"CB" 0.003" 81" 44.3" L"ATR" 0.02" 465" 37.5"
R"ATR" 0.01" 441" 35.6" L"CB" 0.01" 4959" 33.3"
R"ILF" 0.008" 615" 33" R"SLF" 0.01" 593" 31.8"
R"SLF" 0.01" 647" 27.2" R"ILF" 0.01" 454" 17.2"
Fornix" 0.008" 124" 22.2" R"CST" 0.04" 89" 15.9"
L"ATR" 0.01" 333" 21.3" L"SLF" 0.01" 230" 14.7"
L"ILF" 0.007" 470" 17.8" L"ILF" 0.02" 691" 10.3"
L"SLF" 0.03" 376" 13.8" R"ATR" 0.03" 187" 7.9"
R"CST" 0.01" 904" 13.5" Fornix" 0.03" 479" 6.5"
L"CST" 0.01" 604" 8.2" L"CST" 0.04" 98" 3.6"
FA"bvFTD<AD" AX"bvFTD<AD"
Tract" pSvalue" Voxels" %"Voxels" Tract" pSvalue" Voxels" %"Voxels"
R"UF" 0.004" 350" 89.3" No"significant"results"
L"UF" 0.004" 563" 86.1"
"
"" "" ""
R"CB" 0.004" 585" 69" " "" "" ""
L"CB" 0.006" 8908" 59.8"
"
"" "" ""
CC" 0.004" 89" 48.6" " "" "" ""
R"ATR" 0.009" 1054" 44.3" " "" "" ""
R"SLF" 0.01" 777" 41.7"
"
"" "" ""
L"CST" 0.01" 1023" 37.6" " "" "" ""
L"ATR" 0.01" 412" 33.2"
"
"" "" ""
R"ILF" 0.01" 661" 25.1" " "" "" ""
L"SLF" 0.01" 345" 22.1"
"
"" "" ""
L"ILF" 0.007" 1070" 15.9" " "" "" ""
Fornix" 0.01" 911" 12.4" " "" "" ""










After" correction" for" the" effects" of" global" mean" diffusivity" values," more" focal"
profiles"of"white"matter"alteration"emerged.""






group"showed" the"most" significant"and"consistent" (i.e." change" in"all"DTI"metrics)"





Tract$ pSvalue$ Voxels$ %$Voxels$ Tract$ pSvalue$ Voxels$ %$Voxels$
R$UF$ 0.03$ 17$ 4.3$ R$UF$ 0.03$ 9$ 2.3$
R$ILF$ 0.03$ 8$ 0.4$ R$ILF$ 0.04$ 3$ 0.2$
L$UF$ 0.05$ 1$ 0.2$ $ $ $ $
AX&bvFTD>Controls& FA&bvFTD<Controls&
Tract$ pSvalue$ Voxels$ %$Voxels$ Tract$ pSvalue$ Voxels$ %$Voxels$
L$UF$ 0.003$ 379$ 58$ CC$ 0.04$ 875$ 5.9$
R$UF$ 0.008$ 198$ 50.5$ R$UF$ 0.04$ 17$ 4.3$
CC$ 0.01$ 4843$ 32.5$ L$UF$ 0.04$ 11$ 1.7$
R$ILF$ 0.02$ 526$ 28.2$ L$ATR$ 0.05$ 1$ 0.1$
Fornix$ 0.005$ 111$ 19.9$ $ $ $ $
L$ATR$ 0.007$ 276$ 17.7$ $ $ $ $
R$SLF$ 0.01$ 385$ 16.2$ $ $ $ $
R$ATR$ 0.03$ 138$ 11.1$ $ $ $ $
L$CB$ 0.01$ 72$ 8.5$ $ $ $ $
L$SLF$ 0.02$ 151$ 5.6$ $ $ $ $
R$CST$ 0.01$ 156$ 2.3$ $ $ $ $
L$CST$ 0.01$ 143$ 1.9$ $ $ $ $





Compared" with" the" AD" group" (see" figure" 3.5" and" table" 3.6)," the" bvFTD" group"
showed" the" most" significant" and" consistent" white" matter" pathology" in" bilateral"
uncinate" fasciculus;" comparing" DTI" metrics," the" most" extensive" white" matter"
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extensive"white"matter" alterations" in" the"AD"group" compared"with"bvFTD"group"
were"detected"in"left"inferior"longitudinal"fasciculus"using"TR."
"









Tract$ pSvalue$ Voxels$ %$Voxels$ Tract$ pSvalue$ Voxels$ %$Voxels$
R$UF$ 0.02$ 263$ 67.1$ R$UF$ 0.02$ 215$ 54.8$
L$UF$ 0.01$ 390$ 59.6$ L$UF$ 0.03$ 237$ 36.2$
R$CB$ 0.04$ 52$ 28.4$ R$ILF$ 0.02$ 306$ 16.4$
CC$ 0.03$ 1919$ 12.9$ L$ILF$ 0.03$ 123$ 4.7$
R$ATR$ 0.03$ 146$ 11.8$ CC$ 0.03$ 246$ 1.7$
R$ILF$ 0.01$ 181$ 9.7$ R$CST$ 0.04$ 88$ 1.3$
L$ILF$ 0.02$ 210$ 8$ AX&bvFTD>AD&
R$CST$ 0.02$ 378$ 5.6$ Tract$ pSvalue$ Voxels$ %$Voxels$
R$SLF$ 0.03$ 124$ 5.2$ L$UF$ 0.04$ 107$ 16.4$
L$ATR$ 0.02$ 80$ 5.1$ R$UF$ 0.03$ 13$ 3.3$
L$CST$ 0.02$ 232$ 3.2$ R$ILF$ 0.02$ 3$ 0.2$
L$CB$ 0.02$ 10$ 1.2$ CC$ 0.05$ 2$ 0.01$
Table& 3.6& Summary& of& diffusivity& data& indicating& regions& of& interest& with& greater& white& matter&







Tract$ pSvalue$ Voxels$ %$Voxels$ Tract$ pSvalue$ Voxels$ %$Voxels$
L$ILF$ 0.03$ 289$ 11$ L$ILF$ 0.03$ 736$ 27.9$
L$SLF$ 0.04$ 87$ 3.2$ L$SLF$ 0.02$ 524$ 19.3$
CC$ 0.03$ 162$ 1.1$ CC$ 0.02$ 303$ 2$
$ $ $ $ L$CB$ 0.02$ 10$ 1.2$












to" the" healthy" control" group," the"MAPT+mutation+ subgroup" showed" consistent"
alterations" in" left" uncinate" fasciculus" across" DTI"metrics," albeit" highly" variable" in"
extent" within" the" tract;" the" most" extensive" alterations" were" detected" with" AX,"
which" revealed" additional" involvement" of" right" uncinate" fasciculus," corpus"
callosum," fornix" and" bilateral" inferior" longitudinal" fasciculus" and" superior"
longitudional"fasciculus.""Compared"to"the"AD"group,"the"MAPT"mutation"subgroup"
showed" altered" RD" and" TR" in" corticospinal" tract," anterior" thalamic" radiation,"
inferior" longitudinal" fasciculus" and" TR," ILF" and" uncinate;" again," these" alterations"
varied"widely"in"extent"between"DTI"metrics."
"
Alterations" detected" in" the" smaller" C9ORF72" mutation" subgroup" were" less"
extensive:" compared" to" the" healthy" control" group," the" C9ORF72" mutation" cases"












Figure( 3.6( Patterns( of( white( matter( alteration( in( the( MAPT( and( C9ORF72( mutation( groups(







Tract" pSvalue" Voxels" %Voxels" Tract" pSvalue" Voxels" %Voxels"
L"UF" 0.008" 53" 8.1" L"UF" 0.009" 37" 5.7"
L"ILF" 0.01" 82" 1.6" L"ILF" 0.01" 59" 2.2"
Fornix" "0.05" "9" 1.6" Fornix" 0.04" 49" 8.8"
"" "" "" "" CC" 0.04" 21" 0.1"
MAPT>CONT(AX( MAPT<CONT(FA(
Tract" pSvalue" Voxels" %Voxels" Tract" pSvalue" Voxels" %Voxels"
Fornix" 0.004" 123" 22" L"UF" 0.01" 62" 9.5"
L"UF" 0.006" 275" 42" Fornix" 0.02" 169" 30.2"
R"UF" 0.008" 180" 45.9" L"ILF" 0.02" 130" 4.9"
L"ATR" 0.009" 140" 9" R"ATR" 0.02" 21" 1.7"
R"ATR" 0.02" 13" 1" L"ATR" 0.02" 12" 0.8"
L"CB" 0.02" 90" 10.6" "" "" "" ""
CC" 0.03" 2477" 16.6" "" "" "" ""
L"CST" 0.03" 106" 1.4" "" "" "" ""
L"SLF" 0.03" 52" 1.9" "" "" "" ""
L"ILF" 0.03" 13" 0.5" "" "" "" ""
R"ILF" 0.03" 184" 9.9" "" "" "" ""
R"CB" 0.05" 7" 3.8" "" "" "" ""
C9>CONT(AX(
Tract" pSvalue" Voxels" %Voxels"
CC" 0.04" 278" 1.9"
L"CB" 0.03" 32" 3.8"
MAPT>AD(RD( MAPT>AD(TR(
Tract" pSvalue" Voxels" %Voxels" Tract" pSvalue" Voxels" %Voxels"
L"ILF" 0.02" 209" 7.9" L"ILF" 0.02" 188" 7.1"
L"UF" 0.02" 136" 20.8" R"UF" 0.03" 105" 26.8"
R"UF" 0.03" 44" 11.2" L"UF" 0.03" 277" 42.4"
R"ILF" 0.03" 84" 4.5" R"ILF" 0.03" 200" 10.7"
Fornix" 0.04" 145" 25.9" CC" 0.04" 172" 1.2"
R"ATR" 0.04" 35" 2.8" L"ATR" 0.05" 25" 1.6"
CC" 0.05" 92" 0.6" "" "" "" ""
R"CST" 0.05" 11" 0.2" "" "" "" ""
MAPT>AD(AX(
Tract" pSvalue" Voxels" %Voxels"
"L"ILF" 0.04" 24" 0.9"







the" greatest" sensitivity" (82%)" and" specificity" (80%)" for" distinguishing" the" bvFTD"
group"from"the"healthy"control"group;"TR"performed"comparably,"and"AX"and"FA"
somewhat"less"favourably.""








corpus" callosum," left" uncinate" fasciculus," and" left" cingulum" bundle" showed"
greatest"sensitivity"(93%,"82%"and"74%"respectively)"and"specificity"(75%,"75%"and"70%"
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respectively)" for"distinguishing" the"bvFTD"group" from" the"healthy" control"group."
Whole" brain"mean" FA" had" the" greatest" sensitivity" (78%)" and" specificity" (68%)" for"
distinguishing"the"bvFTD"group"from"the"AD"group"(see"Figure"3.7);"RD,"TR"and"AX"
performed" somewhat" less" favourably." Comparing" specific"white"matter" tracts" of"
interest" using" mean" FA" (see" Figure" 3.7)," left" uncinate" fasciculus" showed" the"
greatest" sensitivity" (77%)" and" specificity" (68%);" left" cingulum" bundle" and" corpus"




In" the" VBM" analysis," compared"with" the" healthy" control" group" the" bvFTD" group"
showed," as" anticipated," areas" of" significantly" (p<0.05" after" wholeSbrain" FWE"
correction" for" multiple" voxelSwise" comparisons" with" TFCE)" reduced" grey" matter"
predominantly" distributed" in" frontal" and" temporal" cortices" in" both" cerebral"





(Figure" 3.8)" showed" that" white" matter" damage" generally" occurred" in" close"
anatomical" proximity" to" areas" of" grey" matter" atrophy," particularly" noting" the"
proximity"right"anterior"temporal"lobe"atropy"and"white"matter"tract"pathology"of"
the" right" uncinate" fasciculus." However," compared" with" the" distribution" of" grey"
matter" atrophy" overall," white" matter" tract" pathology" across" DTI" metrics" was"
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spatially" more" extensive," with" anatomical" involvement" of" more" dorsal" and"
posterior"parts"of"both"cerebral"hemispheres.""
"
Figure(3.8(Maps(of(grey(matter( (GM)(atrophy((light(blue)(and(regions(of( intersection(of(all( four(
white( matter( DTI( metrics( (adjusted( for( mean( global( diffusivity( value)( in( the( bvFTD( group(
compared(with(the(healthy(control(group.(Maps(are(overlaid(on(representative(coronal(sections(of(












The" work" presented" in" this" chapter" has" employed" quantitative," stateSofStheSart"
image" registrationSbased" DTI" methods" to" demonstrate" profiles" of" white" matter"
tract"pathology"in"a"large"cohort"of"patients"with"bvFTD,"representing"both"major"
genetic" and" sporadic" disease" subtypes." Considering" the"bvFTD" cohort" firstly" as" a"




emphasis"of"white"matter" tract"alterations"was" identified"when" the"bvFTD"group"
was"compared"with"the"AD"group,"suggesting"that"involvement"of"these"tracts"may"
be"a" relatively"specific" index"of"pathologies" in" the"bvFTD"spectrum."Adjusting" for"
the"effects"of"global"mean"diffusivity"further"consolidated"the"findings:"after"global"
adjustment," involvement" of" uncinate" fasciculus" was" a" prominent" and" consistent"
indicator"of"bvFTD"pathology"compared"both"with"healthy"individuals"and"patients"
with"AD."""""
These" findings" further" build" upon" those" studies" listed" in" table" 3.1" and" further"
extend"our"knowledge"of"the"role"of"white"matter"pathology"in"bvFTD."Comparing"
tract"profiles"in"the"present"study"with"those"performed"previously"it"is"of"note"that"




extensive" profile" of" white"matter" alterations" demonstrated" here"may" be" in" part"
attributable" to" the" use" of" a" customised" white" matter" template" as" well" as" the"




The"white"matter" pathways" delineated" here" are" plausible" candidates" to"mediate"
brain" network" dysfunction" and" the" most" prominently" involved" tracts" have"





taking"behaviours" (Linke" et" al.," 2013):" such"processes" are" likely" to"be" relevant" to"
various"canonical"features"of"bvFTD"(Rascovsky"et"al.,"2011)."The"uncinate"fasciculus"
has" also"been"directly" implicated" in" the"modulation"of" inhibition" in" patients"with"
bvFTD"(Hornberger"et"al.,"2011)."The"cingulum"bundle"is"intimately"associated"with"
cingulate" cortex," previously" identified" as" a" key" component" of" the" ‘salience"
network’," breakdown" of" which" has" been" implicated" in" the" pathogenesis" of" the"
bvFTD" syndrome" (Kim" et" al.," 2012;" Seeley" et" al.," 2009;" Zhou" et" al.," 2012)." The"
cingulum" bundle" has" also" been" implicated" in" the" pathogenesis" of" obsessive–
compulsive" symptoms" and" executive" dysfunction" (Bora" et" al.," 2011;" Linke" et" al.,"




and"may" lead" to" disconnection" between" brain" regions"which" integrate" semantic"
knowledge" with" emotional" meaning" impacting" on" the" ability" to" interpret"
paralinguistic" information" and" situational" context," a" common" feature" in" bvFTD"
(Rankin" et" al.," 2009)." The" ATR" has" been" linked" to" aspects" of" attention" and"
executive" function" (Andreasen" et" al.," 1996;" Schmahmann" and"Pandya," 2008;" Van"
der"Werf" et" al.," 2003)" as"well" as" the"pathogenesis"of" autism" (Cheon"et" al.," 2011);"
while" the" fornix" has" recently" been" identified" as" a" key" locus" of" damage" in" bvFTD"
(Hornberger" et" al.," 2012)." The" disease" specificity" of" other" white" matter" tracts"
identified"here," in"particular," involvement"of"the" long" intraShemispheric"tracts"SLF"
and" ILF," is" less" clear:" portions" of" these" tracts" were" found" to" be" involved" more"
prominently"in"either"bvFTD"or"AD."This"apparent"paradox"may"reflect"evolution"of"
pathology" across" white" matter" pathways" common" to" the" distributed" brain"





white"matter" pathology"within" the" broader" bvFTD" spectrum."Most" striking"were"
alterations" within" the" uncinate" fasciculus" in" those" with"MAPT+mutations," which"
persisted" when" compared" with" AD" and" C9ORF72" groups." " These" more" localised"






more" dorsal" white" matter" tract" pathology," which" targeted" the" cingulum" bundle"
and" corpus" callosum." " These" findings" are" in" line" with" evidence" from" previous"
neuroanatomical" studies" of" genetic" subtypes" of" bvFTD" " (Mahoney" et" al.," 2012a,"
2012b;"Rohrer"et"al.,"2011)."Notably"a"significant"difference"was"not"generated"when"
MAPT+was" contrasted" with" the" sporadic" bvFTD" group." Whilst" the" absence" of" a"
group"difference" is" certainly" not" a" conclusive" finding" it" could" be" speculated" that"
this" finding" could" result" from" overlapping" profiles" of" white"matter" pathology" in"
these" two"groups," at" least" in" part.." This" subgroup" analysis" does"not" fully" resolve"
neuroanatomical" subtyping" of" molecularly" defined" bvFTD:" case" numbers" across"
subgroups" were" small" (precluding," for" example," differentiation" of" individual"
mutations" within" each" subgroup)" while" certain" key" bvFTD" phenotypes" (in"
particular,"bvFTD"due"to"progranulin"gene"mutations"and"sporadic"forms"of"bvFTD"
associated" syndromes" of" atypical" parkinsonism" or"motor" neurone" disease)"were"
either" underrepresented" or" not" represented" at" all." The" likely" variability" of"
pathologies"within" the"sporadic"bvFTD"group"may"also"have" limited" the"ability" to"
detect" white" matter" changes" specific" to" this" group." Taking" these" caveats" into"
account," the"above" findings"provide" further"evidence" that" the"profile"of" regional"
brain"network"disintegration"in"bvFTD"may"be"modulated"by"underlying"molecular"




The" compatibility" of" different"DTI"metrics" is" an" issue" of" considerable" clinical" and"
neurobiological" relevance"to"the"application"of"DTI" in"neurodegenerative"disease."
The" current" study" suggests" partial" convergence" of" metrics" for" particular" white"
matter" tracts," although" it" is" also" noteworthy" that" there" was" also" substantial"
divergence" in" the" white" matter" profiles" generated" using" different" DTI" metrics"
across"both"sporadic"and"genetic"forms"of"bvFTD"(compare"Figures"3.2"and"3.3"to"
Figures" 3.4" and"3.5)." In"principle," there" is" likely" to"be"a" tradeSoff"between"higher"
sensitivity" and" higher" specificity" for" any" candidate" DTI" metric," presenting" a"
practical"problem"of"optimisation" if"particular"metrics"are" in" future" to"be"used"as"





uncinate" fasciculus" was" identified," suggesting" it" may" be" a" candidate" tract" for"
monitoring"white"matter" pathology" in" bvFTD" across"DTI"metrics." In" addition" it" is"
notable" that" alterations" in" AX"were"more" apparent," both" across" the" group" as" a"
whole" and" within" the" genetically" defined" group." This" may" suggest" that" this"
particular" DTI" metric" is" less" likely" to" result" in" a" ‘false" positive’" result," and" this"
greater"specificity"may"be"due"to"certain"DTI"metrics"being"better"suited"to"detect"
particular" underlying" neuropathology." Data" from" the" current" study" suggest" that"
the"absolute"values"of"diffusion"(AX/RD/TR)"performed"better"than"FA"in"detecting"
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pathology" when" comparing"MAPT+ patients" with" both" controls" and" AD" patients,"
whilst" also" noting" that" FA" performed" well" when" comparing" the" overall" bvFTD"
group"with"controls"and"AD"patients."One"caveat"to"the"above"is"that"AD"and"MAPT+
associated" bvFTD" are" both" tauopathies" so" one" might" expect" similar" findings;"
however" at" least" two"possible" explanations" for" these" findings" exist," first"AD" is" a"
process" involving" two" pathological" proteins" and" secondly" the" degree" of" white"
matter" pathology" in" the" MAPT+ group" may" simply" be" greater" in" this" particular"
cohort.""
A" comparison"of"DTI"metrics"was" further" expanded"on" by" a" formal"ROC" analysis"
assessing"the"seperability"of"bvFTD"from"healthy" individuals"and"patients"with"AD"
(see" Figure" 3.7)." " Comparing" global" brain" diffusivity" values," RD" and" TR" appeared"
most" sensitive" in" distinguishing" bvFTD" from" healthy" controls," in" keeping" with"
previous"work"(AcostaSCabronero"et"al.,"2010;"F"Agosta"et"al.,"2012;"Mahoney"et"al.,"
2013)," and" suggesting" these" metrics" might" potentially" assist" in" early" bvFTD"
diagnosis." On" the" other" hand," FA" appeared" to" be" have" a" greater" specificity" in"
distinguishing"bvFTD"from"AD,"suggesting"that"this"metric"might"be"preferred"as"a"
future" disease" biomarker" (for" example," in" treatment" trials" targeting" particular"
pathologies)."However,"data"in"the"genetic"subgroups"(see"Table"3.8)"suggest"that"
the" ‘optimal’" diffusivity" metric" may" be" further" stratified" within" the" bvFTD"
spectrum.""
In" line" with" some" of" the" variability" in" metric" performance" above," the" current"
literature" on" the" performance" of" DTI"metrics" is" also" not" clearScut." " For" example"
previous" studies" suggest" that" AX" or" RD" may" have" greater" sensitivity" to" FA" in"
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detecting"white"matter"pathology"in"AD"(AcostaSCabronero"et"al.,"2010),"although"
unlike" the" current" study" this" study" lacks" comparisons" between" different" disease"
groups." Whilst" a" number" of" other" studies" within" other" degenerative" conditions"
have"demonstrated"that"FA"has"some"specificity"in"distinguishing"different"disease"
subtypes"(Menke"et"al.,"2012;"Prakash"et"al.,"2009)."This"underlines"the"need"to"take"
the" specific" application" into"account," such"as" the" likely"underlying"pathology"and"
whether"the"study"is"crossSsectional"or"longitudinal,"when"evaluating"candidate"DTI"
metrics" (AcostaSCabronero" et" al.," 2010)." Variation" among" DTI" metrics" may" in"
addition" potentially" hold" neurobiological" insights:" for" example," the" apparent"
discrepancy" between" RD" and" FA" in" signifying" bvFTD" (whether" referenced" to"
healthy"controls"or"to"AD)"might"be"driven"by"changes"in"either"RD"or"AX"as"change"
in" either"metric" could" affect" FA." It" is" likely" that" some"discrepancies" in"DTI"metric"
performance"will" remain"until" such"time"as"better"specific"prior"hypothesis"about"




A" related" key" issue" concerns" the" relationship" of" grey" matter" atrophy" to" white"
matter"pathology"in"bvFTD."Here,"changes"in"white"matter"tracts"occurred"in"close"
anatomical" proximity" to" regions" of" grey" matter" loss" but" were" more" spatially"
distributed" (see"Figure"3.8)." In" line"with" this"another" recent"study"has"also" found"
somewhat"more"widespread"white"matter"changes"in"bvFTD"when"compared"with"
AD" (Zhang" et" al.," 2011)." White" matter" and" grey" matter" alterations" were" most"
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robustly" coSlocalised" in" the" right" anterior" temporal" lobe" including" the" most"
consistently" involved"white"matter" tract," the"uncinate" fasciculus." There" is" a"need"
for" caution"when" comparing" different" neuroimaging"modalities," such" as" DTI" and"
VBM," as" they" use" very" different" methodologies" to" assess" anatomy" and" the"




or"withdrawal" of" trophic" support)" (Hardy" and"Revesz," 2012;"Warren" et" al.," 2012);"
alternatively,"however,"white"matter"pathology"might"drive"grey"matter"loss,"such"
that" over" time" grey" matter" atrophy" spreads" to" become" more" contiguous" with"
white"matter" damage." Substantial" emerging" histopathological" evidence" suggests"
that"white"matter"pathology"may"be"significant"in"bvFTD"(Ahmed"et"al.,"2011;"Hiji"et"
al.,"2008;"Neumann"et"al.,"2007),"may"develop"early"in"the"disease"process"(Broe"et"
al.," 2004;" Martin" et" al.," 2001)" " and" may" promote" subsequent" upstream" cortical"
degeneration"(Drzezga"et"al.,"2011;"Villain"et"al.,"2008)."An"early"pathophysiological"
role" for" white" matter" pathology" has" already" been" suggested" by" previous"








a" large," representative" cohort" of" patients"with" bvFTD," using" a" groupSwise" image"
registration"technique."This"study"identified"a"distributed"signature"of"white"matter"
alterations" likely" to" be" core" to" the" pathophysiology" of" this" syndrome" and"
suggesting" that" this" signature" is" further" modulated" by" specific" underlying"




of" course" a" number" of" limitations," which" include" relatively" small" numbers" of"
molecularly"defined"individuals"and"lack"of"confirmatory"histopathology,"as"well"as"
methodological" constraints" in" comparing" differing" imaging" modalities."
Notwithstanding" these" issues" the" current" data" suggest" that"DTI"may"be" a" useful"










disease" modifying" therapies" is" of" high" priority." Potential" disease" modifying"
therapies" for" neurodegenerative" disease" are" now" emerging," creating" an" urgent"
need"to"develop"biomarkers"with"improved"accuracy"to"detect"and"monitor"disease"
progression"in"bvFTD,"not"least"because"a"high"proportion"of"cases"have"a"genetic"
basis,"making"preSsymptomatic" intervention"a" real"prospect" (Dopper"et"al.," 2013)."
To" date," longitudinal" MRI" has" been" shown" to" be" a" useful" biomarker" in"
neurodegenerative"diseases"given" its"wide"availability," ease"of" interpretation"and"
its" sensitivity" in" detecting" change" (most" typically" in" brain" volume)" over" time.""
Furthermore" longitudinal" imaging" allows" us" to" better" understand" the" natural"
history"of"bvFTD,"establishing"where"the"disease"starts"and"which"brain"networks"
are" particularly" vulnerable," as" it" allows" us" to" use" each" subject" as" his/her" own"




Previous" longitudinal" imaging" studies" of" bvFTD" have" used" structural" MRI" to"
measure" rates" of" whole" brain" and" ventricular" change" (Gordon" et" al.," 2010;"
Knopman" et" al.," 2009;" Mahoney" et" al.," 2012b;" Whitwell" et" al.," 2006)" and" are"
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discussed" in" section" 1.4." However" with" the" current" study" in" mind," it" is" worth"
pointing" out" their" limitations;" the" tendency" to" measure" rates" of" whole" brain"
atrophy," which" may" be" insensitive" to" the" focal" losses" often" seen" in" bvFTD;"
volumetric"MRI"may"miss"microstructural"damage"and"may"not"provide"sufficient"
sensitivity" to" detect" meaningful" change" in" individuals" with" slowly" progressive"
forms" of" bvFTD," or" in" preSsymptomatic" individuals" with" little" macroscopic" brain"
atrophy"(Brodtmann"et"al.,"2013;"Dopper"et"al.,"2013)."""
"
A" further" problem" in" tracking"progression" in" bvFTD" is" its" broad"pathological" and"
clinical" heterogeneity." Predicting" underlying" pathology" on" clinical" or" radiological"
grounds"remains"challenging."As"such,"the"use"of"current"clinical"or"neuroimaging"
measures" to" evaluate" treatments," which" will" likely" target" specific" molecular"
pathologies," is" problematic." " As" already" alluded" to" monitoring" molecularly"
vulnerable" brain" networks" such" as" the" Salience" Network" may" offer" greater"
specificity" in" tracking"disease" trajectory" in"bvFTD."Longitudinal"DTI"may"offer" the"
methodology"to"monitor"largeSscale"structural"network"degeneration"over"time."At"
the" time"of"writing" only" one" prior" study" has" applied" this"methodology." Lam" and"
colleagues" studied" 12" patients" with" bvFTD" and" found" widespread" longitudinal"
declines" in" FA" and" increased" RD," AX" and" MD" in" both" right" and" left" uncinate"
fasciculus" and" corpus" callosum." They" noted" that" FA" and"RD" seemed" to" be"more"
sensitive"at" tracking" longitudinal" change," compared"with"AX"and"MD" (Lam"et"al.,"
2014)."However"this"study"did"not"quantify"the"extent"of"change"within" individual"
white" matter" tracts," nor" did" it" use" robust" imaging" methodologies" to" register"
images"longitudinally"to"minimise"issues"such"as"timeSpoint"bias."
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The" current" study" aimed" to" improve" upon" this" previous" study" by" investigating"
longitudinal" white" matter" change" in" key" white" matter" structures" in" a" group" of"
patients" with" bvFTD" with" serial" scanning" approximately" 1.2" years" from" baseline,"
using" quantifiable" methods" as" well" as" a" robust" image" registration" pipeline."
Furthermore" this" study" used" quantitative" data" to" assess" the" utility" of" DTI" as" a"
potential" biomarker" for" clinical" trials" by" comparing"DTI"measures"of" change"with"





Patients" were" recruited" from" 2009S2014" as" part" of" a" prospective" study" tracking"
disease" progression" in" patients" suspected" to" have" Frontotemporal" Lobar"
Degeneration" at" the" Specialist" Cognitive" Disorders" Clinic," National" Hospital" for"
Neurology" and"Neurosurgery," London,"United"Kingdom."All" patients"met" current"
consensus" criteria" (Rascovsky" et" al.," 2011)" for" a" diagnosis" of" either" probable" or"
definite"bvFTD"and"had"two"clinical"and"neuropsychological"assessments"and"MRI"
scans"(to"include"both"T1Svolumetric"and"DTI"sequences)"a"minimum"of"six"months"
apart" were" considered" for" study" inclusion." All" patients" in" the" current" study" also"
participated" in" the" study" contained" in" Chapter" 3" of" this" thesis" and" as" such"
underwent" the" same" clinical," neuropsychological" and" genetic" assessments" as"
described"previously."23"participants"were"identified"as"fulfilling"inclusion"criteria."4"
participants"were"not" included" in" the"DTI" analysis" for" the" following" reasons:" two"
had"significant"artefact"on" followSup"DTI" scans,"one"had"an" incomplete"sequence"
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due"to"scanner"intolerance,"and"another"had"a"sphenoid"wing"meningioma."18"age"
and" genderSmatched" controls" were" also" included" and" underwent" the" same" test"
batteries"as"those"with"bvFTD.""Each"study"participant"underwent"the"same"battery"
of" neuropsychological" and" clinical" tests" at" baseline" and" followSup." Patients" and"






the" longitudinal" DTI" imageSprocessing" pipeline" (see" chapter" 2," section" 2.2.8.)." As"
specified"an" initial"within"subject" template"was"created"followed"by"a"groupSwise"
template" to"which" each"baseline" and" followSup" scan"was" registered." FA,"MD,"AX"
and"RD"were"then"computed"from"these"final"images."As"per"the"pipeline"in"section"
2.7"a"ROI"based"analysis"was"performed,"with"tracts"chosen"either"based"on"apriori"
prediction" of" disease" involvement" or" based" on" the" previous" chapters" crossS
sectional" results." RegionsSofSinterest" included" genu," body" and" splenium" of" the"
corpus"callosum,"bilateral"uncinate"fasciculus,"parahippocampal"(ventral)"cingulum"
bundle," paracallosal" (dorsal)" cingulum" bundle," corticospinal" tract," superior"
cerebellar" peduncle" and" fornix." The" uncinate" fasciculus" did" not" undergo" any"
additional" erosion," as" on" inspecting" this" tract" after" erosion," too" few" voxels"











12©" (Statacorp," College" Station," TX)." CrossSsectional" DTI" metric" data" were"
compared"between"disease"and"cognitively"normal"groups"using"a"linear"regression"
model" adjusting" for" age," gender" and" disease" duration." MixedSeffects"linear"
regression"models" with" random" intercept" were" used" to"compare" longitudinal"
change"between"groups"for" each"DTI"metric" and" region"of" interest," adjusting" for"
age," gender" and" disease" duration." For" longitudinal" models"the" log" of" each" DTI"
metric"was"the"dependent"variable,"with"disease"group,"time"from"baseline"scan"in"
years" and" interaction" between" disease" group" and" time" included" in" order" to"
provide"estimates" of" differences" in"the" rate" of" change" as" a" percentage" per" year."
This" methodology" was" also" used" to" compare" crossSsectional" and" longitudinal"
neuropsychological"data"between"groups."
"
To" determine" the" accuracy," sensitivity" and" specificity" of" each" DTI" metric" in"
classifying" individual" participants" into" separate" groups" (bvFTD" or" control)" ROC"
curves" were" constructed" using" either" raw" DTI" metric" data" (for" baseline"
measurement)" or" the" estimated"mean" difference" in" the" rate" of" change" for" each"
diffusivity" metric" (for" longitudinal" measurement)." "AreasSunderScurve" were"
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power" and" 5%" twoStailed" significance" using" the" mean" difference" in" the" rate" of"





4.3.1- Demographics,- neuropsychological- performance- and- changes- in-whole- brain-
volume-
Demographic" and" volumetric" imaging" characteristics" of" study" participants" are"





intracranial" volume." Compared"with" controls," those"with" bvFTD" had" significantly"
lower" miniSmental" state" examination" (MMSE)" scores" (p<0.01)" and" whole" brain"
volumes" (p≤0.001)" at" baseline" and" followSup." Rates" of" atrophy" were" greatest"















(( Mean" SD" Mean" SD" Mean" SD" Mean" SD" Mean" SD" ""
Age(at(baseline(
(years)( 61.3" 9.5" 56.7" 8.9" 64.1" 8.7" 68.8" 8.4" 63.8" 10.0" 0.4"
Disease(duration(at(
baseline((years)(
"" "" 5.2" 5.4" 9.3" 5.9" 6.8" 4.7" 6.7" 5.1" N/A"
Sex,(male/female( 12/6" 5/3" 4/0" 10/1" 18/5" 0.7§"
Interscan(Interval(
(years)(
1.4" 0.5" 1.3" 0.5" 1.0" 0.1" 1.2" 0.5" 1.2" 0.4" 0.2"
Education((years)( 16.55" 1.42" 14.6" 3.9" 15.5" 4.1" 16.6" 3.0" 15.5" 3.5" 0.3"
(( "" "" "" "" "" "" "" "" "" "" ""
MMSE(baseline(( 29.7" 0.6" 25.5" 4.2" 2.5" 6.9" 25.8" 3.4" 25.3" 4.2" <0.001^"
MMSE(followFup( 29.7" 0.5" 26.3" 5.4" 25.3" 4.3" 25.1" 3.5" 25.6" 4.2" 0.002^"
(( "" "" "" "" "" "" "" "" "" "" ""
TIV((ml)( 1572" 134" 1503" 135" 1649" 135" 1565" 123" 1556" 137" 0.6"
Whole(brain(volume,(
baseline((ml)(
1193" 91" 1047" 88" 1192" 93" 1026" 48" 1070" 95" 0.001"
Whole(brain(volume,(
followFup((ml)( 1184" 95" 1028" 95" 1167" 93" 1001" 37" 1047" 95" <0.001"
BBSI(ml/year( 5.2" 6.7" 15.7" 6.7" 14.4" 17.8" 14.8" 10.6" 15.2" 10.4" 0.002"
"
Table& 4.1.& Study& participant’s& clinical& and& imaging& characteristics.& *& Linear& regression& comparing&
controls&with&all&bvFTD&subjects&(n=23),&§&Fisher’s&exact&test,&&^&Wilcoxon&rankCsum&test.&&
"
Neuropsychological" performance" at" baseline" and" longitudinally" is" shown" in" table"
4.2"for"the"entire"bvFTD"group"and"controls."Neuropsychological"performance"for"
each"bvFTD"subgroup" is"shown" in"table"4.3."Compared"with"controls,"at"baseline,"
those" with" bvFTD" had" significantly" poorer" performance" on" tests" of" general"
intellect," recognition" memory," naming," object" perception," executive" function,"
emotion" recognition" and" social" inference." Longitudinally" the" greatest" change"
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4.7" respectively" and" should" be" compared" with" data" from" the" previous" chapter"
(although" noting" different" methodologies)," broadly" results" presented" in" the"
current" chapter" show" similar" anatomical" profiles" of" crossSsectional" pathology," as"
well" as" showing" similar" profiles" of" DTI"metric" alterations" comparing" bvFTD"with"

















Regions-of-interest-(FA)- Mean" SD" Mean" SD"
Genu"Corpus"Callosum" 0.74" 0.03" 0.73" 0.04" 0.3" S2.6" 3.3" 0.8"
Body"Corpus"Callosum" 0.7" 0.04" 0.66" 0.04" S4.9" S8.9" S1.1" 0.01"
Splenium"Corpus"Callosum" 0.79" 0.02" 0.78" 0.02" S1.3" S3.2" 0.6" 0.2"
Cingulum"(paracallosal)"R" 0.63" 0.05" 0.58" 0.06" S4.3" S9.3" 0.7" 0.09"
Cingulum"(paracallosal)"L" 0.6" 0.04" 0.55" 0.07" S2.3" S7.1" 2.6" 0.4"
Cingulum"(parahippocampal)"R" 0.43" 0.04" 0.38" 0.04" S5.8" S9.6" S2.0" 0.004"
Cingulum"(parahippocampal)"L" 0.45" 0.04" 0.4" 0.04" S5.3" S9.2" S1.3" 0.01"
Fornix" 0.59" 0.03" 0.57" 0.04" S1.9" S4.2" 0.4" 0.1"
Uncinate"Fasciculus"R" 0.48" 0.05" 0.43" 0.04" S4.7" S8.6" S0.7" 0.02"
Uncinate"Fasciculus"L" 0.48" 0.04" 0.43" 0.07" S6.2" S11.3" S1.2" 0.02"
Corticospinal"tract"R" 0.62" 0.05" 0.62" 0.07" S1.5" S7.2" 4.3" 0.6"
Corticospinal"tract"L" 0.65" 0.04" 0.64" 0.05" S2.2" S6.1" 1.8" 0.3"
SCP"R" 0.79" 0.05" 0.78" 0.06" S2.2" S7.2" 2.7" 0.4"
SCP"L" 0.79" 0.04" 0.77" 0.05" S2.9" S7.2" 1.4" 0.2"




























-(MD-10O3mm-2/s)- Mean" SD" Mean" SD"
Genu"Corpus"Callosum" 0.76" 0.04" 0.8" 0.08" 0.3" S4.8" 5.4" 0.9"
Body"Corpus"Callosum" 0.8" 0.06" 0.88" 0.08" 8.7" 2.6" 14.8" 0.01"
Splenium"Corpus"Callosum" 0.74" 0.03" 0.77" 0.05" 3.8" S0.1" 7.7" 0.06"
Cingulum"(paracallosal)"R" 0.72" 0.04" 0.72" 0.05" 1.6" S2.5" 5.8" 0.4"
Cingulum"(paracallosal)"L" 0.71" 0.04" 0.73" 0.05" 0.5" S3.5" 4.4" 0.8"
Cingulum"(parahippocampal)"R" 0.74" 0.03" 0.85" 0.12" 9.3" 1.5" 17.2" 0.02"
Cingulum"(parahippocampal)"L" 0.73" 0.04" 0.83" 0.11" 10.6" 3.1" 18.2" 0.007"
Fornix" 0.84" 0.06" 0.91" 0.1" 5.4" S0.1" 11.0" 0.05"
Uncinate"Fasciculus"R" 0.7" 0.04" 0.83" 0.13" 13.5" 4.8" 22.2" 0.003"
Uncinate"Fasciculus"L" 0.71" 0.03" 0.85" 0.18" 14.9" 2.7" 27.1" 0.02"
Corticospinal"tract"R" 0.66" 0.06" 0.67" 0.09" 1.8" S5.3" 9.0" 0.6"
Corticospinal"track"L" 0.62" 0.05" 0.62" 0.09" 2.5" S4.3" 9.2" 0.5"
SCP"R" 0.85" 0.07" 0.87" 0.09" 5.4" S2.0" 12.8" 0.1"
SCP"L" 0.78" 0.07" 0.8" 0.07" 4.2" S2.3" 10.7" 0.2"














Mean" SD" Mean" SD"
Genu"Corpus"Callosum" 0.34" 0.05" 0.38" 0.09" S0.3" S5.7" 5.2" 0.92"
Body"Corpus"Callosum" 0.39" 0.06" 0.48" 0.09" 9.3" 2.5" 16.1" 0.01"
Splenium"Corpus"Callosum" 0.3" 0.03" 0.33" 0.05" 3.1" S0.5" 6.7" 0.09"
Cingulum"(paracallosal)"R" 0.41" 0.05" 0.45" 0.06" 3.9" S1.9" 9.3" 0.15"
Cingulum"(paracallosal)"L" 0.43" 0.05" 0.48" 0.07" 1.9" S3.2" 7.1" 0.45"
Cingulum"(parahippocampal)"R" 0.55" 0.04" 0.68" 0.12" 10.6" 2.3" 19.0" 0.01"
Cingulum"(parahippocampal)"L" 0.54" 0.05" 0.65" 0.11" 11.2" 3.2" 19.1" 0.01"
Fornix" 0.51" 0.06" 0.59" 0.1" 5.4" S0.4" 11.1" 0.07"
Uncinate"Fasciculus"R" 0.5" 0.05" 0.64" 0.12" 14.7" 6.1" 23.2" 0.001"
Uncinate"Fasciculus"L" 0.51" 0.04" 0.66" 0.18" 16.6" 4.4" 28.9" 0.01"
Corticospinal"tract"R" 0.4" 0.07" 0.41" 0.09" 2.05" S5.6" 9.7" 0.59"
Corticospinal"track"L" 0.36" 0.05" 0.37" 0.08" 3.11" S2.9" 9.1" 0.3"
SCP"R" 0.36" 0.08" 0.38" 0.11" 5.58" S3.0" 14.1" 0.19"
SCP"L" 0.32" 0.07" 0.35" 0.08" 5.16" S1.9" 12.2" 0.14"














Mean" SD" Mean" SD"
Genu"Corpus"Callosum" 1.59" 0.04" 1.62" 0.08" 1.4" S3.4" 6.3" 0.55"
Body"Corpus"Callosum" 1.62" 0.05" 1.68" 0.08" 7.4" 2.2" 12.6" 0.01"
Splenium"Corpus"Callosum" 1.63" 0.05" 1.67" 0.07" 5.3" S0.1" 10.7" 0.06"
Cingulum"(paracallosal)"R" 1.32" 0.06" 1.27" 0.05" S2.9" S7.8" 2.1" 0.24"
Cingulum"(paracallosal)"L" 1.28" 0.06" 1.23" 0.06" S2.5" S8.2" 3.3" 0.39"
Cingulum"(parahippocampal)"R" 1.11" 0.03" 1.2" 0.11" 6.7" S0.7" 14.1" 0.07"
Cingulum"(parahippocampal)"L" 1.1" 0.04" 1.19" 0.11" 9.6" 2.4" 16.8" 0.01"
Fornix" 1.49" 0.05" 1.56" 0.1" 5.6" 0.3" 10.9" 0.04"
Uncinate"Fasciculus"R" 1.11" 0.05" 1.22" 0.14" 11.0" 1.3" 20.7" 0.03"
Uncinate"Fasciculus"L" 1.12" 0.04" 1.24" 0.19" 11.4" S1.4" 24.1" 0.08"
Corticospinal"tract"R" 1.17" 0.06" 1.18" 0.11" 1.4" S6.8" 9.6" 0.73"
Corticospinal"tract"L" 1.14" 0.06" 1.12" 0.14" 1.1" S9.0" 11.3" 0.82"
SCP"R" 1.85" 0.1" 1.85" 0.11" 5.1" S4.3" 14.4" 0.28"
SCP"L" 1.69" 0.1" 0.8" 0.07" 2.3" S7.0" 11.6" 0.61"







in" FA" over" time" are" displayed" for" key" affected" tracts" in" figures" 4.1" to" 4.3."
Longitudinally,"compared"with"controls,"bvFTD"patients"as"a"group"had"the"largest"
reductions" in" FA"within"bilateral" paracallosal" cingulum" (right," S6.8%/year," 95%"CI," S




























































































































































































The" largest" increases" in" MD" were" within" bilateral" uncinate" fasciculus" (right,"
5.1%/year,"95%"CI"2.3%"to"8.0%,"p<0.001;"left,"6.2%/year,"95%"CI"1.6%"to"10.8%,"p=0.01;)"






































































































































































The" largest" increases" in" RD" were" within" bilateral" paracallosal" cingulum" (right,"
8.6%/year," 95%" CI" 2.8%" to" 11.6%," p<0.001;" left" 6.9%/year," 95%" CI" 2.5%" to" 10.0%,"
p<0.001.)," bilateral" uncinate" fasciculus" (right," 5.6%/year," 95%" CI" 3.0%" to" 10.7%,"
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Rates"of"change" for"each" region"of" interest"and"as"measured"by"FA,"MD,"RD"and"
AX,"by"bvFTD"subgroup,"are"shown"in"Table"4.8"to"4.11"respectively."Compared"with"
controls"the"largest"reduction"in"FA"were"within"bilateral"uncinate"fasciculus"(right,"
S7.2%/year," 95%" CI" S9.7%" to" S4.7%," p<0.001;" left," S7.9%/year," 95%" CI" S12.0%" to" S3.7%,"
p<0.001)"in"MAPT+mutation"carriers;"bilateral"paracallosal"cingulum"bundle"(right,"S
6.7%/year," 95%" CI" S10.0%" to" S3.4%," p<0.001;" left," S5.6%/year," 95%" CI" S8.3%" to" S2.8%,"
p<0.001)" in" those"with" sporadic"bvFTD;"and" in" right"paracallosal" cingulum"bundle"
(6.8%/year,"95%"CI"S11.3%"to"2.2%,"p=0.004)"in"C9ORF72+mutation"carriers."Compared"
with" controls" the" largest" increased" in" MD" were" in" bilateral" uncinate" fasciculus"
(right,"6.7%/year,"95%"CI"3.7%"to"9.6%,"p<0.001;"left,"10.9%/year,"95%"CI"5.2%"to"16.5%,"
p<0.001)" in"MAPT+mutation" carriers;" bilateral"paracallosal" cingulum"bundle" (right,"
3.8%/year,"95%"CI"1.5%"to"6.0%,"p=0.001;"left,"3.4%/year,"95%"CI"0.8%"to"6.1%,"p=0.01)"in"
sporadic" bvFTD;" and" in" left" uncinate" fasciculus" (6.0%/year," 95%" CI" 0.8%" to" 11.2%,"
p=0.02)"in"C9ORF72+mutation"carriers."Compared"with"controls"the"largest"increase"
in"RD"were"within"bilateral"uncinate"fasciculus"(right,"7.4%/year,"95%"CI"4.7%"to"12.6%,"
p<0.001;" left" 12.7%/year,"95%"CI"6.3%" to"20.6%,"p<0.001)" in"MAPT+mutation"carriers;"
bilateral"paracallosal"cingulum"(right,"9.5%/year,"95%"CI"3.0%"to"13.0%,"p=0.002;"left,"
8.0%/year,"95%"CI"2.9%"to"11.7%,"p=0.001)"in"sporadic"bvFTD;"and"within"left"uncinate"
fasciculus" (8.2%/year," 95%" CI" 1.4%" to" 16.1%," p=0.02)" in" C9ORF72+mutation" carriers."
Compared"with"controls" the" largest" increase" in"AX"were"within"bilateral"uncinate"
fasciculus"(right,"3.8%/year,"95%"CI"2.2%"to"6.6%,"p<0.001;"left,"8.0%/year,"95%"CI"3.7%"
to" 12%," p<0.001)" in" MAPT" mutation" carriers;" right" parahippocampal" cingulum"






To" determine" optimal" DTI" metrics" AUC" data" were" calculated" and" indicated" that"
classification" of" control" and" bvFTD" groups" crossSsectionally" were" best" achieved"
using"RD,"measured"within"the"right"uncinate"fasciculus"(AUC=0.86,"specificity"94%,"
sensitivity" 68%);" followed" by" MD" (AUC=0.83," specificity" 89%," sensitivity" 74%)," FA"
(AUC=0.79," specificity" 67%," sensitivity" 84%)" and" AX" (AUC=0.75," specificity" 83%,"
sensitivity" 74%)." This" is" similar" to" the" findings" from" the" study" in" Chapter" 3" (see"
Figure" 3.7)," despite" the" current" study" having" a" different" methodology" in"
determining" DTI" metric" values." Classification" of" control" and" bvFTD" groups"
longitudinally" were" best" achieved" using" FA" change," measured" within" the" right"
cingulum" bundle" (AUC=0.79," specificity" 94%," sensitivity" 63%);" followed" by" MD"
(AUC=0.77," specificity" 89%," sensitivity" 68%)" and" RD" (AUC=0.76," specificity" 100%,"




Sample" sizes" required" for" future" clinical" trials" were" calculated" using" annualised"
change" score" in" three" potential" outcome"measures;" whole" brain" atrophy" (using"
BBSI)," change" in" graded" naming" test," chosen" as" this" was" the" only" longitudinal"
neuropsychological"measure"to"show"statistical"difference"from"cognitively"normal"
participant" over" time," and" DTI" change" for" each" metric" within" either" right"
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paracallosal"cingulum"or"right"uncinate"fasciculus"(chosen"on"the"basis"of"statistical"
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for" DTI" spatial" normalization," which" enforces" longitudinally" and" crossSsectionally"
consistent" and" accurate" ROI" segmentations," thus" reducing" potential" timeSpoint"
biases" and" reducing" issues" such" excessive" warping" due" to" atrophy" and" partial"
volume" effects" during" the" registration" process." Using" these" improved" DTI"
methods,"this"study"reports"(1)"both"core"and"mutation"specific"patterns"of"white"








consistent" finding" within" both" right" and" left" uncinate" fasciculus." The" cingulum"
bundle" was" also" preferentially" involved" across" metrics" with" decreasing" FA" and"
increasing"MD"and"RD"within"the"paracallosal"portions,"and"increasing"MD,"TR"and"
AX" within" the" parahippocampal" portions." The" corpus" callosum" was" also"
consistently" involved"across"all"DTI"metrics,"with" the"splenium"showing" the"most"
robust"change,"followed"by"the"body"of"the"corpus"callosum."These"findings"are"in"
line" with" a" number" of" crossSsectional" DTI" studies" in" bvFTD" as" well" as" the" crossS




previously" discussed" in" Chapter" 3," with" the" cingulum" bundle" being" a" key" tract"
linking" anterior" cingulate" and" prefrontal" cortices" and" likely" underpinning" many"
executive"and" social" cognitive"processes." It" is"of" interest" that" the"greatest" crossS
sectional" differences" in" the" cingulum" were" within" the" parahippocampal"




of" the" more" subtle" changes" in" general" intellectual" function" seen" in" early" bvFTD"
(Janssen" et" al.," 2005)." However," over" time" the" paracallosal" cingulum," linking"
cingulate" and" prefrontal" cortices" and" overlapping" with" the" functionally" relevant"
‘Salience"Network’"(Seeley"et"al.,"2009),"showed"greater"disease"progression,"with"




assumption" would" need" confirmation" through" histopathology," something" the"
current" study" lacks." However" it" is" noteworthy" that" in" the"MAPT+mutation" group"




These" longitudinal" imaging"changes"may"be"associated"with" the"clinical"evolution"
of" bvFTD"with" progressive" disintegration" of" social" cognition" and" executive" skills"
such"as"response"inhibition"and"set"shifting"(Linke"et"al.,"2013;"MetzlerSBaddeley"et"
al.," 2012)." These" findings" build" on" the" crossSsectional" data" already" presented" in"
chapter"3"and"detailed"discussions"of"the"neurobiological"relevance"of"these"tracts"
can" be" found" there." Longitudinal" DTI" studies" are" limited," however" many" of" the"
relevant" studies," examining" conditions"which" result" in" abnormal" social" cognition"
and"executive"dysfunction,"show"concordance"with"the"findings"here."For"example"
previous" longitudinal" studies" in" mild" cognitive" impairment" and" AD" have" also"
implicated"the"cingulum"bundle,"corpus"callosum"and"uncinate"fasciculus"(Kitamura"
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et" al.," 2013;" Teipel" et" al.," 2010)." A" recent" study" in" Huntington’s" disease" has" also"
implicated"the"corpus"callosum"in"disease"progression"(Poudel"et"al.,"2014),"whilst"a"
study" in" Motor" Neuron" Disease," a" condition" which" overlaps" with" bvFTD," has"
demonstrated"changes" in"white"matter"beyond" just" the"corticospinal" tracts,"with"
frontal"white"matter"tract"involvement"also"(Keil"et"al.,"2012)."Longitudinal"studies"
in"psychiatric"disorders"are"few"however"one"study"did"show"the"corpus"callosum"






uncinate" fasciculus," bilateral" paracallosal" and"parahippocampal" cingulum"and" the"




with" a" high" burden" of" white" matter" change" occurring" in" medial" temporal" lobe"
regions."Breakdown"of"these"tracts"is"biologically"plausible"given"that"these"tracts"
link"grey"matter"structures"which"show"preferentially"more"longitudinal"atrophy"in"
affected"MAPT+mutation" carriers" (Rohrer" et" al.," 2010c)." Compelling" evidence" for"
involvement"of"the"uncinate"fasciculus"in"MAPT"related"bvFTD"comes"from"a"recent"








mutation" carriers" (Downey"et" al.," 2012;"Mahoney"et" al.," 2012a," 2012b)." In" addition"
another" recent" longitudinal"DTI"study"of"motor"neuron"disease,"which"C9ORF72+ is"
the"most" frequent" genetic" cause," identified" reduced" FA" in" the" cerebellar" vermis"
(Keil"et"al.,"2012)."These"converging" lines"of"evidence"appear" to"offer"support" for"
the"idea"that"the"cerebellar"involvement"may"be"a"specific"signature"of"bvFTD"due"
to" C9ORF72." In" the" sporadic" bvFTD" group" bilateral" paracallosal" cingulum" bundle"
was"the"primary"regionSofSinterest"affected,"which" is" in"keeping"with"the"broader"
group" level" finding." The" heterogeneity" of" the" group" could" provide" a" possible"
explanation"for"the"emergence"of"a"more"limited"profile"of"white"matter"change"in"
this" group." However," it" is" noteworthy" that" the" paracallosal" cingulum" displayed"
significant"differences" from"controls" across" subgroups"both" crossSsectionally" and"













sensitive" crossSsectional" DTI" metric," particularly" when" sampled" within" the" right"
uncinate" fasciculus." FA" change" within" the" right" paracallosal" cingulum" bundle"
performed"best" longitudinally,"with" largest"area"under"the"curve"and"yielding"the"
lowest" sample" size" estimation." These" differences" may" in" part" be" explained" by"
variations" in"disease"neurobiology"and" tract" anatomy."Changes" in"RD"and"AX"are"




crossSsectional"metrics." The" longitudinal" changes" detected"may" reflect"Wallerian"
degeneration,"rather"than"focal"white"matter"demyelination,"a"process"commonly"
seen" in"a" range"of"neurodegenerative"disorders" (Raff"et"al.," 2002),"which"may"be"
better" detected" by" FA" (Brennan" et" al.," 2013)." " However," it" could" not" be" validly"
argued"that"FA" is"the"only"metric"to"capture"change;"particularly"as"FA"values"are"
determined"to"some"degree"by"changes" in"RD."The"performance"of"particular"DTI"
metrics" is"also" likely"affected"by" individual"patient"variability,"particularly" relevant"
to" bvFTD" given" its" pathological" heterogeneity," which" may" result" in" variable"
trajectories"of"disease"progression" (see" figures"4.1" to"4.3)." It" is" also"possible" that"
certain" white" matter" structures" are" more" suited" to" longitudinal" measurements"
than" others," perhaps" due" to" their" orientation" or" size" thus" allowing" better"
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registration."For"example"change"within"the"genu"and"body"of"the"corpus"callosum"





the"progranulin"genetic" subtype,"which" the" current" study" lacks."Notwithstanding"
these" limitations" the" current" study" has" demonstrated" that" a" withinSsubject"
measure"of"DTI"change"is"a"potentially"useful"disease"biomarker"with"the"ability"to"
detect" greater" differences" across" white" matter" regions" compared" with" crossS
sectional" measures." The" current" study" also" identified" that" FA," as" an" outcome"
measure,"requires"fewer"subjects"compared"to"more"traditional"outcome"metrics."












of" white" matter" change" over" time," offering" new" insights" into" the" disease"
progression" of" bvFTD." As" a" group" bvFTD" shows" progressive" alteration" of" white"







uncinate" fasciculus" being" the" sight" of" maximal" change" in" the"MAPT+ group," and"
some"weaker"evidence"suggesting"change"within"the"superior"cerebellar"peduncle"
may"be"a" signature"of"C9ORF72+disease."Other" longitudinal"DTI" studies"examining"
conditions" with" similar" clinical" phenotypes" have" found" similar" evidence" for"
involvement"of"these"white"matter"structures."Comparison"of"DTI"metrics"revealed"
that"FA"had" the"best"performance"at" separating"bvFTD" from"healthy"participants"
longitudinally," and" identified" the" discrepancies" between" crossSsectional" and"
longitudinal"sensitivities"of"specific"DTI"metrics.""Finally"change"in"FA"was"found"to"













2010;" Rohrer" et" al.," 2010d)." Clinically," PPA" is" associated" with" the" selective" but"
relentless" erosion" of" language" functions," while" neurobiologically" PPA" illustrates"
regional"vulnerability"of"brain"language"systems"to"neurodegenerative"pathologies"
that" are" collectively" characterised" by" abnormal" protein" accumulation." The"




Despite" the" recent" formulation" of" new" consensus" diagnostic" criteria" for" PPA"
(GornoSTempini"et"al.,"2011),"substantial"nosological"difficulties"remain"(Knibb"et"al.,"
2006)." These" include" the" frequent" occurrence" of" overlap" syndromes," clinicoS
anatomical" convergence" between" syndromic" subtypes" and" pathological"
heterogeneity" (Rogalski" et" al.," 2011;" Rohrer" et" al.," 2011;" Rohrer" et" al.," 2008)." A"










in" this" case" those" that" underpin" language," may" offer" a" potentially" powerful"
framework"for"understanding"the"regionally"specific"but"distributed"effects"of"PPA."
However," whereas" substantial" evidence" has" been" amassed" concerning" regional"
cortical"profiles"of"PPA"(Mummery"et"al.,"2000;"GornoSTempini"et"al.,"2004;"Josephs"
et"al.,"2006;"Pereira"et"al.,"2009;"Rohrer"et"al.,"2009b;"Rohrer"et"al.,"2010c),"relatively"
little" information" is" available" concerning" changes" in" white" matter" tracts" within"
brain" language" networks" produced" by" neurodegenerative" disease" (Agosta" et" al.,"
2010;"Whitwell"et"al.,"2010;"Zhang"et"al.,"2009)."Previous"white"matter"tract"studies"
in" PPA" (AcostaSCabronero" et" al.," 2011;" Agosta" et" al.," 2012;" Agosta" et" al.," 2010;"
Galantucci"et"al.," 2011;" Iaccarino"et"al.," 2015;"Mandelli" et"al.," 2014;"Schwindt"et"al.,"
2011)" have" shown" considerable" anatomical" and" methodological" variability" (see"
table" 5.1)." There" remain" few" detailed" comparisons" between" PPA" subtypes" and"
other" neurodegenerative" diseases," and" between" grey" matter" (GM)" and" white"
matter"changes"in"these"diseases."Besides"facilitating"diagnosis"and"tracking"of"PPA"
(Larsson" et" al.," 2004;" Schmierer" et" al.," 2007)" identification" of"white"matter" tract"
signatures" of" PPA" syndromes" might" improve" our" understanding" of" the"
pathophysiology" of" network" disintegration" in" these" diseases" and" could" yield"




The" aim"of" this" chapter" is" to" assess"white"matter" tract" pathology" in" each" of" the"
canonical"PPA"syndromes"using"multiple"DTI"metrics"with"a"relatively"anatomically"
unbiased"whole"brain" analysis" technique." The"primary" hypothesis" for" the" current"
study"is"that"distinct"profiles"of"white"matter"pathology"will"emerge"for"each"of"the"










are! included!here;!see!also!Table!5.2!to!5.5).!*=only! left!hemispheric!tracts!reported.! !^=Results!reported!based!on!authors! figures.!nt!=!data!not!reported/tested,! L!
indicates! no! significant! result! found.! 1=Arcuate! and! frontoLparietal! SLF,! 2=Genu,! 3=Posterior! ILF,! 4=Anterior! SLF,! 5=! Bilateral! anterior! ILF! and! left! medial! ILF,! 6=SLF!
temporoLparietal! fibres,! 7=Arcuate! and! SLF! temporoLparietal,! 8=Inferior! frontoLoccipital! fasciculus.
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Consecutive+ patients+ fulfilling+ current+ consensus+ criteria+ (see+ table+ 1.2)+ for+ a+
diagnosis+ of+ PPA+were+ recruited+ from+ the+ Specialist+ Cognitive+Disorders+ Clinic+ at+
the+ National+ Hospital+ for+ Neurology+ and+ Neurosurgery.+ Subjects+ underwent+ a+
structured+ clinical+ and+ neurolinguistic+ assessment+ and+ structural+MRI+ to+ exclude+
significant+white+matter+ disease+ or+ other+ focal+ cerebral+ lesions.+ For+ purposes+ of+
syndrome+definition,+a+general+neuropsychological+assessment+using+standardised+
tests+ was+ performed+ (see+methods,+ section+ 2.1.2.+ for+ details).+ Demographic+ and+
neuropsychological+data+were+analysed+statistically+in+STATA+10+(Statacorp,+Texas,+
USA)+ using+ Student’s+ tNtest+ and+ Wilcoxon+ RankNsum+ tests+ of+ significance.+ In+





Volumetric+ and+ DTI+ MRI+ scans+ were+ acquired+ for+ all+ subjects,+ using+ the+ same+






addition+ as+ lvPPA+ is+ associated+ with+ AD+ pathology,+ an+ additional+ contrast+
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comparing+ patients+ with+ typical+ AD+ and+ controls+ was+ generated+ for+ each+ DTI+
metric.++Post+statistical+analysis+involved+projecting+significant+results+onto+a+study+
specific+ mean+ brain+ registered+ to+ standard+ (MNI)+ space+ and+ performing+ a+ ROI+
analysis.+To+provide+accurate+anatomical+localisation+a+series+of+tract+specific+masks+
were+ applied:+ 14+ masks+ were+ generated,+ including+ right+ and+ left+ inferior+
longitudinal+ fasciculus,+ superior+ longitudinal+ fasciculus,+ uncinate+ fasciculus,+
anterior+ thalamic+ radiation,+ cingulum+ bundle+ and+ corticospinal+ tract,+ as+ well+ as+
corpus+ callosum+ (CC)+ and+ fornix.+ The+ extent+ of+ tract+ involvement+ within+ each+
disease+ group+ and+ for+ each+ DTI+metric+ (FA,+ AX,+ RD+ and+ TR)+ was+ calculated+ and+
expressed+as+a+proportion+of+the+entire+white+matter+region+of+interest.++
$
Grey+ matter+ analyses+ were+ carried+ out+ on+ each+ subject’s+ volumetric+ MRI+ scans+
using+ VBM+ following+ the+ steps+ outlined+ in+ the+ Methods+ chapter+ (see+ methods,+
section+2.4.+for+details).+Grey+and+white+matter+analyses+were+carried+out+using+the+








Patients+were+ characterised+ as+ follows,+ thirteen+ having+ nvPPA,+ ten+ having+ lvPPA+
!151!%
and+ 10+ having+ svPPA.+ Twenty+ age+ and+ gender+ comparable+ cognitively+ normal+
individuals+also+participated+ (mean+age+64.7+±+5.5+ years;+ 12+ females).+ Twenty+age+
and+gender+comparable+patients+with+a+diagnosis+of+AD+were+also+included+(mean+














5.2.+ There+were+no+ significant+differences+ in+ age+or+gender+between+disease+and+







+ nvPPA$ lvPPA$ svPPA$ AD$ Controls$
No$(female)$ 13+(10)+ 10+(5)+ 10+(7)+ 20+(11)+ 20+(12)+
$ Mean$ S.D$ Mean$ S.D$ Mean$ S.D$ Mean$ S.D$ Mean$ S.D$
Age$ 65.7+ 9.4$ 67.0+ 6.1$ 63.4+ 6.7$ 62.8+ 5.0$ 64.7+ 5.5$
Disease$Duration$ 3.3+ 1.2$ 4.0+ 1.4$ 5.0+ 2.0$ 5.6+ 3.8$ + $
MMSE$(/30)$ 18.0+ 10.9$ 16.9+ 8.5$ 20.6+ 8.5$ 21.0+ 4.6$ 29.6*+ 0.5$
RMT$G$Words$(/50)$†$ 40.5+ 8.9$ 29.9+ 9.1$ 32.0+ 8.0$ 30.1+ 6.1$ 47.1*+ 2.3$
RMT$G$Faces$(/50)$††$ 36.7+ 5.8$ 29.8+ 7.4$ 31.7+ 7.8$ 33.7+ 6.0$ 41.8*+ 5.0$
BPVS$(/150)^$ 120.6+ 41.0$ 87.4+ 46.4$ 65.6+ 49.2$ 135.5+ 22.8$ 147.8*+ 1.5$
GNT$(/30)^^$ 10.8+ 10.6$ 4.4+ 4.3$ 1.6+ 4.3$ 13.4+ 8.7$ 26.8*+ 1.7$
GDA$(/24)#$ 4.2+ 2.6$ 0.1+ 0.3$ 8.3+ 8.8$ 5.1+ 4.3$ 12.9**+ 4.4$
VOSP$(/20)$ 16.5+ 3.1$ 14.6+ 6.2$ 14.6+ 4.3$ 15.7+ 2.5$ 18.0*+ 3.5$
Stroop$Colour$
Naming$(secs)##$ 74.5+ 21.4$ 68.0+ 20.6$ 56.8+ 23.0$ 55.2+ 18.6$ 30.2*+ 3.8$
Word$Repetition$
(/45)$§$
21.8+ 16.0$ 40.3+ 5.1$ 43.9+ 1.4$ $ $ 44.3**+ 1.0$
Sentence$
Repetition$(/10)$§§$
3.7+ 3.9$ 6.2+ 3.1$ 9.6+ 0.7$ $ $ 9.8**+ 0.6$
Receptive$Grammar$
GPALPA55$(/24)$
16.1+ 7.4$ 11.6+ 6.0$ 21.1+ 3.0$ $ $ 23.5*+ 0.7$
Baxter$Spelling$Test$
(/30)$ 11.2+ 9.7$ 6.7+ 5.9$ 14.0+ 10.4$ $ $ 26.9**+ 1.3$
$ CSF+N=7+ CSF+N=9+ CSF+N=5+ CSF+N=10$ + $
CSF$Total$Tau$
(pg/ml)$ 540+ 370$ 888+ 318$ 350+ 131$ 770+ 355$ + $


















CSF+ data+ were+ available+ on+ 31+ (56%)+ of+ all+ 53+ affected+ individuals+ (comprising+ seven+
nvPPA,+ nine+ lvPPA,+ five+ svPPA,+ 10+ AD).+ Two+ of+ seven+ nvPPA+ cases+ (29%)+ had+ CSF+
consistent+with+underlying+nonNAD+pathology+and+eight+of+nine+ lvNPPA+cases+(89%)+had+









Individual+ tracts+ are+ listed+ and+ their+ involvement+ in+ each+ PPA+ syndrome+ relative+ to+
healthy+ controls+ is+ quantified+ in+ tables+ 5.3+ to+ 5.6;+ quantitative+data+ relative+ to+ the+AD+
group+ are+ presented+ in+ table+ 5.7;+ quantitative+ date+ comparing+ PPA+ syndromic+ groups+
with+ each+ other+ are+ presented+ in+ table+ 5.8.+ The+ overall+ profile+ of+ white+ matter+ tract+
pathology+ in+ each+ syndrome,+ taking+ all+ DTI+ metrics+ into+ account,+ is+ discussed+ in+ the+




Figure$ 5.1.$ Patterns$ of$ decreased$ FA$ in$ PPA$ groups$ compared$ with$ controls.$ Results$ are$ overlaid$ on$











Figure$ 5.3.$ Patterns$ of$ increased$ TR$ in$ PPA$ groups$ compared$ with$ controls.$ Results$ are$ overlaid$ on$







Figure$ 5.4.$ Top$ panel$ shows$ areas$ of$ altered$ white$ matter$ in$ svPPA$ compared$ with$ AD$ patients;$
indicating$ profiles$ of$ increased$ AX$ (top),$ RD$ (middle)$ and$ TR$ bottom.$ Results$ are$ overlaid$ on$
representative$ sections$ (MNI$ coGordinates$ shown$ on$ left)$ derived$ from$ the$ average$ FA$ skeleton.$ For$













temporal+ tracts,+ in+ particular+ within+ anteriorNventral+ fibres+ of+ bilateral+ uncinate+
fasciculus+and+bilateral+inferior+longitudinal+fasciculus,+with+less+significant+involvement+
of+dorsal+and+posterior+white+matter+tracts.+Comparing+DTI+metrics,+the+most+extensive+
changes+ (%+ of+ significant+ voxels+ within+ a+ white+ matter+ tract)+ were+ detected+ by+ RD,+
followed+by+TR,+FA+and+AX.+Compared+with+healthy+subjects,+the+nvPPA+group+had+white+
matter+ tract+pathology+within+both+ cerebral+hemispheres+predominantly+ involving+ the+
left+ anterior+ frontal+ lobe+ (uncinate+ fasciculus)+ and+ subcortical+ (anterior+ thalamic+
radiations+ and+ corticospinal+ tracts)+ projections;+ comparing+ nvPPA+ with+ AD,+ the+ AD+
group+ showed+ more+ extensive+ posterior+ hemisphere+ white+ matter+ tract+ pathology+
(splenium+ corpus+ callosum,+ fornix,+ right+ inferior+ longitudinal+ fasciculus,+ right+ superior+




Tract$ pGvalue$ voxels$ %$ Tract$ pGvalue$ voxels$ %$ Tract$ pGvalue$ voxels$ %$
L+UF+ 0.003+ 526+ 80.4+ L+UF+ 0.005+ 334+ 51.1+ L+UF+ 0.009+ 459+ 70.2+
R+UF+ 0.002+ 309+ 78.8+ CC+ 0.01+ 7334+ 49.3+ CC+ 0.01+ 9711+ 65.2+
CC+ 0.01+ 8694+ 58.4+ L+ATR+ 0.01+ 618+ 39.5+ L+ILF+ 0.009+ 1628+ 61.8+
L+ILF+ 0.008+ 1265+ 48+ R+ATR+ 0.01+ 288+ 23.2+ R+ILF+ 0.015+ 1085+ 58.3+
L+SLF+ 0.01+ 1229+ 45.2+ R+UF+ 0.02+ 90+ 23+ L+CB+ 0.009+ 392+ 46.2+
R+ILF+ 0.01+ 767+ 41.2+ L+SLF+ 0.03+ 595+ 21.9+ R+CB+ 0.013+ 245+ 40.8+
R+CB+ 0.004+ 243+ 40.5+ Fornix+ 0.01+ 33+ 5.9+ R+UF+ 0.014+ 145+ 37+
R+SLF+ 0.02+ 853+ 35.8+ L+ILF+ 0.03+ 78+ 3+ L+ATR+ 0.012+ 526+ 33.7+
L+CB+ 0.01+ 244+ 28.8+ R+CB+ 0.04+ 15+ 2.5+ R+SLF+ 0.032+ 719+ 30.2+
L+ATR+ 0.008+ 133+ 8.5+ R+ILF+ 0.02+ 15+ 0.8+ L+SLF+ 0.012+ 788+ 29+
Fornix+ 0.02+ 45+ 8.1+ R+SLF+ 0.02+ 17+ 0.7+ R+ATR+ 0.019+ 300+ 24.2+
R+ATR+ 0.03+ 36+ 2.9+ L+CST+ 0.009+ 47+ 0.6+ Fornix+ 0.006+ 41+ 7.3+
L+CST+ 0.02+ 17+ 0.2+ L+CB+ 0.01+ 3+ 0.4+ R+CST+ 0.02+ 284+ 4.2+
R+CST+ ++ ++ 0+ R+CST+ 0.01+ 19+ 0.3+ L+CST+ 0.019+ 223+ 3+
Table&5.3.&Profiles&of&changes& in&FA& in&each&PPA&groups&compared&with&healthy&controls.&Results&are&FWE&




Tract$ pGvalue$ voxels$ %$ Tract$ pGvalue$ voxels$ %$ Tract$ pGvalue$ voxels$ %$
R+UF+ 0.02+ 257+ 65.6+ L+ATR+ 0.007+ 672+ 43+ CC+ 0.005+ 9711+ 65.2+
L+UF+ 0.004+ 405+ 61.9+ CC+ 0.02+ 4164+ 28+ R+UF+ 0.007+ 233+ 59.4+
L+ILF+ 0.004+ 1113+ 42.2+ R+UF+ 0.03+ 66+ 16.8+ R+ILF+ 0.006+ 994+ 53.4+
R+ILF+ 0.01+ 685+ 36.8+ L+UF+ 0.02+ 71+ 10.9+ L+ILF+ 0.004+ 1381+ 52.4+
CC+ 0.02+ 3268+ 22+ R+ATR+ 0.03+ 111+ 9+ L+SLF+ 0.004+ 1303+ 47.9+
L+SLF+ 0.02+ 542+ 19.9+ R+SLF+ 0.05+ 210+ 8.8+ L+ATR+ 0.004+ 724+ 46.3+
L+ATR+ 0.01+ 308+ 19.7+ L+CST+ 0.01+ 312+ 4.3+ L+UF+ 0.009+ 262+ 40.1+
R+ATR+ 0.02+ 108+ 8.7+ R+CST+ 0.02+ 267+ 4+ R+SLF+ 0.006+ 913+ 38.3+
R+SLF+ 0.02+ 67+ 2.8+ Fornix+ 0.04+ 10+ 1.8+ R+ATR+ 0.011+ 281+ 22.7+
L+CST+ 0.03+ 196+ 2.7+ L+CB+ 0.04+ 7+ 0.8+ L+CB+ 0.005+ 172+ 20.3+
R+CST+ 0.04+ 147+ 2.2+ L+SLF+ 0.02+ 15+ 0.6+ L+CST+ 0.006+ 276+ 3.8+
Fornix+ 0.04+ 12+ 2.1+ L+ILF+ ++ ++ 0+ R+CST+ 0.007+ 190+ 2.8+
L+CB+ ++ ++ 0+ R+CB+ ++ ++ 0+ R+CB+ 0.022+ 17+ 2.8+
R+CB+ ++ ++ 0+ R+ILF+ ++ ++ 0+ Fornix+ 0.019+ 9+ 1.6+





Tract$ pGvalue$ voxels$ %$ Tract$ pGvalue$ voxels$ %$ Tract$ pGvalue$ voxels$ %$
R+UF+ 0.001+ 371+ 94.6+ L+UF+ 0.01+ 395+ 60.4+ CC+ 0.004+ 11278+ 75.8+
L+UF+ 0.002+ 566+ 86.5+ CC+ 0.01+ 7853+ 52.8+ R+ILF+ 0.004+ 1403+ 75.3+
L+ILF+ 0.01+ 1621+ 61.5+ L+ATR+ 0.01+ 672+ 43+ L+ILF+ 0.003+ 1888+ 71.6+
Fornix+ 0.01+ 330+ 59+ R+UF+ 0.01+ 134+ 34.2+ L+UF+ 0.005+ 394+ 60.2+
R+ILF+ 0.01+ 1077+ 57.8+ R+ATR+ 0.01+ 406+ 32.7+ L+SLF+ 0.01+ 1470+ 54+
CC+ 0.01+ 8139+ 54.7+ L+SLF+ 0.02+ 752+ 27.6+ L+ATR+ 0.01+ 711+ 45.5+
L+SLF+ 0.01+ 1286+ 47.3+ R+CB+ 0.02+ 99+ 16.5+ L+CB+ 0.005+ 374+ 44.1+
L+CB+ 0.02+ 338+ 39.9+ Fornix+ 0.02+ 33+ 5.9+ R+SLF+ 0.01+ 979+ 41.1+
L+ATR+ 0.01+ 584+ 37.4+ L+ILF+ 0.04+ 98+ 3.7+ R+CB+ 0.01+ 237+ 39.5+
R+SLF+ 0.01+ 831+ 34.9+ L+CB+ 0.03+ 21+ 2.5+ R+ATR+ 0.01+ 351+ 28.3+
R+CB+ 0.01+ 205+ 34.2+ R+ILF+ 0.04+ 27+ 1.5+ R+UF+ 0.01+ 237+ 9+
R+ATR+ 0.01+ 378+ 30.5+ L+CST+ 0.01+ 49+ 0.7+ Fornix+ 0.005+ 45+ 8.1+
L+CST+ 0.01+ 221+ 3+ R+SLF+ 0.01+ 16+ 0.7+ R+CST+ 0.02+ 233+ 3.5+









pathology+ within+ bilateral+ frontoNtemporoNparietal+ regions,+ more+ marked+
posteriorly+ and+within+ the+ left+ hemisphere+with+ involvement+ of+ both+ dorsal+ and+
ventral+white+matter+tracts+(ILF,+UF,+SLF,+CB,+ATR,+fornix)+and+also+corpus+callosum;+
when+compared+with+the+AD+group,+no+significant+white+matter+ tract+differences+
were+ observed.+ Comparing+ maps+ of+ altered+ diffusivity+ in+ lvPPA+ versus+ healthy+
control+(e.g.+figure+5.2)+and+AD+diseaseNcontrols+versus+healthy+controls+(figure+5.5)+







Tract$ pGvalue$ voxels$ %$ Tract$ pGvalue$ voxels$ %$ Tract$ pGvalue$ voxels$ %$
R+UF+ 0.003+ 364+ 92.9+ L+UF+ 0.01+ 323+ 49.4+ CC+ 0.004+ 12320+ 82.8+
L+UF+ 0.004+ 573+ 87.6+ CC+ 0.01+ 7184+ 48.3+ R+ILF+ 0.004+ 1349+ 72.4+
Fornix+ 0.02+ 349+ 62.4+ L+ATR+ 0.01+ 644+ 41.2+ L+ILF+ 0.002+ 1848+ 70.1+
L+ILF+ 0.008+ 1508+ 57.2+ R+UF+ 0.02+ 111+ 28.3+ R+UF+ 0.005+ 241+ 61.5+
R+ILF+ 0.01+ 1025+ 55+ R+ATR+ 0.01+ 300+ 24.2+ L+SLF+ 0.005+ 1577+ 58+
CC+ 0.02+ 7578+ 50.9+ Fornix+ 0.02+ 20+ 3.6+ L+UF+ 0.005+ 366+ 56+
L+SLF+ 0.01+ 1200+ 44.1+ L+SLF+ 0.03+ 77+ 2.8+ L+ATR+ 0.005+ 728+ 46.6+
L+ATR+ 0.01+ 537+ 34.4+ L+CB+ 0.02+ 18+ 2.1+ R+SLF+ 0.01+ 1012+ 42.5+
R+SLF+ 0.03+ 608+ 25.5+ R+CST+ 0.02+ 106+ 1.6+ R+ATR+ 0.01+ 364+ 29.4+
R+ATR+ 0.02+ 312+ 25.2+ R+SLF+ 0.03+ 28+ 1.2+ L+CB+ 0.002+ 230+ 27.1+
L+CB+ 0.04+ 202+ 23.8+ L+CST+ 0.03+ 40+ 0.5+ Fornix+ 0.01+ 50+ 8.9+
R+CB+ 0.03+ 83+ 13.8+ R+CB+ 0.03+ 1+ 0.2+ R+CB+ 0.01+ 41+ 6.8+
L+CST+ 0.03+ 206+ 2.8+ L+ILF+ ++ ++ 0+ R+CST+ 0.01+ 209+ 3.1+




Tract$ p$ voxels$ %$ Tract$ p$ voxels$ %+ Tract$ p$ voxels$ %+
R+UF$ 0.01$ 90$ 5.2$ L+UF$ 0.01$ 385$ 13.8$ L+UF$ 0.02$ 298$ 10.7$
L+UF$ 0.003$ 132$ 4.7$ R+UF+ 0.02+ 207+ 12+ R+UF+ 0.02+ 162+ 9.4+
L+ILF+ 0.01+ 393+ 4.1+ L+ILF+ 0.01+ 512+ 5.4+ L+ILF+ 0.01+ 463+ 4.9+
R+ILF+ 0.02+ 213+ 3.2+ R+ILF+ 0.02+ 236+ 3.5+ R+ILF+ 0.02+ 214+ 3.2+
CC+ 0.02+ 18+ 0.1+ CC+ 0.04+ 12+ 0.2+ CC+ 0.02+ 7+ 0.1+
White$Matter$changes$in$AD$vs.$nvPPA$
Axial$Diffusivity$(AD>nvPPA)$
Tract$ p$ voxels$ %$
R+ILF+ 0.05+ 216+ 3.2+
CC+ 0.04+ 1244+ 1.4+
R+SLF+ 0.05+ 36+ 0.3+





Differences+ in+ profiles+ of+ white+matter+ tract+ pathology+ between+ PPA+ syndromic+
groups+were+also+identified+(for+details+see+figure+5.5+and+table+5.8).++
+
SvPPA+ was+ associated+ with+ greater+ alterations+ in+ bilateral+ inferior+ longitudinal+
fasciculus+ and+uncinate+ fasciculus+ (left+ >+ right)+ relative+ to+nvPPA;+ and+ in+bilateral+
inferior+ longitudinal+fasciculus+(left+>+right)+and+left+uncinate+fasciculus+relative+to+
lvPPA.+ LvPPA+ was+ associated+ with+ more+ posterior+ bilateral+ white+ matter+ tract+
pathology+ in+ most+ tracts,+ with+ the+ most+ striking+ difference+ in+ bilateral+ inferior+
longitudinal+ fasciculus,+ superior+ longitudinal+ fasciculus+ and+ the+ splenium+ of+ the+


























voxels! %! Tract! p5
value!
voxels! %! Tract! p5
value!
voxels! %! Tract! p5
value!
voxels! %!
L"ILF" 0.01" 622" 6.6" L"UF" 0.009" 125" 4.5" CC" 0.03" 1496" 1.6" L"ILF" 0.01" 1565" 16.5"
L"UF" 0.004" 129" 4.6" L"ILF" 0.01" 190" 2.0" L"CST" 0.05" 25" 0.3" R"ILF" 0.01" 998" 14.9"
R"ILF" 0.02" 303" 4.5" " " " " " " " " R"SLF" 0.02" 848" 7.6"
R"UF" 0.02" 67" 3.9" " " " " " " " " R"CST" 0.02" 437" 6.5"
CC" 0.03" 102" 0.1" " " " " " " " " L"SLF" 0.02" 817" 5.9"
" " " " " " " " " " " " CC" 0.02" 4427" 4.9"
" " " " " " " " " " " " L"CST" 0.02" 271" 3.7"
" " " " " " " " " " " " R"UF" 0.04" 42" 2.4"
" " " " " " " " " " " " L"CB" 0.02" 66" 2.2"
" " " " " " " " " " " " R"ATR" 0.02" 63" 0.6"












L"UF" 0.01" 314" 11.3" L"UF" 0.02" 271" 9.7"
"
L"ILF" 0.02" 1262" 13.3"
R"UF" 0.02" 109" 6.3" L"ILF" 0.02" 278" 2.9" R"ILF" 0.04" 794" 11.9"
L"ILF" 0.02" 516" 5.4" " " " " R"CST" 0.04" 245" 3.7"
R"ILF" 0.02" 309" 4.6" " " " " CC" 0.03" 2601" 2.9"
CC" 0.03" 6" 0" " " " " L"SLF" 0.03" 381" 2.8"
" " " " " " " " R"SLF" 0.05" 93" 0.8"

























L"UF" 0.01" 232" 8.3" L"UF" 0.01" 144" 5.2"
"
L"ILF" 0.01" 1636" 17.2"
L"ILF" 0.02" 556" 5.9" L"ILF" 0.02" 259" 2.7" R"ILF" 0.01" 1150" 17.2"
R"ILF" 0.02" 280" 4.2" " " " " R"CST" 0.03" 490" 7.3"
R"UF" 0.02" 88" 5.1" " " " " L"SLF" 0.01" 813" 5.9"
CC" 0.02" 13" 0.1" " " " " L"CB" 0.01" 170" 5.6"
! ! ! ! ! ! ! ! CC" 0.01" 4452" 4.9"
" " " " " " " " L"CST" 0.03" 262" 3.6"
" " " " " " " " R"SLF" 0.02" 372" 3.4"
" " " " " " " " R"UF" 0.02" 29" 1.7"
" " " " " " " " R"ATR" 0.04" 126" 1.2"
" " " " " " " " L"UF" 0.03" 30" 1.1"
" " " " " " " " L"ATR" 0.04" 45" 0.4"
" " " " " " " " Fornix" 0.02" 5" 0.1"
FA
! " " " "
R"CST" 0.05" 68" 1"
L"ILF" 0.04" 85" 0.9"
CC" 0.05" 170" 0.2"
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5.3.4%Grey%matter%analysis%




Figure' 5.7.' Maps' of' grey' matter' (GM)' atrophy' (blue:green)' and' reduced' white' matter' fractional'
anisotropy' (FA)' (orange:yellow)' in' PPA' syndromic' groups' compared' to' healthy' controls' overlaid' on' a'





svPPA# was# associated# with# bilateral# but# predominantly# leftDsided# atrophy# of# anteroD
inferior# temporal#and#orbitofrontal#cortices.#nvPPA#was#associated#with#atrophy#of# left#
inferior# frontal# and# opercular# cortex.# lvPPA# was# associated# with# more# extensive# left#




and# left# insular# cortex# in# nvPPA,# left# inferior# longitudinal# fasciculus# and# left# temporoD
parietal# cortex# in# lvPPA,# anterior# inferior# longitudinal# fasciculus# and# anterior# temporal#
cortices# in# svPPA.).# However# the# tract# alterations# were# spatially# more# distributed,#
extending# beyond# the# zones# of# grey# matter# loss.# This# anatomical# disparity# was# most#
evident# for# lvPPA,# and# less# evident# for# nvPPA# and# svPPA.# The# extent# of#white#matter#






This# study# has# identified# signatures# of# white# matter# tract# pathology# across# the# PPA#
spectrum# both# in# relation# to# healthy# controls# and# patients# with# a# diagnosis# of# AD.#
Differences#in#the#profile#of#white#matter#tract#pathology#also#emerged#on#direct#groupD
wise# comparisons# of# PPA# syndromes,# suggesting# relative# specificity# of# white# matter#
pathology#for#particular#syndromes#and#pathologies.#Broad#anatomical#profiles#of#white#
matter#tract#pathology#were#identified#for#each#of#the#disease#groups.#These#profiles#of#
tract# pathology#demonstrated# show# some# convergence#with# previous# studies# (AcostaD
Cabronero# et# al.,# 2011;# Agosta# et# al.,# 2012;# Agosta# et# al.,# 2010;# Galantucci# et# al.,# 2011;#
Schwindt# et# al.,# 2011;# Whitwell# et# al.,# 2010)# (see# Table# 5.1);# however,# a# number# of#
additional#white#matter##tracts#were#also#identified#for#each#of#the#syndromic#groups,#and#
there# was# substantial# overlap# between# PPA# syndromes.# On# visual# inspection,# white#
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matter#pathology#appeared#more#widespread#compared#to#areas#of#grey#matter#atrophy.#
These# findings# provide# further# evidence# that# what# matter# tract# metrics# constitute#
markers#of#structural#neural#network#disintegration#across#the#PPA#spectrum#and#help#to#
define# networkDlevel# substrates# for# individual# PPA# syndromes# that# may# be# helpful# in#
diagnosis#and#tracking#of#PPA.#These#profiles#align#with#patterns#of#network#breakdown#
previously#identified#in#svPPA,#nvPPA#and#lvPPA#(Seeley#et#al.,#2009;#Rohrer#et#al.,#2010c)#
and#with# language#pathways#proposed# in# the#healthy#brain# (Saur# et# al.,# 2008).# #Whilst#
syndromic# profiles# did# emerge# there# were# also# white# matter# tract# pathology# which#
overlapped# across# all# syndromes.# This#may# be# in# keeping#with# the# fact# that# over# time#
clinical#syndromes#converge#with#one#another#(Kertesz#et#al.,#2005)#and#may#account#for#







this# would# be# consistent# with# previous# evidence# concerning# the# neuroanatomical#
substrates# of# articulatory,# phonemic# and# grammar# processing# (Katanoda# et# al.,# 2001;#




prominent# involvement# of# leftDsided# anterior/frontal# fibres,# there# was# substantial#
!168!%
variability#in#significance#levels#for#each#DTI#metrics#(see#Table#5.3#to#5.6),#and#this,#along#
with# the# boundary# limits# of# the# ROI# masks# used,# may# explain# why# more# prominent#
involvement# of# this# particular# tract# was# not# seen.# Indeed# n# the# next# chapter# (which#
contains# many# of# the# some# subjects),# where# a# different# methodology# tracking#
longitudinal# change,# involvement# of# the# SLF# becomes# more# apparent# in# this# group,#
confirming# its# role# in# the# pathogenesis# of# nvPPA.# The# profiles# delineated# above# also#
provide# a# substrate# for# the# nonDlanguage# cognitive# difficulties# reported# in# nvPPA,# in#
particular# executive# dysfunction# (Rohrer# et# al.,# 2010b).# svPPA# here# was# associated# in#
particular# with# involvement# of# inferior# longitudinal# fasciculus# and# uncinate# fasciculus:#
these# tracts# could# support# the# putative# anterior# temporal# –# inferior# frontal# network#
mediating#semantic#and#evaluative#processing#of#words#and#nonverbal#objects#(Awad#et#
al.,#2007;#Parker#et#al.,#2005;#Scott#et#al.,#2000).#lvPPA#was#associated#with#involvement#of#
both# dorsallyDdirected# (superior# longitudinal# fasciculus# and# cingulum# bundle)# and#
ventrallyDdirected# (inferior# longitudinal# fasciculus)# tracts,# prominently# including# more#
posterior# temporoDparietal# projections# and# similar# to# the# pattern# seen# in# typical# AD#
(AcostaDCabronero# et# al.,# 2011):# these# widely# distributed# tracts# are# likely# to# support# a#
distributed# network# that# in# the# dominant# hemisphere# mediates# phonological# working#
memory#as#well# as#praxis#and#other#parietal# functions# (Awad#et#al.,# 2007;#Simon#et#al.,#
2002),#and#which#has#been#previously# implicated# in#the# lvPPA#syndrome#(Rohrer,#et#al.,#
2010d;# GornoDTempini# et# al.,# 2011).#Whilst# inferior# longitudinal# fasciculus# pathology# has#
been#inconsistently#reported#in#lvPPA,#identification#of#this#tract#in#the#lvPPA#group#in#the#
current#study#is#consistent#with#the#known#engagement#of#the#ventral#language#network#
in# lexical# retrieval# (Wong#et# al.,# 2011)# and#with#previous# studies#of# lvPPA# linking# lexical#
retrieval# deficits#with#more# ventral# grey#matter# atrophy# (Wilson# et# al.,# 2010).# # Despite#
!169!%
their#distinct#clinical#phenotypes#there#was#no#significant#difference#in#white#matter#tract#








It# is# noteworthy# that,# for# each# of# the# PPA# syndromes,# white# matter# tract# pathology#
occurred#in#proximity#to#regions#of#grey#matter#atrophy#but#also#extended#more#widely#
within#each#cerebral#hemisphere#(see#Figure#5.6).#While#caution#is#needed#in#comparing#















change,# the# possibility# that# white#matter# pathology# occurs# in# advance# of# grey#matter#
pathology,# or# a# combination# of# both.# To# evaluate# this# issue# further# preDsymptomatic#
studies#measuring#both#white#matter#and#grey#matter#are#required;#however#longitudinal#





Whilst# the# role# of# particular# DTI# metrics# in# defining# neurodegenerative# pathologies#
remains#controversial#the#current#study#has#replicated#findings#from#a#number#of#other#
studies#(AcostaDCabronero#et#al.,#2010;#Agosta#et#al.,#2012);#(see#table#5.1).#Together#this#




2011;# Galantucci# et# al.,# 2011).# Tracts# with# the# most# marked# involvement# on# voxelDwise#
analysis#(e.g.,#uncinate#fasciculus#in#svPPA;#see#table#5.3#to#5.5)#tended#to#show#broadly#
similar#patterns#of# involvement#across#DTI#metrics.#This#suggests# that# the#sensitivity#of#
metrics#for#detecting#white#matter#pathology#may#relate#to#the#extent#of#tract#damage,#
at# least#crossDsectionally,#or# that#particular#metrics# (e.g.,#RD;#see#Table#5.5)#may#detect#
change#earlier#or#may#be#intrinsically#more#sensitive#to#particular#tissue#pathologies#(such#
as,# potentially,# AX# for#AD#pathology,# since#AX# revealed#more# extensive# damage# in# the#
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lvPPA#group.# relative# to#other#metrics#and#compared#with#nvPPA#or#svPPA#subtypes# in#







from# largeDscale# network# breakdown.# However,# comparing# tract# signatures# across#
disease# groups# (Figures# 5.1# to# 5.3),# certain# tracts# seem# to# have# a# greater# burden# of#
pathology:# svPPA# was# associated# with# predominant# ventral# tract# involvement,# nvPPA#
with# more# anteriorDdorsal# tract# involvement# and# lvPPA# with# more# widespread# tract#
changes.##
#
This# study# corroborates# previous# work# suggesting# that# the# overall# profile# of# tract#
involvement# may# signal# particular# pathologies.# For# example,# the# fornix# and# cingulum#
bundle#were#most#markedly# involved# in# lvPPA:#these#structures#have#been# identified#as#
potentially# useful# anatomical# biomarkers# in# the# detection# of# AD# pathology,# which#
underpins#a#high#proportion#of#lvPPA#cases#(Huang#et#al.,#2011;#Keihaninejad#et#al.,#2012;#
Oishi# et# al.,# 2011).# Other# tracts# (for# example,# uncinate# fasciculus# and# corpus# callosum)#
were# involved#across#syndromes:# such# tracts#could#potentially#play#a#critical# role# in# the#
diffusive#spread#of#pathogenic#proteins,#which#may#constitute#a#common#mechanism#of#
network# disintegration# in# neurodegenerative# diseases# (Raj# et# al.,# 2012;# Warren# et# al.,#
2012;# Zhou# et# al.,# 2012).# # # The# present# findings# support# the# concept# of# differentially#
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vulnerable#neuronal#networks#in#particular#PPA#syndromes#and#proteinopathies#with#the#
tractographic# delineation# of# PPA# contributing# new# information# about# the#







core# clinical# hallmark# of# impaired# language.# These# relatively# circumscribed# cognitive#




pathology,# and# lvPPA# having# diffuse,# both# ventral# and# dorsal# profiles# of#white#matter#
pathology.#These#differing#profiles#may#account#for#the#clinical#variability#seen#across#the#
PPA# spectrum.# Tracts# such# as# the# uncinate# fasciculus# and# corpus# callosum# were#
commonly# involved# across# the# PPA# spectrum,# indicating# a# degree# of# overlap# across#
distributed# languageDnetworks,# which# may# account# for# some# of# the# observed#
convergence#of#each#clinical#phenotype#with#one#another#over#time.#Whilst#much#of#the#













The# previous# chapter# set# about# establishing# crossDsectional# profiles# of# white# matter#
pathology# in# PPA.# Whilst# syndromic# signatures# emerged# there# was# still# overlapping#
profiles# of# pathology# across# syndromes.# Further# information# on# syndromic# profiles# of#
white#matter# pathology#may# be# generated# by# studying# change# in# the# same# individual#
over# time,# improving# the# quality# of# potential# future# syndrome# specific# imaging#
biomarkers.# This# is# of# current# interest,# as#whilst# there# has# been#much# progress# in# the#
clinicopathological# correlations# within# PPAs,# there# remains# an# absence# of# measures,#
which#have# the# robustness# and# sensitivity# to# tract# PPA#over# time.# These# issues# in# turn#
present# challenges# for# planning# future# clinical# trials# of# diseaseDmodifying# therapies# in#
PPA:#such#trials#are#likely#to#target#specific#pathologies#and#to#seek#to#initiate#treatments#
early# in#the#disease#course#to#minimise#cognitive#decline.#Having#sensitive#biomarkers#is#





most# likely# due# to# a# combination# of# under# recognition# of# these# syndromes,# as#well# as#
relative# rarity# in# comparison# to# other# neurodegenerative# conditions.# A# number# of#
longitudinal#studies#examining#whole#brain#and#grey#matter#atrophy#have#been#reported.#
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Gordon# and# colleagues# reported# an# annual# rate# of#whole# brain# atrophy# of# 2.5%# above#
controls#in#svPPA#and#2.8%#in#nvPPA#(Gordon#et#al.,#2010).#Some#contradictory#data#exists#
regarding#which#brain#regions#atrophy#greater#in#PPA#with#some#studies#suggesting#that#
atrophy#of# the#right#hemisphere#accelerates#over#time#compared#to#the# left# (Rohrer#et#




longitudinal# fasciculus# and# superior# longitudinal# fasciculus#were# reported,#with#greater#
change# seen#on# the# left;#within# the# svPPA#group# change#over# time#was#only#observed#
within# left# sided# tracts# including# cingulum# bundle,# inferior# longitudinal# fasciculus,#
superior# longitudinal# fasciculus# and# uncinate# fasciculus# (Lam# et# al.,# 2014).# Overall# the#
trajectory# of# disease# across# PPA# remains# somewhat# unclear,# and# there# is# a# need# for#
further# neuroimaging# studies,# using# more# sophisticated# techniques,# to# clarify# these#
discrepancies.#
#
The# current# study# will# aim# to# build# and# expand# on# previous# studies# of# longitudinal#
imaging# changes# in# PPA.# The# primary# aim# here# is# to# assess# the# potential# role# of#
longitudinal#DTI#as#a#clinical#biomarker#in#tracking#progression#of#white#matter#pathology#
in#PPA#and#comparing#with#other#traditional#biomarkers.#In#addition,#longitudinal#DTI#may#
hold# important# insights# into# more# basic# aspects# of# the# neurobiology# of# PPA# and#
secondary#aims#include#establishing#if#common#or#syndrome#specific#trajectories#of#white#






progression# in# patients# suspected# to# have# frontotemporal# lobar# degeneration# at# the#
specialist# cognitive# disorders# clinic,#National#Hospital# for#Neurology# and#Neurosurgery,#
London,#United#Kingdom.#All#patients#met#current#consensus#criteria#(GornoDTempini#et#
al.,#2011)#for#a#diagnosis#of#probable#or#define#PPA#and#were#also#included#in#the#Chapter#
5#of# this#Thesis.#Participants#who#had# two#clinical# and#neuropsychological# assessments#
and# MRI# scans# (to# include# both# T1Dvolumetric# and# DTI# sequences),# a# minimum# of# six#
months# apart,# were# considered# for# study# inclusion.# 32# participants# were# identified# as#
fulfilling#the#criteria#for#study#inclusion,#with#11#participants#further#meeting#the#diagnosis#




tests#were# the# same# at# baseline# and# followDup# visits,# although# in# some# circumstances,#
due#to#clinical#progression,#some#affected#participants#were#unable#to#fully#complete#all#




All# participants’# baseline# and# followDup# DTI# scans# underwent# processing# as# previously#
specified# in# the# section# describing# longitudinal# DTI# image# processing# (see# chapter# 2,#
section# 2.2.8.)# ROI# based# analysis# was# performed,# with# tracts# chosen# either# based# on#
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apriori#prediction#of#disease# involvement,#given#their# likely# roles# in# linking#a#distributed#











Statistical# analyses#were# carried# out# using# STATA# 12©# (Statacorp,# College# Station,# TX).#
Statistical#analysis#for#crossDsectional#and#longitudinal#data#mirrored#the#analysis#used#in#
chapter# 4,# applying# a# mixedDeffects# linear# regression# model,# with# confounds# of# age,#
gender#and#disease#duration#included#within#the#model#design#(see#chapter#5,#section#2.3#
for#details).#Accuracy,#sensitivity#and#specificity#of#each#DTI#metric#in#classifying#individual#
participants# into# separate# groups# (PPA# subtype# or# control)# and# estimation# of# sample#














At# baseline,# compared# with# controls,# those# with# PPA# performed# significantly# worse#
(p<0.05)# on# tests# of# general# intellect# and# most# other# neuropsychological# measures.#
nvPPA#performed#significantly#worse#on#all#measures#except#single#word#comprehension#
and# spatial# perception.# svPPA# performed# significantly# worse# on# all# measures# except#
spatial# perception.# Those# with# lvPPA# were# significantly# impaired# on# all#
neuropsychological#measures.##
#
Longitudinal# change# in# neuropsychological# performance# for# PPA# subDgroups# is# also#
shown# in# table# 6.2# and# is# reported# as# the# estimated# percentage# per# year# change# in#
performance#from#baseline.#Over#time#those#with#nvPPA#displayed#the#most#significant#
(p<0.05)#reductions# in#neuropsychological#performance#on#tests#of#naming#(55.9%/year)#
and# executive# function# (18%/year);# those# with# svPPA# showed# the# most# significant#
reductions# on# tests# of# naming# (50.3%/year),# arithmetic# (27.9%/year)# and# executive#
function# (16.5%/year);# and# those#with# lvPPA#showed# the#most# significant# reductions#on#





%% Controls'(n=20)' Non:fluent/agrammatic'variant'PPA'(n=13)' Semantic'variant'PPA'(n=11)' Logopenic'variant'PPA'(n=6)'
'' Mean# SD# Mean# SD# pDvalue# Mean# SD# pDvalue# Mean# SD# pDvalue#
Age'at'baseline'




N/A$ 4.0$ 2.5$ 0.7$ 5.0$ 1.5$ 0.1$ 3.8$ 1.0$ 0.6$
Sex,'
male/female'
11/9$ 2/11$ 0.07§$ 6/5$ 0.4§$ 4/2$ 0.1§$
Interscan'
Interval'(years)' 1.3$ 0.4$ 1.0$ 0.2$ 0.02$ 1.1$ 0.6$ 0.3$ 1.0$ 0.3$ 0.1$








1172## #90# #1003*# #61# <0.001## 1010## #113# <0.001## 999## 95## <0.001##
BBSI'ml/year' #6.8# 7.1# #28*# 14## <0.001## #22# 14## <0.001## #15# 7# 0.02##
Table&6.1.&Study&participants’&clinical&and&imaging&characteristics.&Linear&regression&comparing&controls&with&








!! Baseline( Baseline( Change(over(time( Baseline( Change(over(time( Baseline( Change(over(time(
(( Mean! SD! Mean! SD! %/year! 95%!CI! Mean! SD! %/year! 95%!CI! Mean! SD! %/year! 95%!CI!
VIQ( 122.2! 8.3! 72.3*! 16.6! 86.1! 812.7! 0.6! 66.9*! 19.9! /5.8( /11.4( /0.3( 63.5*! 9.4! 6.3! 81.1! 13.8!
PIQ( 119.1! 8.2! 91.3*! 20.4! 0.7! 84.9! 6.2! 105.1*! 19.7! 82.6! 86.3! 1! 74.8*! 17.3! 81.6! 89.3! 6.1!
RMT(Faces(
(/50)(




45.7! 3.2! 37.6*! 10.2! /13.8( /24.3( /3.3( 30.8*! 7.8! 83.2! 89.8! 3.5! 33.4*! 10.4! 89.5! 820.2! 1.2!
GNT((/30)( 26! 2.3! 10.3*! 8.8! /55.9( /104.2( /7.7( 1.3*! 3.3! /50.3( /64.9( /35.6( 7.8*! 7.8! /84.5( /110.7( /58.2(
BPVS(
(/150)(
147.8! 1.7! 122.1! 47.1! 83.7! 821.5! 14.1! 68.9*! 47.2! 86.6! 819.2! 6! 108.3*! 35.1! /31.2( /46.2( /16.2(
Word(Rep(
(/45)( 44.2! 1.5! 19.3*! 14.4! 833.9! 868! 19.2! 42.1*! 3.8! 1.8! 80.6! 4.3! 39.4*! 4.6! /11.2( /16.9( /5.4(
Sent(Rep(
(/10)(
9.9! 0.4! 3.6*! 4! 817.5! 849.3! 14.3! 9.4*! 0.7! 82.9! 87! 1.1! 3.9*! 3.1! /83.8( /128.7( /38.8(
GDA((/24)( 13.2! 6! 4.8*! 6.4! 80.6! 846.9! 45.6! 7.7*! 7.9! /27.9( /54.8( /1.1( 0.7*! 1.2! 80.4! 859.3! 58.5!








30.1! 5.1! 77.4*! 24.7! /15.5( /1.6( /29.4( 71.9*! 23.1! /16.5( /5.5( /27.5( 85.2*! 25! 87.1! 1.1! 815.4!
Table&6.2.&Neuropsychological&performance&at&baseline&and&longitudinally&displayed&as&estimated&mean&difference&from&controls&with&change&expressed&as&a&percentage&
per& year.& *Indicates& baseline& values& signifantly& (p<0.05)& different& from& controls.& Bold& values& indicate& significant& (p<0.05)& change& over& time.&
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6.3.2%Cross*sectional%DTI%results%in%PPA%subtypes%
Cross%sectional- DTI-metric- data- for- FA,-MD,- RD- and-AX- are- shown- in- tables- 6.4- to- 6.7-
respectively- and- should- be- compared- with- data- from- the- previous- chapter- (noting-
different-methodologies-used-to-determine-metric-values).-Broadly-results-presented-in-
the- current- chapter- show- similar- anatomical- profiles- of- cross%sectional- white- matter-
pathology.- Absolute- values- representing- white- matter- pathology- were- greater- using-
TBSS,- particularly- in- the- case- of- the- nvPPA- group- were- baseline- differences- were-
relavtively- few- in-the-current-study.- Individual-DTI-metrics-showed-a-similar-ordering- in-











































































































































































































































































































































































































































































Table& 6.6& Table& 6.5& Baseline& RD& values& and& estimated& mean& differences& within& white& matter& regions& of& interest&
comparing& control& participants& and& PPA& syndromic& groups.& *& p@value& following& linear& regression& comparing& PPA&
























































































































































Rates- of- change- over- time- for- each- PPA- subtype- are- shown- in- tables- 6.8- to- 6.10.-
Individual-subjects-trajectories-of-change-in-FA-over-time-are-displayed-for-key-affected-
tracts- in- Figures- 6.1- to- 6.3.- Longitudinally,- compared- with- controls,- nvPPA- patients-
showed- widespread- changes- in- white- matter- tract- pathology,- the- largest- changes-
(reported-after-adjusting- for-controls- rates-of-change)- in-FA-were-within- the-body-and-
genu-of- the- corpus- callosum- (body,- %10.6%/year,- 95%- CI- %15.1%- to- %4.9%,- p<0.001;- genu,- %
5.2%/year,- 95%- CI- %6.0%- to- %2.3%,- p<0.001),- right- and- left- superior- longitudinal- fasciculus-
(right-SLF,-%5.7%/year,-95%-CI%7.6%-to-%2.2%,-p<0.001;- left-SLF,-–-4.3%/year,-95%-CI-%5.9%-to-%
1.1%,- p=0.004)- and- right- uncinate- fasciculus- (%6.2%/year,- 95%- CI- %10.4%- to- %0.3%,- p=0.04).-
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Similar- profiles- of- increasing-MD-were- observed- comparing- nvPPA- with- controls.- The-
largest- magnitudes- of- change- were- observed- using- RD,- with- the- greatest- increases-
within-the-body-and-genu-of-the-corpus-callosum-(body,-19.4%/year,-95%-CI-9.0%-to-29.7%,-
p<0.001;- genu,- 13.5%/year- 95%- CI- 7.6%- to- 19.5%,- p<0.001),-with- all- other- tracts,-with- the-
exception-of-the-left-uncinate-fasciculus,-showing-significant-increases-in-RD.-Significant-
increases,-but-of-lower-magnitude,-were-also-observed-using-AX-with-the-most-significant-
increases- occurring- in- the- left- inferior- longitudinal- fasciculus- (4.4%/year,- 95%- CI- 1.6%- to-




right- uncinate- fasciculus- (14.7%/year,- 95%- CI- %19.6%- to- %8.1%,- p<0.001),- the- right- and- left-
inferior-longitudinal-fasciculus-(right-ILF,-9.8%/year,-95%-CI-%11.7%-to-%6.0%,-p<0.001;-left-ILF,-
6.5%/year,- 95%- CI- %8.3%- to- %1.4%,- p=0.006)- and- the- right- and- left- superior- longitudinal-
fasciculus-(right-SLF,-3.6%/year,-95%-CI-%4.7%-to-%0.9%,-p=0.004;-left-SLF-%4.1%/year,-95%-CI-%
5.1%- to- %1.6%,- p<0.001).- - Similar- anatomical- profiles- of- increasing-MD- and-RD-were- also-
observed,- with- broadly- similar- magnitudes- of- change.- - No- significant- longitudinal-
differences-in-AX-were-detected-comparing-those-with-svPPA-with-controls.-Longitudinal-
changes- in- those- with- lvPPA,- compared- with- cognitively- healthy- participants- were-
relatively- limited.- The- largest- change- in- FA- occurred- within- the- body- of- the- corpus-
callosum- (3.4%/year- 95%- CI- %5.3%- to- 0.0%,- p=0.05).- Increasing- RD- and- AX-was- observed-
within-the-right-inferior-longitudinal-fasciculus-(RD,-5.8%/year-95%-CI-0.3%-to-11.4%,-p=0.04;-
AX,- 0.8%/year,- 95%- CI- 0.3%- to- 11.4%,- p=0.04).- No- significant- differences- in- MD- were-
detected-when-lvPPA-patients-were-compared-with-controls.-
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(%10.2-to-2.7)- (0.1-to-13.6)- (%0.7-to-19.1)- (0.7-to-10.2)-
Table& 6.8& Estimated& percentage& per& year& difference& in& the& rate& of& change& for& each& DTI& metric& for& non@
fluent/agrammatic& PPA& patients& (nvPPA),& by& region,& compared& with& controls.& Data( is( uncorrected( for(
multiple(comparisons.&
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and- sensitivity- in- classifying- PPA- syndromic- groups- from- controls.- Calculations- were-
made-for-both-cross%sectional-values-and-longitudinal-rates-of-change.-Examining-cross%
sectional- data- first,- in- those- with- svPPA,- measurements- within- the- right- inferior-
longitudinal- fasciculus- achieved- the- best- classification,-with-MD-performing- best- (AUC-
0.93,-sensitivity-100%,-specificity-80%,-correctly-classified-87%),-followed-by-AX-(AUC-0.91,-
sensitivity- 91%,- specificity- 85%,- correctly- classified- 87%),- RD- (AUC- 0.88,- sensitivity- 82%,-
specificity-85%,-correctly-classified-84%),-and-FA-(AUC-0.78,-sensitivity-64%,-specificity-85%,-
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corpus-callosum-achieved-the-best-classification,-with-MD-best-(AUC-0.82,-sensitivity-73%,-
specificity- 85%,- correctly- classified- 81%),- followed- by- RD- (AUC- 0.82,- sensitivity- 64%,-
specificity- 90%,- correctly- classified- 81%),- FA- (AUC- 0.79,- sensitivity- 73%,- specificity- 80%,-
correctly- classified- 77%)- and- AX- (AUC- 0.79,- sensitivity- 45%,- specificity- 95%,- correctly-





change- within- right- inferior- longitudinal- fasciculus- achieved- the- best- classification-
overall,- with- FA- performing- best- (AUC- 0.86,- sensitivity- 73%,- specificity- 95%,- correctly-
classified- 87%),- followed- by- RD- (AUC- 0.85,- sensitivity- 82%,- specificity- 90%,- correctly-
classified- 87%),-MD- (AUC-0.83,- sensitivity- 64%,- specificity- 100%,- correctly- classified- 87%)-
and- AX- (AUC- 0.76,- sensitivity- 64%,- specificity- 100%,- correctly- classified- 87%).- In- nvPPA-
change-within- the- right- superior- longitudinal- fasciculus- achieved- the-best- classification-
overall,- with- AX- performing- best- (AUC- 0.95,- sensitivity- 100%,- specificity- 80%,- correctly-
classified- 87%),- followed- by- MD- (AUC- 0.93,- sensitivity- 91%,- specificity- 85%,- correctly-
classified-87%),-RD-(AUC-0.89,-sensitivity-73%,-specificity-95%,-correctly-classified-87%),-and-
FA- (AUC-0.85,- sensitivity-82%,- specificity-85%,- correctly- classified-84%).- In- lvPPA-change-
within-the-genu-of-the-corpus-callosum-achieved-the-best-classification-overall,-with-RD-
performing- best- (AUC- 0.77,- sensitivity- 50%,- specificity- 95%,- correctly- classified- 85%),-
followed-by-MD- (AUC-0.77,- sensitivity- 50%,- specificity- 90%,- correctly- classified- 81%),- AX-




To- assess- the- utility- of- DTI- as- an- outcome- measure- sample- size- calculations- were-












largest- AUC- on- the- classification- analysis;- the- choice- of- FA- was- based- on- its- overall-
longitudinal- performance- across- syndromes,- again- based- on- values- from- the-
classification-analysis.- In- svPPA- the- lowest- sample- size-estimates-were-obtained-assing-
FA- change- within- the- right- inferior- longitudinal,- in- nvPPA- the- lowest- sample- size-
estimates-were-obtained-when-assessing-FA-change-within-the-right-superior-longitudinal-










-- SvPPA( NvPPA( LvPPA( SvPPA( NvPPA( LvPPA(
20%( 59- 464- 238- 86- 481- 63-
30%( 26- 207- 106- 38- 216- 28-
40%( 15- 116- 60- 21- 122- 16-
-- Body(CC(
-- FA(( RD(
-- SvPPA( NvPPA( LvPPA( SvPPA( NvPPA( LvPPA(
20%( 268- 162- 255- 613- 196- 642-
30%( 120- 72- 117- 269- 88- 283-
40%( 68- 41- 67- 149- 50- 159-
(( Right(SLF(
(( FA(( RD(
(( SvPPA( NvPPA( LvPPA( SvPPA( NvPPA( LvPPA(
20%( 194- 159- 9681- 427- 174- 67201-
30%( 87- 70- 4824- 188- 77- 51451-
40%( 49- 39- 2881- 106- 43- 32929-
(( BBSI(
(( SvPPA( NvPPA( LvPPA(
20%( 342- 175- 301-
30%( 152- 78- 134-
40%( 86- 44- 76-
Table&6.11&Sample&size&estimates&per&treatment&arm&of&a&clinical&trial&comparing&2&DTI&metrics&(FA&and&RD)&








presented- in- the-previous- chapter- by- providing- novel- data,- giving- further- insights- into-
the-evoloution-of-PPA.-This-study-also-suggests-that-longitudinal-DTI-may-be-a-potentially-
useful- disease- biomarker.- Across- syndromic- groups,- both- cross%sectionally- and-
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longitudinally,-decreasing-FA-and-increasing-MD,-RD-and-AX-was-observed,-with-specific-
trajectories- of- white- matter- change- emerging.- In- those- with- svPPA- the- most- notable-








Relatively- few-studies-of- longitudinal- imaging- in-PPA-have-been-carried-out.-One-study-
has-examined-longitudinal-change-in-white-matter-tracts-in-patients-with-PPA,-although-
did-not- include-patients-with- lvPPA-(Lam-et-al.,- 2014).-Similar- to- the-current-study,- this-
study- found- bilateral- (left>right)- changes- in- superior- longitudinal- fasciculus,- inferior-
longitudinal- fasciculus- and- corpus- callosum-at- baseline,- and-overtime- changes-became-
more- apparent- within- the- right- hemisphere,- which- is- similar- to- the- current- studies-




tracts- and- the- corpus- callous.- -Whilst- there- are- few- longitudinal- DTI- studies- there- is- a-




progression- beyond- these- regions,- most- often- mirroring- the- same- regions- within- the-
contralateral-hemisphere-(Brambati-et-al.,-2009;-Czarnecki-et-al.,-2008;-Faria-et-al.,-2014;--
Rogalski- et- al.,- 2011;- Rohrer- et- al.,- 2008;- Rohrer- et- al.,- 2013).- In- one- recent- study-
progressive- atrophy- in- the- right- temporal- lobe-was- also- shown- to- be- correlated-with-
further-declines- in-word-comprehension-(Faria-et-al.,-2014)-providing-evidence-that-this-
atrophy- may- have- a- clinical- correlate.- A- number- of- longitudinal- functional- imaging-
studies- have- suggested- that-within- these- ‘mirror- regions’- there- is- an- initial- increase- in-
activation-activity-on-specific-language-tasks-(Heim-et-al.,-2014;-Maguire-et-al.,-2010).-This-
is- thought- to-be-a-compensatory-mechanism-to-help-maintain-cognition,-but-over- time-
this- activity- reduces- and- eventually- specific- cognitive- abilities- collapse.- These- areas- of-







identified- occurred- remote- to- the- sites- of- maximal- grey- matter- atrophy.- The- current-
study-adds- further- support- for- this- finding-as-much-of- the- largest-pathological- change-
within-white-matter-tracts-occurred-in-the-hemisphere-contralateral-(in-this-case-right)-to-
maximal-grey-matter-atrophy.-The-current-study-does-indicate-that-there-is-progression-
of- left- sided- white- matter- tract- pathology- over%time,- and- indeed- cross%sectional- data-
indicate- significant- left- hemispheric- tract- pathology- at- baseline,- however- the- rate- of-
change- within- the- right- hemisphere- appears- to- accelerate- more- rapidly.- PPA- could-
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therefore-be- viewed-as- a-bihemispheric-disease-process,-which- initially- targets- specific-
brain-networks,- in-this-case- left%sided- language-networks,-but-over-time-encroaches-on-
other-brain-regions.-The-pattern-of-progression-observed-may-results-from-the-fact-that-




hemisphere.- Whilst- traditionally- the- left- hemisphere- has- been- viewed- as- the- primary-
language- hemisphere,- increasing- evidence- indicates- that- the- right- hemisphere- is-
important- in- paralinguistic- processing,- such- as- sarcasm-perception- and- contextualising-
other-external-stimuli-(Rankin-et-al.,-2009),-as-well-as-being-associated-with-problems-in-
accent- processing- and- voice- recognition- (Hailstone- et- al.,- 2010).- The- right- hemisphere-
also-plays-a-key-role- in-giving-objects-meaning,-and-has-been- linked-with-visual-agnosia-
for- both- objects- and- faces- (Chan- et- al.,- 2009;- Garrido- et- al.,- 2009).- These- non%verbal-
deficits-often-become-more-apparent-with-time-in-svPPA-and-in-some-cases-may-be-the-
presenting- feature,- as- in- a- right%side- predominant- svPPA.-Data- from- the- current- study-
would-suggest-that-prior-concepts-of-svPPA-being-a-predominantly-unilateral-disease-are-
incorrect-and-that-overtime-it-evolves-to-involve-the-contra%lateral-hemisphere,-possibly-








finding- of- superior- longitudinal- fasciculus- involvement- is- of- particular- interest- as- this-
tract-has-been- identified-as-a-key-structure- involved- in-both-articulation-of- speech-and-
phoneme- encoding- for- speech- (Davtian- et- al.,- 2008;- Han- et- al.,- 2014).- The- superior-
longitudinal- fasciculus- is- a- long- intra%hemispheric- tract- and- is- likely- to- support- a-
distributed-speech-production-network-connecting-brain-regions-traditionally-associated-
with- speech- production- (i.e.- Broca’s- area),- with- regions- such- as- the- parietal- lobe- and-
cerebellum,-which-are- increasing-recognised-as-areas-that-modulate-speech-production-
(Simonyan- and- Fuertinger,- 2015;- van- Geemen- et- al.,- 2014).- The- discrepancy- between-
cross%sectional-and- longitudinal-differences-was-most-notable-within- the-nvPPA-group.-
This- may- suggest- that- the- trajectory- of- nvPPA- may- be- somewhat- multiphasic- with-








of- these-differences-may-be-explained- in-part-by- the-smaller- size-of- this-group,-and-of-
course- given- this- small- group- size- these- results- should- be- viewed-with- some- caution.-






As- outlined- previously- it- is- unclear- if- one- particular- DTI- metric- offers- better-
specificity/sensitivity- than-another,- and- it-has-been-a-major-aim-of- the-current-work- to-
improve-our-understanding-of- this.- In- the-case-of-PPA-syndromes-a-somewhat-variable-




fasciculus- as- measured- with- MD- achieved- the- best- classification- (sensitivity- of- 91%,-





chapter- (see- Figures- 5.1- to- 5.3).- However- sensitivities- and- specificities-were- enhanced-
when- longitudinal- rates- of- change- were- used- to- classify- groups,- with- MD- and- AX-
performing-best,-and-enhanced-further-by-targeting-change-in-the-superior-longitudinal-
fasciculus- (right- SLF- sensitivity- 91%,- specificity- 85%).- - Finally- in- those- with- lvPPA,- AX-
appeared- to- perform- best- cross%sectionally,- achieving- up- to- 100%- sensitivity- and- 85%-
specificity-within- the-corpus-callosum,-although-there-was-poor-performance-across-all-
metrics- in- this- group- longitudinally.- As- pointed- out- in- the- previous- chapter- svPPA- is-






with- lvPPA- compared- to- other- PPA- groups,- suggesting- that- pathology- within- this-
structure-may-be-a- relatively- specific- feature-of- lvPPA.- This- region-was-not- considered-
longitudinally-as-following-review-of-raw-data-obtained-from-this-region,-an-unacceptably-
high- level-of- variation-between-subjects-was- seen,-which-may- reflect- limitations- in- the-
registration- of- this- small- and- complex- anatomical- structure.- The- pathological-
heterogeneity-of-nvPPA-may-also-explain-why-there-was-relatively-little-change-captured-
cross%sectionally,- but- when- intra%subject- comparisons- (rather- than- inter%subject-
comparisons)-are-made-there-is-a-greater-ability-to-detect-change.-Again-it-is-important-to-
point-out-that-the-choice-between-having-a-highly-sensitive-metric,-i.e.-a-test-that-screens-
a- population- for- disease,- or- a- highly- specific- metric,- i.e.- a- test- that- can- distinguish-
pathological- subtypes,- depends- on- the- question- being- asked.- If- the- purpose- of- the-
biomarker- is- to- simply- track- the-same-disease- longitudinally- than-a-highly- sensitive-DTI-
metric-may-be-required;-however-if-we-wish-to-compare-disease-biology,-or-the-effect-of-
a- particular- treatment- across- multiple- pathologies,- a- more- specific- marker- may- be-









all- subtypes-of-PPA.-Particular- trajectories-of-pathological- change-have-been- identified-
for-individual-PPA-subtypes,-suggesting-longitudinal-DTI-may-have-a-role-as-an-outcome-
measure- for- clinical- trials- in- future.- This- potential- role- is- supported-by- the- sample- size-
estimates-calculated,-particularly-when-compared-to-more-traditional-outcome-measures-
such-as-whole-brain-atrophy.-The-cross%sectional-data-presented-here,-calculated-using-a-
different- methodology,- are- broadly- concordant- with- that- seen- in- chapter- 5.- The-
longitudinal- data- suggest- that- there- is- acceleration- of- white- matter- tract- pathology,-
particularly-in-contra%hemispheric-tracts-remote-to-areas-of-maximal-cross%sectional-grey-
and- white- matter- pathology.- In- svPPA- this- was- most- apparent- in- the- right- inferior-
longitudinal- fasciculus- and- uncinate- fasciculus;- in- nvPPA- this- was- apparent- within- the-
right-superior- longitudinal-fasciculus;-and- in- lvPPA-within-the-corpus-callosum-and-right-
inferior- longitudinal- fasciculus.- In- those-with-svPPA-and- lvPPA-both-cross%sectional-and-
longitudinal-DTI-performed-well-in-separating-PPA-from-healthy-controls,-this-was-not-the-
case- in- those-with- nvPPA-where- longitudinal- analysis-was-more- sensitive- and- specific.-
The-current-study-also-adds-further-support-to-the-concept-that-DTI-metrics-may-signal-








Over- the- past- number- of- decades- our- understanding- of- the- collection- of- clinical- and-
pathological- syndromes- that- make- up- FTLD- has- evolved- rapidly.- New- proteins- and-
molecular-mechanisms-have-been-identified,-new-genetic-mutations-uncovered-thanks-to-
next- generation- sequencing,- novel- frameworks- for- understanding- how- these- diseases-
start-and-evolve,-thanks-to-complex-mathematical-techniques-such-as-graph-theory.-The-
next-major-challenge-to- the-scientific-community- is- to-apply-many-of- these-clinical-and-
basic- science- discoveries- to- develop- biomarkers,- which- can- accurately,- diagnose- and-










4 Establish-the-sensitivity-and-specificity-of- individual-DTI-metrics- in-the-monitoring-of-
FTLD.-
Regarding- aim- 1- this- study- has- demonstrated- that- DTI- can- be- applied- to- study- white-
matter- pathology- in- patients-with- bvFTD- and-PPA,-with- potential- practical- advantages-
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including- availability- and- tolerability- by- patients,- and- its- biological- application- in-
identifying- syndrome- specific- profiles- of- white- matter- pathology- cross%sectionally- and-
trajectories- of- white- matter- change- longitudinally.- These- studies- further- refine- the-
neuroimaging- phenotype- of- bvFTD- and- PPA- by- providing- detailed- profiles- of- white-
matter- tract- pathology,- which- may- aid- in- the- diagnosis- and- monitoring- of- these-
conditions.-Tables-7.1-and-7.2-provide-an-overview-of- the-profiles-of-white-matter- tract-
pathology- identified- longitudinally- and- cross%sectionally.- - Across- the- bvFTD- group- we-
note- bilateral- antero%ventral- white- matter- tract- pathology.- A- key- finding- was- the-
involvement-of-the-cingulum-bundle-across-subtypes-of-bvFTD,- indicating- it- likely-has-a-
key- role- in- modulating- the- clinical- phenotype.- The- absence- of- strongly- asymmetric-
profiles-of-white-matter-tract-pathology-is-perhaps-somewhat-surprising,-given-that-FTLD-
is- commonly-associated-with-an-asymmetric-neuroimaging-phenotype,- this-may- in-part-
relate-to-either-the-absence-of-the-GRN$mutations-which-are-the-most-asymmetric-of-the-
FTLDs,-or-more-generally-it-may-relate-to-the-sensitivity-of-DTI-in-detecting-pathological-




fasciculus- in- nvPPA- and- all- three- of- the- above- tracts- and- the- fornix- in- lvPPA.- Again-
perhaps-an-unexpected-finding-is-the-degree-of-pathological-white-matter-tract-change-
within- the- right- (non%language)- hemisphere.- Again- this- signifies- that- DTI- may- offer-
greater- sensitivity- in- detecting- pathology,- but- also- that- strucutural- changes- in- PPA-














extent- of-white-matter- tract- pathology-was- greater- than- that- of- grey-matter- atrophy,-
although-the-most-significant-areas-of-white-matter-pathology-were-co%localised-to-sites-
of- maximal- grey- matter- atrophy,- supporting- the- notion- that- there- is- a- common-
degenerative- process- resulting- in- pathological- change- to- both- grey- and-white-matter.-
Overall,- there- is- compelling- evidence- across- for- anatomically- distributed- patterns- of-
white- matter- tract- pathology,- which- is- in- line- with- the- notion- that- FTLD- (and- other-
neurodegenerative-syndromes),- target- large%scale-brain-networks,-which- in- the-current-
study- is- signalled- by- disintegration- of- distributed- structural- networks,- occurring- in-
advance-of-grey-matter-atrophy.-The-concept-of-white-matter- involvement-being-a-key-
feature- in- the- FTLDs- is- also- based- on- the- numerous- imaging- studies- reporting- wide-
spread-white-matter-tract-pathology-(Agosta-et-al.,-2011;-Galantucci-et-al.,-2011;-Lam-et-al.,-
2014;-Whitwell-et-al.,-2010),-as-well-as-histopathological-data-which-provide-evidence-of-
pathogenic-proteins- localised- to-white-matter- (Hiji- et- al.,- 2008;-Neumann-et- al.,- 2007).-
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identifying- an- abnormality- in- the- first- instance)- and- specific- (i.e.- correctly- classifying-
those-with-FTLD-from-controls)-measure-of-pathology.- It-should-be-noted-that- in-some-
instances- specific- DTI- metrics- did- not- necessarily- fulfil- criterion- to- be- a- suitable-
biomarker,- for- example- in- those-with- lvPPA- the- FA- change- in- the- copus- callosum-only-
reached-an-AUC-of-0.7.-However-it-is-only-through-these-assessments-that-we-will-begin-
to- form- an- understanding- of- how- each- metric- relates- to- particular- syndromes- and-
pathologies,- and- by- doing- so- we-will- have- a- better- understanding- of- the- relationship-
between-changes-occurring-within-axons-and-changes-seen-on-DTI.-On-the-other-hand-a-
specific- merit- of- DTI,- over- other- imaging- methods,- is- that- it- results- in- a- quantitative-
measure,-meaning-it-may-have-a-role-as-a-personalised-biomarker,-rather-than-say-fMRI-






white- matter- tract- pathology- in- bvFTD- and- PPA?- This- was- perhaps- the- most- difficult-
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question-asked-by-this-study,-particularly-as-specific-hypotheses-on-the-role-of-individual-
DTI- metrics- are- lacking.- Table- 7.3- compares- the- overall- performance- of- individual- DTI-
metrics-in-this-study.-DTI-metrics-were-assessed-in-all-disease-groups,-both-longitudinally-
and- cross%sectionally.- RD- seemed- to- offer- the- best- overall- sensitivity- in- terms- of- both-
extent-and-magnitude-of-pathological-change.-Some-differences-did-appear-on-subgroup-
analysis;- for- example- FA- appeared- to- have- better- qualities- in- monitoring- longitudinal-




greater- specificity- than- other-metrics.- In- addition,- AX- performed- relatively- better- as- a-
measure-of-white-matter-pathology-in-those-with-lvPPA-indicating-it-may-have-a-greater-
specificity- for- particular- histopathologies- such- as- AD,- or- perhaps- tauopathies,- as- on-




Whilst- it-must-be-acknowledged- that-much-of- the-above-suggestions-are-hypothetical,-
given- the- lack- of- histopathological- correlation,- it- is- at- least- worth- pointing- out- that-
technical-modifications-(such-as-correcting-for-global-DTI-mean)-can-provide-substantially-
different- results,-and-as-such-warrant- further-evaluation,-particularly-when-deciding-on-






the- utility- of- individual- DTI- metrics- in- FTLD.- Of- course- the- downside- of- this- is- large-









Tract( All(bvFTD( MAPT( C9ORF72( All(bvFTD( MAPT( C9ORF72(
R-UF- ++++- +++- - ++- +++- --
L-UF- ++++- +++- - ++- ++- ++-
R-CB- ++++- ++- - +- ++- --
L-CB- ++++- ++- +- +- ++- --
R-ILF- +++- +- - -- - --
L-ILF- ++- +- - -- - --
CC- +++- ++- +- +- ++- +-
R-CST- +- - - +- - --
L-CST- -- - - -- - --
Fornix- ++- ++- -- -- -- --
Table&7.1&Overview&of&WM&tract&involvement&in&bvFTD&cross@sectionally&and&longitudinally&based&on&FA&data.&











Tract( SvPPA( NvPPA( LvPPA( SvPPA( NvPPA( LvPPA(
CC- ++++- +++- -++++- ++- +++- --
ILF-R- ++++- +++- -++++- ++- ++- ++-
ILF-L- ++++- ++- -++++- +- ++- --
SLF-R- ++++- ++- +++- +- ++- --
SLF-L- +++- +- -+++- -- -- --
UF-R- ++- +- -+++- -- -- --
UF-L- +++- ++- ++++- +- ++- +-
Fornix- -- -- ++- ns- ns- ns-
Table&7.2&Overview&of&WM&tract&involvement&in&PPA&cross@sectionally&and&longitudinally&based&on&FA&data.&









-- All(bvFTD( SvPPA( NvPPA( LvPPA(
Cross?sectional( -- -- -- --
FA- ++- ++- +- +-
MD/TR- ++- ++- +- ++-
RD- ++- ++- +- +-
AX- +- ++- +- ++-
Longitudinal( -- -- -- --
FA- ++- +++- ++- %-
MD/TR- ++- ++- +++- +-
RD- ++- ++- ++- +-












brain- networks- is- a- key- factor- in- the- neurobiology- of- bvFTD- and- PPA.- Examining- the-
change-across-structural-brain-networks-may-offer-a-more-useful-way-of-tying-together-
proteinopathies,- clinical- symptoms- and-macroscopic- brain- atrophy,- or- indeed-multiple-
discrete-regions-of-atrophy-or-reduce-functionality-(Warren-et-al.,-2013;-Zhou-et-al.,-2012).--
Figure- 7.1- provides- an- overview- of- pathological- changes- to- normal- brain- networks-
identified-in-the-current-study,-and-highlights-the-extent-of-white-matter-tract-pathology-
across- each- syndrome,- and- provides- a- framework- for- explaining- how- cognitive-
dysfunction-may-occur-in-areas-remote-to-maximal-grey-matter-atrophy.-Historically-it-has-
long- been- held- that- damage- to- structural- connections- within- the- brain- can- lead- to-
specific- clinical- syndromes,-with-Geschwind,- the-most-prominent- ‘connectionist’-of- the-
twentieth- century,- describing- multiple- disconnection- syndromes.- One- aspect- of-
Geschwinds'- research- seems- relevant- to- the- current- study:- the- concept- that- lesions-
within-white-matter-association-tracts-would-also-result- in-a-‘lesion’-within-the-cortex-it-
connects,- particularly- emphasising- higher- cortical- functions- such- as- behaviour- and-
language,-and-further-that-lesions-within-association-cortex,-which-are-region-that-show-
high- interconnection,- may- also- lead- to- widespread- widespread- cognitive- demise-
(Geschwind,-1965).--More-recently-Geschwinds-theories-on-disconnection-between-brain-
regions- have- been- updated- to- reflect- new- evidence- on- brain- connectivity- based- on- a-
multidiude- of- functional- and- structural- imaging- studies- as- well- as- high- quality- animal-
tracing- studies- (Schmahmann- et- al.,- 2007).- These- new- theories- reflect- the- fact- the-
connections-can-work-in-a-feed%forward-and-feed%back-fashion-(Geshwinds-view-was-that-
‘information’- flowed- from- temporoparietal- regions- exclusively- anterogradely- towards-
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limbic- regions),- as- well- as- excerting- both- inhibitory- and- excitatory- functions- (Catani,-
2007;-Catani-and-ffytche,-2005;-Warren-et-al.,-2013).--In-addition-our-understanding-of-the-
role-of-association-cortex-has-also-been-updated,-to-reflect-the-fact-that-many-of-these-
regions- anatomically- overlap- with- network- hubs,- which- have- a- central- position- in-
integratrion- and- disementaion- of- ‘information’- throughout- brain- networks,- and- when-
damaged-or-disconnected-can-result-in-widespread-cognitive-failure-(van-den-Heuvel-and-
Sporns,- 2013).- Whereas- Geschwind- tended- to- focus- on- disconnection- between- long%
range- association- tracts- newer- models- also- emphasise- the- fact- that- cognitive-
dysfunction-can-also-result-from-failure-of-short%range-connections-within-intraterritorial-
regions.- Additionally- these-models- also- allow- an- explanation- for- cognitive- dysfunction-
based- hyperconnectivity- between- brain- regions- –- either- through- loss- of- inhibitory-
connections,- damage- to- regions- involved- in- gating- certain- modalities- or- through- on-











relative-weakness- is- that- it- can- not- continusouly-monitor- changes- in- diffusion- in$ vivo,$
neither- does- it- tell- us- what- are- the- mechanisms- which- result- in- both- baseline- and-
longitudinal-white-matter- pathology.-A- number- of-mechanisms-may- support- a- gradual-
spatial-evolution-of-disease,-possibly-facilitated-by-cognitive-networks,-and-may- include-
transynaptic-spread-of-toxic-proteins,-wallerian-degeneration,-or-loss-of-trophic-support-
from- downstream- network- components,- which- have- undergone- degeneration-
(Clavaguera- et- al.,- 2013;- Pievani- et- al.,- 2011).- This- tracjectory- of- change- shares- some-
commonality- with- longitudinal- grey- matter- changes,- and- whilst- not- assessed- in- this-
study,-previous-studies-have-shown-that-acceleration-in-grey-matter-atrophy-also-occurs-
in- regions- contralateral- to-baseline- regions-of- atrophy- (Faria- et- al.,- 2014;-Rohrer- et- al.,-
2008;-Rohrer-et-al.,-2013),-supporting-the-idea-that-initial-focal-damage-(or-disconnection)-
can- lead- to- remote- cortical- damage- and- progressive- cognitive- dysfunction.- The-
mechanisms- for- this- are- unclear- but- it- is- plausible- that- white- matter- pathology- may-
facilitate- downstream- grey- matter- damage,- leading- to- further- deterioration- in- higher-
cognitive-abilities.-As-mentioned- in-previous- chapters- it- is-unlikely- that-white-matter- is-
the- sole- driver- of- pathology- in- FTLD,- however- it- is- increasingly- clear- that- it- plays- an-
important- role,- likely- in- concert- with- grey- matter,- to- result- in- particular- clinical-
phenotypes.- - This- ‘disconnection’- between- brain- regions,- is- evidenced- in- the- current-
study-by-the-extent-of-white-matter-tract-pathology-compared-with-grey-matter-atrophy,-
and-may-explain-why-there-is-deterioration-in-parietal-skills-such-as-space-perception,-in-









most- complex- cognitive- tasks- result- from- synchronous- brain- activity- across- multiple-
brain-regions-(Cabeza-and-Nyberg,-2000).-Therefore-the-concept-of-cognitive-demise-due-
to- loss- of- connectivity- between- these- brain- regions- is- plausible- (Greicius- et- al.,- 2004;-
Hornberger-et-al.,-2012;-Seeley-et-al.,-2009).-Somewhat-more-hypothetical- is-the-notion-
that- the- initial- phase- of- neurodegeneration- involves- toxic- proteins- targeting- specific-
brain- networks,- and- that- these- networks- have- certain- characteristics- that-make- them-
tractable- to- certain- proteinopathies- (possible- reasons- for- this- are- discussed- in- the-
opening-chapter).-Following-this- initial- insult-abnormal-proteins-may-then-either- impair-
normal- cellular-process- such-as-axonal- transport,- leading- to- local-axonal-degeneration,-
and-then-either-spread-to,-and-ultimately-damage,-other-brain-regions-via-direct-(white-
matter-tracts)-or-indirect-(i.e.-loss-of-input-from-other-functional-networks)-connections-
(Raj- et- al.,- 2012;- Warren- et- al.,- 2012).- This- concept- of- abnormal- proteins- spreading-




tau- has- a- templating- effect- (i.e.- one- abnormal- isoform- of- tau- can- induce- changes- in-
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healthy- tau)- and- the- ability- to- spread- along- axons- and- cross- synapses- (Goedert- et- al.,-
2014;- Liu- et- al.,- 2012).- Yet- despite- this- acquired- pathogenicity- of- tau- in- certain-
tauopathies,- such- as- AD- or-MAPT$mutations,- tau- propagation- seems- to- follow- a- fairly-
ordered- anatomical- pattern- (see- Figure- 1.2),- rather- than- say- uniformly- diffusing-
throughout-the-brain.-It-may-be-that-physical-barriers-and-compartments-within-the-brain-
constrict-the-spread-of-disease;-or- it-may-be-that-spread-is,-at- least- initially,-confined-to-
particular-brain-networks.-The-role-of-networks-in-neurodegeneration-is-underpinned-by-
the- fact- that- patients- with- bvFTD- who- have- significant- frontal- atrophy,- have- normal-
activations-within-their-default-mode-network,-which-involves-prefrontal-cortex-(Zhou-et-
al.,- 2010);- whilst- patients- with- AD,- who- have- a- significant- burden- of- amyloid- and- tau-
pathology-within-their-frontal-lobes-(Klunk-et-al.,-2004)-overlapping-areas-of-the-salience-
network,- show-normal-or- increased-activations- in- this- region- (Agosta-et-al.,- 2012).- This-
suggests-that-a-mechanism-beyond-either-focal-grey-matter-atrophy-or-the-presence-or-
absence-of-a-particular-protein-is-required-to-facilitate-neurodegeneration,-both-clinically-
and- histopathological.- The- current- studies- provide- some- support- for- this- given- that-
syndrome-specific-signatures-of-white-matter-pathology,-which-signal-structural-network-
degeneration- between- functional- brain- regions,- were- identified.- Over- time- syndrome-
specific- trajectories- of- white- matter- pathology,- linking- dysfunctional- brain- regions- to-
relatively-more- functional- brain- regions- also- emerged.- Providing- evidence- that- certain-
clinical- syndromes- show- specific- trajectories- of- white- matter- pathology,- rather- than-






the- most- important- measure- will- be- halting- the- degenerative- process- or- indeed- an-
improvement- in- symptoms;-however- from-previous-experience-with-disease-modifying-
treatments,- such- as- Bapinizumab- in- AD- (Salloway- et- al.,- 2014),- we- know- that-
neuropsychological- and- clinical- measures- may- not- actually- improve;- whilst- it- is- still-
possible- that- a- particular- treatment- has- a- disease- modifying- effect,- at- least- at- a-
pathological- level,- and- it- is- therefore- important- to- have- other- biomarkers- available- to-




as- an- outcome- measure- for- a- number- of- neurological- conditions,- in- particular- in-
Alzheimer’s- disease,- firstly- as- a- safety- endpoint,- with- the- ability- to- detect- treatment-
related-problems-such-as-amyloid-related-imaging-abnormalities-related-to-monocloncal-
antiobodies,-but-also-as-secondary-endpoints-to-determine-clinical-efficacy-of-a-particular-
treatment- (Cash- et- al.,- 2014).- However- based- on- larger- population- studies- structural-
imaging- still- requires- 100%200- subjects- per- treatment- arm- to- detect- large- changes-
(approximately- 25%- reduction)- in- brain- atrophy,- providing- challenges- in- terms- of-
recruitment-and-cost-(Weiner-et-al.,-2012).-Furthermore-whilst-the-FDA-are-open-to-using-
surrogate%endpoints- such- as- imaging- to- accelerate- treatments- in- neurodegenerative-
disorders,-there-remains-an-ongoing-lack-of-robust-data-to-confirm-a-strong-correlation-






an- important- role- as- outcome-measures,- and-may- complement- novel- imaging-metrics-
such- as- DTI.- The- data- from- the- current- study- identifies- DTI- as- a- useful- metric- cross%
sectionally- and- longitudinally,- offering- levels- of- sensitivity- and- specificity- comparable-
with- other- accepted- biomarkers- in- other- neurodegenerative- conditions- (Shaw- et- al.,-
2007).-This-is-of-importance-as-it-has-been-difficult-to-identify-robust-biomarkers-in-FTLD-




data- including- structural- imaging,- novel- neuropsychological- paradigms- and- wet-
biomarkers- including- CSF- and- blood;- indeed- it- is- noteworthy- that- large- differences- in-
sample- sizes- between- bvFTD- and- PPA- were- observed,- possibly- due- to- the- greater-








is- unlikely- to- have- sampled- the- full- range- of- patients-with- FTLD- syndromes,- as- such- a-
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degree-of-assertainment-bias-is-likely-to-have-occurred.-Equally-patients-within-the-severe-
spectrum- could- not- be- sampled- owing- to- inability- to- consent- and- perform- even- basic-
elements- of- the- assessment.- Indeed- several- subjects- included- had- elements- of- their-
imaging-excluded-due-to-excessive-motion-artefact,-again-meaning-that-those-with-more-
behavioural- phenotypes- are- perhaps- under- represented- within- the- study- population.-
Whilst-the-current-study-hypothesises-that-the-signatures-of-white-matter-pathology-may-
relate- to- specific- underlying- molecular- pathologies,- there- is- a- paucity- of- confirmed-
histopathological- data-within- the- current- disease- cohort.- Larger- studies- encompassing-
the-broad-range-of-genetic-and-pathological-subtypes-will-be-required-to-confirm-these-
putative-molecularly-defined-white-matter-profiles-of-pathology.-In-particular-the-lack-of-
patients- with- PGRN$mutations- is- noteworthy,- as- this- is- one- of- the- three- major- genes-
associated- with- FTLD- pathology.- More- broadly- there- is- a- poor- understanding- of- the-
relationships- between- the- cellular- histopathology,- including- the- presumed- underlying-
axonal-degeneration-and-demyelination-and-the-changes-observed- in$vivo$ imaged-using-
DTI.-Whilst-the-current-study-posits-that-certain-changes-may-reflect-axonal-degeneration-
or- demyelination- we- do- not- as- yet- have- precise- enough- data- to- confirm- these-
assumptions.-This-will-be-a-difficult-challenge-given-that-post%mortem-brains-are-likely-to-
take-on-different-characteristics-to-those-imaged-in-living-subjects-however-an-important-
study- in- the- longer%term- will- be- one- involving- pre%mortem- and- post%mortem- imaging-
comparisons- in- the- same- individuals,- comparing- changes- seen- in- vivo- with- higher-
resolution-post%mortem-imaging-and-then-further-comparing-these-changes-with-cellular-
histopathology- using- stereotactic- approaches- to- maximise- co%localisation- of- imaging-
regions- with- anatomical- dissection.- Additional- techniques- such- as- combining- imaging-
with-post%mortem-tract- imaging-techniques-such-as-autoradiography-may-also- improve-
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is- likely- that- these- studies-do-not- capture- the-entirety-of-white-matter-pathology.- The-
current- study- focused- on- providing- greater- anatomical- specificity- by- choosing- certain-
ROIs- to- study,- in- particular- long%range- association- tracts- and- commissural- fibres.- It- is-
plausible,- however- that- shorter- range,- intra%nodal,- white- matter- tracts- play- a- role- in-
disease-pathology,-perhaps-playing-an-early-role-in-disruption-of-local-networks,-an-event-
which- may- precede- failure- of- long%range- association- fibres.- Improvements- in- imaging-
acquisition-and-analysis,-such-as-the-recently-proposed-neurite-orientation-dispersion-and-
density- imaging- (NODDI)- (Zhang-et-al.,- 2012),-may-yield- improved-data-and-allow-us- to-
better- resolve- juxta%cortical-white-matter- tracts.-Other- technical- limitations-of-DTI- also-
exist,- including-the-issue-of-crossing-or-kissing-fibres.-This-poses-a-particular-problem-in-
assessing-tracts-that-lie-in-close-proximity-to-one-another,-such-as-the-anterior-sections-of-
the- inferior- longitudinal- fasciculus- and- uncinate- fasciculus.- Techniques- such- as-
tractography- and- directionally- dependent-measurement-may- improve- the- reliability- of-
assessments-in-these-regions-(Jbabdi-et-al.,-2010).--
-
A- further-major- question-posed-by- this- current- study- is-whether-white-matter- or- grey-
matter-pathology-occurs-first,-or-indeed-simultaneously.-Whilst-the-current-data-suggests-
that- DTI- can- detect- more- widespread- white- matter- tract- pathology,- different-
methodologies- were- used- to- assess- white- and- grey- matter- changes,- so- direct-
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comparisons- are- difficult- to- make,- despite- the- current- study- using- similar- statistical-










diffusion- tensor-model- is- relatively- simplistic-and-makes-a-number-of-assumptions- that-
may- not- be- accurate- in- the- diseased- brain.- Given- issues- such- as- highly- non%normally-
distributed- data- (reflected- by- high- SD- values- in- some- of- the- previous- experiments),-
perhaps-not-surprising- in-syndromes-as-heterogenous-as-FTLD,- imaging-methods-which-
better- take- account- of- non%Gaussian- distributions- may- be- better- suited- to- studying-
diseased- brains.- One- emerging- imaging- method- is- diffusion- kurtosis- imaging- (DKI)-
(Jensen- et- al.,- 2005),-which- aims- to- characterise- the- degree- of- diffusion- that- deviates-
from-a-normal-distribution.-Additionaly-DKI-seems-to-provide-better-a-better-assessment-
of-what- is- occurring- in-white-matter,- and- is- less- affected- by- contamination- from- grey-
matter-and-CSF-containing-voxels.-By-combining-data-acquired-from-DTI-and-DKI-a-better-
model-of-diffusion-in-complex-tissue-structures-may-be-acquired.-Limited-data-is-available-
but- one- encouraging- study- in- an-APP-mouse-model- of- Alzheimer’s- disease- has- shown-
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that- reductions- in-DKI-occur- in- areas-of-high-amyloid-deposition- in- the- absence-of-DTI-
changes-(Vanhoutte-et-al.,-2013).-
-
Whilst- lower- sample- size- estimates-were-obtained- compared- to- volumetric- imaging-or-
neuropsychology-numbers-overall- numbers- for- clinical- trials- remain-quite-high- creating-
practical-implications-for-any-disease-modifying-trials.-Approachs-to-reduce-sample-sizes-
will- be- required- through- improved- phenotyping- of- syndromes- by- applying-multimodal-
clinical- and- imaging- data.- Importantly- in- order- for- DTI- to- be- a- potentially- useful-
biomarker- with- a- possible- role- as- a- surrogate- outcome- measure,- it- must- be- able- to-
capture-clinically-relevant-changes,-which-allow-it-to-accurately-predict-clinical-outcomes.-
For-example- if-a-20%- reduction- in- the- rate-of-change-of-FA- in-a-white-matter- tract-was-
shown- to- result- in- a- decline- or- stabilisation- in- a-measure- reflecting- cognitive- change,-
whilst- requiring- fewer- subjects- to- achieve- statistical- significance,- then- this-may- be- an-
appropriate-surrogate-end-point-for-a-clinical-trial.-This-study-does-not-correlate-clinical-
measures- with- changes- in- white- matter- and- this- is- clearly- an- important- issue- going-
forward.-One-reason-this-is-lacking-from-the-current-study-relates-to-the-fact-that-robust-
clinical- outcome-measures- are- relatively- few- in- FTLD.- Clincal- heterogeneity- as- well- as-
highly-variable-measures-such-as-disease-duration-have-created-difficulty- in-establishing-
reliable- clinically- outcome- measures.- Recently- measures- such- as- the- Frontotemporal-
dementia- rating- scale- have- been- introduced- to- provide- better- accuaracy- regarding-
disease-stage- (Mioshi-et-al.,- 2010).- -However- in- the-current- study-correlations-of- these-
disease- stages- with- white- matter- pathology- is- lacking,- and- this- is- a- clear- priority,-




and-white-matter-and-may- in- turn-provide- for-better-development-of-clinical-measures-
which- track- the- progression- of- FTLD,- although- of- course- there- is- a- need- to- avoid-
circularity-with-such-techniques.-Whilst-the-role-of-grey-matter-and-lobar-atrophy-has-not-





used- to- seed- a- tractography- model- to- allow- a- better- understanding- of- the- inter%
relationship- between- functional- and- structural- network- degeneration.- A- possible-
problem-with-DTI-is-that-is-may-be-too$sensitive,-and-therefore-in-presymptomatic-clinical-
trials- it-may- result- in- over- inclusion- of- subjects,- perhaps- exposing- them- to- hazardous-
compounds.-However-if-measures-of-whole-brain-volume-or-cortical-thickness-were-also-






regression- models- with- basic- nussaince- co%variates.- Whilst- regions- of- interests- were-




for- future- studies.-One- reason- for- this- approach-was- that- clear- guidance- on- the-most-
appropriate- statistical-models- for- large-volume-datasets,- such-as- those-produced- from-
DTI-analysis-are-lacking,-leading-to-a-variety-of-statistical-approaches-(Jones-et-al.,-2013).-
Validation- and- agreement- of- common- statistical- approaches- (and- indeed- other-
methodologies)- across- research- centres- is- a- clear- goal- for- neuroimaging- community.-
Beyond- the- need- for- the- introduction- in- common- standards- there- is- also- the- need- to-
evolve-statistical-techniques-that-can-better-take-account-of-the-complexity-of-changes-




data,- may- be- of- particular- value- in- syndromes- like- FTD- with- its- diverse- range- of-





us- to- conseptualise- these- network- interactions- in- a- simple- manner.- A- benefit- is- that-
multiple-metrics-can-be-used-as-inputs-to-the-graph,-combining-DTI,-volumetric-MRI,-fMRI-
and-even-data- from-cell- cultures-such-as-electrode-spike- timing- recordings.-These-data-
can-then-be-used-to-create-a-map-of-there-inter%relations,-using-an-adjacency-matrix,-and-
from- this- construct- a- brain- graph- from- which- information- on- the- strength- of- brain-
connectivity-can-be-derived.-Combining-multiple-metrics-within-one-statisitical-model-will-
!220!$
provide- for- greater-multidimensionality- of- data- and-may-provide- a- better- reflection-of-
the-complex-changes-that-are-occurring-within-the-white-matter-microstructure.-
-




within- multi%model- analysis- pipelines- (Vergara- et- al.,- 2014).- New- emerging- imaging-
technologies-utilising-optogenetics-and-nanoparticles-may-also-provide-opportunities-to-
study-molecular- changes- owing- to- alterations- in- gene- expression- (Mehta- et- al.,- 2014),-















1. Improving- statistical-models,- using- techniques- such- as- support$ vector$machines-
and- graph- theory,- with- inclusion- of- other- modes- of- data- (e.g.- whole- brain-
atrophy,-cortical-thickness-etc.),-in-a-multivariate-analysis-pipeline.-
2. Expand-studies-to-include-presymptomatic-mutation-carriers.-
3. Develop- new- acquisition- parameters,- such- as- NODDI- and- DKI,- and- acquire-








3. Establish- if-diffusion- imaging-has-a- role-as-an-outcome-measure- in- clinical- trials-
and- use- along- with- more- conventional- imaging- measures- as- therapeutic-
interventions-emerge.-
-
This- thesis- provides- a- comprehensive- account- of-white-matter- tract- changes- in- bvFTD-
and-PPA-utilising-sophisticated-imaging-techniques-to-ensure-robust-data-are-presented.-
It- is- hoped- this- data-will- support- the- development- of- DTI- as- useful- imaging-modality,-
both-at-a-clinical-and-systems-neuroscience-level-and-will-be-of-use-to-other-researchers-
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The- author- conceived,- designed- and- recruited- individuals- for- this- study.- Clinical- and-
neuropsychological-evaluations-were-carried-out-by-the-author;-with-additional-support-
provided-by-Ms-Aisling-Buckley,-Dr-Laura-Downey-and-Ms-Hannah-Golden.- -The-author-
performed-analysis-of-DTI-data-using-TBSS-analysis-with-additional- technical- support- in-




The- author- conceived,- designed- and- recruited- individuals- for- this- study.- The- author-
performed-longitudinal-DTI-image-analysis-with-additional-technical-support-from-Dr-Ivor-

















































• Profiles- of-white-matter- tract- pathology- in- frontotemporal- dementia.-Mahoney-
CJ,-Ridgway-GR,-Malone-IB,-Downey-LE,-Beck-J,-Kinnunen-KM,-Schmitz-N,-Golden-
HL,- Rohrer- JD,- Schott- JM,- Rossor-MN,-Ourselin- S,-Mead- S,- Fox-NC,-Warren- JD.-
Hum-Brain-Mapp.-2014-Aug;35(8):4163%79-
• Frontotemporal- dementia- with- the- C9ORF72- hexanucleotide- repeat- expansion:-
























• Longitudinal- diffusion- tensor- imaging- in- the- primary- progressive- aphasias.-
Mahoney-CJ,-Simpon-IJ,-Golden-HL,-Downey-LE,-Fletcher-PF,-Fox-NC,-Warren-JD.-
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-
-
